Sentence,class,file
"269 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL In and Lee  Table presentation Tables, which convey information that has been converted  into words or numbers in rows and columns, have been used for  nearly 2,000 years.",OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
1)Instructions to authors in KJA; section 5-(9) Table; https://ekja.org/index.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
270 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
271 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL In and Lee  of being represented aside from a table (i.e.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
272 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
273 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL In and Lee  dispersion in the data.,OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
274 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
"ORCID Junyong In, http://orcid.org/0000-0001-7403-4287Sangseok Lee, http://orcid.org/0000-0001-7023-3668  References  1.",Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
Sci Ed 2014; 1: 58-61.2)Instructions to Authors in KJA; section 6-1)-(10) Figures and illustrations  in Manuscript preparation; https://ekja.org/index.php?body=instruction,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
275 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL In and Lee  Appendix Output for Presentation  Discovery and communication are the two objectives of data  visualization.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
"While vector images are used by researchers when working  3)Instructions to Authors in KJA; section 6-1)-(10) Figures and illustrations  in Manuscript preparation; https://ekja.org/index.php?body=instruction 4)Resolution; in KJA, it is represented by “contrast.",Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
276 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/75/41/kjae-70-267.PMC5453888.pdf
"Jae Hoon Oh, Woo Jong Shin, Suin Park, and Kyoung Hun Kim Department of Anesthesiology and Pain Medicine, Hanyang University College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Woo Jong Shin, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Hanyang University Guri Hospital, 153, Gyeongchun-ro, Guri 11923, KoreaTel: 82-31-560-2400, Fax: 82-31-563-1731Email: swj0208@hanyang.ac.krORCID: http://orcid.org/0000-0002-3786-2267  Received: December 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
Korean J Anesthesiol 2017 June  70(3): 277-291 https://doi.org/10.4097/kjae.2017.70.3.277,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
278 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
279 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
280 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
281 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
282 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
283 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
284 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
"ORCID Jae Hoon Oh, http://orcid.org/0000-0003-2129-2033 Woo Jong Shin, http://orcid.org/0000-0002-3786-2267  References 1.",Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
285 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
286 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
287 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
288 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
289 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
290 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
291 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Oh et al.,OADS,/arxiv_data1/oa_pdf/fc/08/kjae-70-277.PMC5453889.pdf
"Key Words: Amnesia, Anxiety, Benzodiazepines, Premedication, Triazolam.The effect of triazolam  premedication on anxiety, sedation,  and amnesia in general anesthesia Taehee Pyeon1, Shiyoung Chung1, Injae Kim2, Seongheon Lee1, and   Seongwook Jeong1 Departments of 1Anesthesiology and Pain Medicine, 2Molecular Medicine, Chonnam National University Medical  School, Gwangju, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Seongwook Jeong, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Chonnam National University Medical School, 42, Jebong-ro, Dong-gu, Gwangju 61469, KoreaTel: 82-62-220-6895, Fax: 82-62-232-6294Email: anesman@gmail.comORCID: http://orcid.org/0000-0002-1958-8436 Received: May 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
Korean J Anesthesiol 2017 June  70(3): 292-298 https://doi.org/10.4097/kjae.2017.70.3.292,Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
293 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Pyeon et al.,OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
"The study was approved by the Institutional Review  Board of our institution and National Research Institute of Health (KCT0001720, https://cris.nih.go.kr/cris/en/).",Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
294 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
295 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Pyeon et al.,OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
296 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
297 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Pyeon et al.,OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
"ORCID Taehee Pyeon, http://orcid.org/0000-0002-0749-7780 Injae Kim, http://orcid.org/0000-0002-7483-8469 Seongheon Lee, http://orcid.org/0000-0002-2675-2521 Seongwook Jeong, http://orcid.org/0000-0002-1958-8436 References 1.",Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
298 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/0b/ed/kjae-70-292.PMC5453890.pdf
"Key Words: Dexmedetomidine, Postoperative nausea and vomiting, Remifentanil.Postoperative nausea and vomiting  after thyroidectomy: a comparison  between dexmedetomidine and  remifentanil as part of balanced anesthesia Eun Kyung Choi1, Yijun Seo2, Dong Gun Lim2, and Sungsik Park2  Department of Anesthesiology and Pain Medicine, 1Yeungnam University College of Medicine, 2Kyungpook  National University School of Medicine, Daegu, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sungsik Park, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Kyungpook National University School of Medicine, 130, Dongdeok-ro, Jung-gu, Daegu 41944, KoreaTel: 82-53-420-5877, Fax: 82-53-426-2760Email: sspark@knu.ac.krORCID: http://orcid.org/0000-0001-5574-7513  Received: September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
Korean J Anesthesiol 2017 June  70(3): 299-304 https://doi.org/10.4097/kjae.2017.70.3.299,Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
300 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
301 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
302 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
303 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Choi et al.,OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
"ORCID Eun Kyung Choi, http://orcid.org/0000-0001-5758-6741Sungsik Park, http://orcid.org/0000-0001-5574-7513  References 1.",Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
304 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/2e/20/kjae-70-299.PMC5453891.pdf
"Key Words: Cholesterol, C-reactive protein, Infection, Mortality, Multiple organ dysfunction, Procalcitonin.The prognostic value of  procalcitonin, C-reactive protein  and cholesterol in patients with  an infection and multiple organ dysfunction Siarhei Anatolevich Tachyla, Alexey Viktorovich Marochkov,   Artur Leonidovich Lipnitski, and Yulia Gennadevna Nikiforova Department of Anesthesiology and Intensive Care, Mogilev Regional Hospital, Mogilev, Belarus CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Siarhei Anatolevich Tachyla, M.D.",Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
"Department of Anesthesiology and Intensive Care, Mogilev Regional Hospital, 12 Byalynitsky-Birulya Str., Mogilev  212026, BelarusTel: 375-222-500881, Fax: 375-222-500373Email: tsa80@inbox.ruORCID: http://orcid.org/0000-0003-1659-5902  Received: September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
Korean J Anesthesiol 2017 June  70(3): 305-310 https://doi.org/10.4097/kjae.2017.70.3.305,Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
306 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
307 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Tachyla et al.,OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
308 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
309 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Tachyla et al.,OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
310 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/13/23/kjae-70-305.PMC5453892.pdf
"Key Words: Opioid analgesics, Pain management, Pain measurement, Patient-controlled analgesia, Postoperative pain.Integration of pain scores,  morphine consumption and  demand/delivery ratio to evaluate  patient-controlled analgesia: the C-SIA score Federico Piccioni1, Andrea Doronzio2, Rossella Brambilla1, Marica Melis1,  and Martin Langer1,3 1Department of Anesthesia, Intensive Care and Palliative Care, Fondazione IRCCS Istituto Nazionale dei Tumori,  Milan, 2Intensive Care Unit, Policlinico San Marco, Zingonia, 3Department of Pathophysiology and Transplantation,  University of Milan, Milan, Italy CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Federico Piccioni, M.D.",Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
Korean J Anesthesiol 2017 June  70(3): 311-317 https://doi.org/10.4097/kjae.2017.70.3.311,Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
312 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
313 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Piccioni et al.,OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
3.1; http://www.gpower.hhu.de) [13].,Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
314 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
315 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Piccioni et al.,OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
316 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
317 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Piccioni et al.,OADS,/arxiv_data1/oa_pdf/56/50/kjae-70-311.PMC5453893.pdf
"Key Words: Change implementation, Nerve block, Perineural catheter, Regional anesthesia, Simulation, Ultrasound.Implementation of clinical  practice changes by experienced  anesthesiologists after simulation- based ultrasound-guided regional anesthesia training T. Edward Kim1,2, Toni Ganaway1,2, T. Kyle Harrison1,2, Steven K. Howard1,2,  Cynthia Shum2, Alex Kuo1,2, and Edward R. Mariano1,2 1Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford,  2Anesthesiology and Perioperative Care Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Introduction Performance of ultrasound-guided regional anesthesia  (UGRA) can be described as a sequence of steps that requires  integration of multiple technical and cognitive skills [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
"Anesthesiology and Perioperative Care Service, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue (112A), Palo Alto, CA 94304, USATel: 1-650-849-0254, Fax: 1-650-852-3423Email: emariano@stanford.eduORCID: http://orcid.org/0000-0003-2735-248X  Received: August 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
Korean J Anesthesiol 2017 June  70(3): 318-326 https://doi.org/10.4097/kjae.2017.70.3.318,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
319 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
It was registered at http://www.clinicaltrials.gov (NCT02295423).,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
320 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
"Statistical analysis Statistical analyses were performed with NCSS-PASS (Kaysville,  UT, USA) and R version 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
321 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
322 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
323 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
"ORCID T. Edward Kim, http://orcid.org/0000-0002-1183-3556 Edward R. Mariano, http://orcid.org/0000-0003-2735-248X   References 1.",Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
324 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
325 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
326 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/a4/f9/kjae-70-318.PMC5453894.pdf
"Key Words: Bibliometrics, Literature based discovery, Peer review, Plagiarism, Similarity index, Social media.Characteristics of the similarity  index in a Korean medical journal Seunghyun Chung1, Jeunghyuk Lee1, Y ounsuk Lee1,2, Ha Y eon Park1, and  Daehwan Kim1 1Department of Anesthesiology, Dongguk University Medical Center, 2D/M Statistics Institute, Dongguk University,  Goyang, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Y ounsuk Lee, M.D., Ph.D. Department of Anesthesiology, Dongguk University Medical Center, D/M Statistics Institute, Dongguk University, 27, Dongguk-ro, Ilsandong-gu, Goyang 10326, KoreaTel: 82-31-961-7872, Fax: 82-31-961-7864Email: dryl@icloud.comORCID: http://orcid.org/0000-0003-2488-5926 Received: January 3, 2017.",Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
Korean J Anesthesiol 2017 June  70(3): 327-334 https://doi.org/10.4097/kjae.2017.70.3.327,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
328 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
329 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Chung et al.,OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
330 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
331 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Chung et al.,OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
332 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
333 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Chung et al.,OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
"ORCID Seunghyun Chung, http://orcid.org/0000-0003-4602-2144Jeunghyuk Lee, http://orcid.org/0000-0001-6947-1669Y ounsuk Lee, http://orcid.org/0000-0003-2488-5926Ha Y eon Park, http://orcid.org/0000-0002-8347-349X  Daehwan Kim, http://orcid.org/0000-0002-3988-0987 1) What are Altmetrics?",Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
From http://www.altmetric.com/about-altmetrics/ what-are-altmetrics/,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
334 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/47/a1/kjae-70-327.PMC5453895.pdf
"Key Words: Anesthesia, Brain, Neurotoxicity, Pediatrics, Sevoflurane.Apocynin preserves glutamatergic  neurons in the basolateral  amygdala in mice with neonatal  sevoflurane exposure Zhongliang Sun1, Maiko Satomoto2, Yushi U Adachi2, and Koshi Makita1 Department of Anesthesiology, 1Graduate School of Medical and Dental Science, Tokyo Medical and Dental  University, Tokyo, 2Graduate School of Medicine, Nagoya University, Aichi, Japan CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Maiko Satomoto, M.D., Ph.D. Department of Anesthesiology, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya 466-8550, JapanTel: 81-52-744-2340, Fax: 81-52-744-2342Email: satomoto@med.nagoya-u.ac.jpORCID: http://orcid.org/0000-0003-2768-7482  Received: December 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
Korean J Anesthesiol 2017 June  70(3): 335-340 https://doi.org/10.4097/kjae.2017.70.3.335,Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
336 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
337 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Sun et al.,OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
338 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
339 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Sun et al.,OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
340 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/bf/3b/kjae-70-335.PMC5453896.pdf
"Key Words: Non-intubated, Thoracic epidural anesthesia, Thoracoscopic surgery.Non-intubated thoracoscopic  surgery for decortication of  empyema under thoracic epidural  anesthesia   -a case report- Eun-Jin Moon, Y oon-Ju Go, Jun-Y oung Chung, and Jae-Woo Yi Department of Anesthesiology and Pain Medicine, Kyung Hee University College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgKorean Journal of AnesthesiologyKJA Corresponding author: Jae-Woo Yi, M.D., Ph.D. Department of Anesthesiology and Pain Medicine,  Kyung Hee University College of Medicine, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, KoreaTel: 82-2-440-7809, Fax: 82-2-440-7808Email: mdyjwchk@khu.ac.krORCID: http://orcid.org/0000-0001-6474-5624  Received: August 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
Korean J Anesthesiol 2017 June  70(3): 341-344 https://doi.org/10.4097/kjae.2017.70.3.341  Case Report pISSN 2005-6419  •  eISSN 2005-7563,Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
342 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
343 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Moon et al.,OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
344 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
"ORCID Eun-Jin Moon, http://orcid.org/0000-0001-9871-1473  Y oon-Ju Go, http://orcid.org/0000-0002-5382-7402Jun-Y oung Chung, http://orcid.org/0000-0002-3517-249XJae-Woo Yi, http://orcid.org/0000-0001-6474-5624  References 1.",Non-OADS,/arxiv_data1/oa_pdf/9b/67/kjae-70-341.PMC5453897.pdf
"Key Words: Dantrolene, Desflurane, Extracorporeal membrane oxygenation, Malignant hyperthermia.Successful early application  of extracorporeal membrane  oxygenation to support  cardiopulmonary resuscitation for a patient suffering from severe  malignant hyperthermia and  cardiac arrest   -a case report- Hyub Huh1, Jae Seung Jung2, Sang Jae Park1, Min Kyung Park1,   Choon Hak Lim1, and Seung Zhoo Y oon1 Departments of 1Anesthesiology and Pain Medicine, 2Thoracic and Cardiovascular Surgery, Korea University  College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Seung Zhoo Y oon, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, 73, Inchon-ro, Seongbuk-gu, Seoul 02841, KoreaTel: 82-2-920-5632, Fax: 82-2-929-2936Email: yoonsz70@gmail.comORCID: http://orcid.org/0000-0002-9816-3531 Received: July 21, 2016.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
Korean J Anesthesiol 2017 June  70(3): 345-349 https://doi.org/10.4097/kjae.2017.70.3.345,Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
346 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
347 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Huh et al.,OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
348 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
"ORCID Hyub Huh, http://orcid.org/0000-0002-2321-1148Jae Seung Jung, http://orcid.org/0000-0002-8848-4112Choon Hak Lim, http://orcid.org/0000-0003-0089-7682Seung Zhoo Y oon, http://orcid.org/0000-0002-9816-3531 References 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
349 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Huh et al.,OADS,/arxiv_data1/oa_pdf/8b/5b/kjae-70-345.PMC5453898.pdf
"Liver transplantation in Jehovah’s  Witnesses  -two cases report- Ju-Y oung Jeong1, Hyeon Sook Jee2, Bon-Sung Koo1, Sung-Hwan Cho1,   Sang-Hyun Kim1, and GaabSoo Kim2 Department of Anesthesiology and Pain Medicine, 1Soonchunhyang University Bucheon Hospital, Soonchunhyang  University College of Medicine, Bucheon, 2Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgKorean Journal of AnesthesiologyKJA Corresponding author: Sang-Hyun Kim, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Wonmi-gu, Bucheon 14584, KoreaTel: 82-32-621-5328, Fax: 82-32-621-5322Email: skim@schmc.ac.krORCID: http://orcid.org/0000-0001-6267-7365 Received: April 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
Korean J Anesthesiol 2017 June  70(3): 350-355 https://doi.org/10.4097/kjae.2017.70.3.350  Case Report pISSN 2005-6419  •  eISSN 2005-7563,Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
351 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Jeong et al.,OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
352 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
353 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Jeong et al.,OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
354 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
"ORCID Bon-Sung Koo, http://orcid.org/0000-0003-1578-6950Sang-Hyun Kim, http://orcid.org/0000-0001-6267-7365 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
355 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Jeong et al.,OADS,/arxiv_data1/oa_pdf/d0/71/kjae-70-350.PMC5453899.pdf
"Key Words: Autonomic nervous system disease, Frontotemporal dementia, Hypotension, Vasopressins.Anesthetic experience of  frontotemporal dementia patient  with severe autonomic dysfunction  -a case report- Hyae-Jin Kim, Hyeon Jeong Lee, Do Won Lee, Jae Y eon Kim, Jae Y oung Kwon,  Hae-Kyu Kim, Won-Sung Kim, and Boo-Y oung Hwang  Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Busan, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Hyeon Jeong Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
"Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, 179, Gudeok-ro, Seo-gu, Busan 49241, KoreaTel: 82-51-240-7399, Fax: 82-51-242-7466Email: lhjksk@pusan.ac.krORCID: http://orcid.org/0000-0002-3450-865X  Received: October 31, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
Korean J Anesthesiol 2017 June  70(3): 356-360 https://doi.org/10.4097/kjae.2017.70.3.356,Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
357 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
358 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
359 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
"ORCID Hyae-Jin Kim, http://orcid.org/0000-0003-1444-1125Hyeon Jeong Lee, http://orcid.org/0000-0002-3450-865XDo Won Lee, http://orcid.org/0000-0001-5140-2358Jae Y eon Kim, http://orcid.org/0000-0002-6314-8710Hae-Kyu Kim, http://orcid.org/0000-0001-8804-3395 Won-Sung Kim, http://orcid.org/0000-0002-8905-9521 Boo-Y oung Hwang, http://orcid.org/0000-0001-6098-0627  References 1.",Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
360 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/5b/70/kjae-70-356.PMC5453900.pdf
"Letter to the Editor Less explored off-label indications  of dexmedetomidine Abhijit Nair  Department of Anesthesiology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Banjara  Hills, India CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/a1/kjae-70-361.PMC5453901.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Abhijit Nair, M.D.",Non-OADS,/arxiv_data1/oa_pdf/17/a1/kjae-70-361.PMC5453901.pdf
"10, Banjara Hills, Hyderabad 500034, Telangana, India.Tel: 91-40-23551235, Fax: 91-40-23553556Email: abhijitnair95@gmail.comORCID: http://orcid.org/0000-0003-2506-0301  Received: January 17, 2017.",Non-OADS,/arxiv_data1/oa_pdf/17/a1/kjae-70-361.PMC5453901.pdf
Korean J Anesthesiol 2017 June  70(3): 361-362 https://doi.org/10.4097/kjae.2017.70.3.361,Non-OADS,/arxiv_data1/oa_pdf/17/a1/kjae-70-361.PMC5453901.pdf
362 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/17/a1/kjae-70-361.PMC5453901.pdf
"CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/e2/kjae-70-363.PMC5453902.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Hong-Seuk Y ang, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: 82-2-3010-3865, Fax: 82-2-470-1363Email: hsyang@amc.seoul.kr Korean J Anesthesiol 2017 June  70(3): 363-364 https://doi.org/10.4097/kjae.2017.70.3.363",Non-OADS,/arxiv_data1/oa_pdf/db/e2/kjae-70-363.PMC5453902.pdf
364 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/db/e2/kjae-70-363.PMC5453902.pdf
"Corrigendum Corrigendum: A first step toward  understanding patient safety Kyoung Ok Kim Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/74/kjae-70-365.PMC5453903.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2017 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Korean J Anesthesiol 2017 June  70(3): 365 https://doi.org/10.4097/kjae.2017.70.3.365  Korean J Anesthesiol 2016 October 69(5): 429-434 In this paper, Acknowledgments section was omitted unintentionally.",Non-OADS,/arxiv_data1/oa_pdf/ed/74/kjae-70-365.PMC5453903.pdf
(Cell Mol Gastroenterol Hepatol 2017;4:125 –134; http://dx.doi.org/ 10.1016/j.jcmgh.2017.04.007 ) Keywords: Liver Fibrosis; Epigenetics; DNA Methylation; Histone Modi ﬁcations; Chronic Liver Disease.,Non-OADS,/arxiv_data1/oa_pdf/ce/fe/main.PMC5453904.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/fe/main.PMC5453904.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.04.007,OADS,/arxiv_data1/oa_pdf/ce/fe/main.PMC5453904.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ce/fe/main.PMC5453904.pdf
(Cell Mol Gastroenterol Hepatol 2017;4:115 –123; http://dx.doi.org/10.1016/j.jcmgh.2017.03.009 ) Keywords: GERD; Esophageal Re ﬂux; Barrett ’s Esophagus; Esophageal Adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/93/f4/main.PMC5453905.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/f4/main.PMC5453905.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.03.009,OADS,/arxiv_data1/oa_pdf/93/f4/main.PMC5453905.pdf
(Cell Mol Gastro enterol Hepatol 2017;4:95 –114; http://dx.doi.org/10.1016/j.jcmgh.2017.03.011 ) Keywords: Intestine; Circadian Rhythms; Gastrointestinal Syndrome; TNF; Intestinal Stem Cells.,Non-OADS,/arxiv_data1/oa_pdf/8a/e7/main.PMC5453906.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/e7/main.PMC5453906.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.03.011,OADS,/arxiv_data1/oa_pdf/8a/e7/main.PMC5453906.pdf
(Cell Mol Gastroenterol Hepatol 2017;4:135 –151; http://dx.doi.org/ 10.1016/j.jcmgh.2017.03.010 ),OADS,/arxiv_data1/oa_pdf/3e/de/main.PMC5453907.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/de/main.PMC5453907.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.03.010136 Oh-oka et al Cellular and Molecular Gastroenterology and Hepatology Vol.,OADS,/arxiv_data1/oa_pdf/3e/de/main.PMC5453907.pdf
"The OCT images are displayed in real time, showing architectural changes of the skinEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8F87F06017F44BCF .",Non-OADS,/arxiv_data1/oa_pdf/91/c3/13555_2017_Article_175.PMC5453917.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/91/c3/13555_2017_Article_175.PMC5453917.pdf
TheEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2097F06079268209 .,Non-OADS,/arxiv_data1/oa_pdf/f8/7d/13555_2017_Article_176.PMC5453918.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f8/7d/13555_2017_Article_176.PMC5453918.pdf
"Therefore, it is possible that horizontal erythronychia is an earlyEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/9297 F0601567D31E .",Non-OADS,/arxiv_data1/oa_pdf/0d/64/13555_2017_Article_177.PMC5453919.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0d/64/13555_2017_Article_177.PMC5453919.pdf
"Sub- sequently, the condition has been referred to asEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0708F06041FF6F12 .",Non-OADS,/arxiv_data1/oa_pdf/0a/89/13555_2017_Article_178.PMC5453920.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0a/89/13555_2017_Article_178.PMC5453920.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The online version of the original article can be found under doi: 10.1007/s13555-016-0161-2 .",Non-OADS,/arxiv_data1/oa_pdf/7c/81/13555_2017_Article_179.PMC5453921.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/32/21/13555_2017_Article_180.PMC5453922.pdf
Keywords: Atopic dermatitis; Dupilumab; EQ-5D; Health-related quality-of-life; Minimal clinically important difference; Treatment responders; Utility scoresEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 9C18F060292A40A9 .,Non-OADS,/arxiv_data1/oa_pdf/7b/57/13555_2017_Article_181.PMC5453923.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7b/57/13555_2017_Article_181.PMC5453923.pdf
2015. https://www.nice.org.uk/guidance/ta350/resources/ secukinumab-for-treating-moderate-to-severe-plaque-psoriasis-82602661589701 .,Non-OADS,/arxiv_data1/oa_pdf/7b/57/13555_2017_Article_181.PMC5453923.pdf
Protective measures such as smoke extraction and airway protection should be instituted forEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ ED18F0607EE69B0C .,Non-OADS,/arxiv_data1/oa_pdf/55/9b/13555_2017_Article_182.PMC5453924.pdf
"The annual estimated age standardised inci- dence rate of MCC in the UK is between 0.1 and 0.2 per 100,000 (1999–2008) and is thought to be increasing [ 9](http://www.ncin.org.uk/ publications/data_brieﬁngs/rareskincancer ).",Non-OADS,/arxiv_data1/oa_pdf/55/9b/13555_2017_Article_182.PMC5453924.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/55/9b/13555_2017_Article_182.PMC5453924.pdf
The innate and adaptive immune systems areEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E128F060166C6BD7 .,Non-OADS,/arxiv_data1/oa_pdf/41/17/13555_2017_Article_183.PMC5453925.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/41/17/13555_2017_Article_183.PMC5453925.pdf
2015 Jan 2016 June 2014. http://epi.grants.,Non-OADS,/arxiv_data1/oa_pdf/41/17/13555_2017_Article_183.PMC5453925.pdf
Aug 2016 [citedJune 2015; Available from: http://epi.grants.cancer.,Non-OADS,/arxiv_data1/oa_pdf/41/17/13555_2017_Article_183.PMC5453925.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.05.013 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/12/main.PMC5454084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/12/main.PMC5454084.pdf
Available from: https://www.sfee.gr/kodikas-deontologias-gia- tin-proothisi-ton-sintagografoumenon-farmakon/ .,Non-OADS,/arxiv_data1/oa_pdf/1a/12/main.PMC5454084.pdf
E-mail address: c.teunissen@vumc.nl http://dx.doi.org/10.1016/j.dadm.2017.04.007 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/5f/main.PMC5454085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/5f/main.PMC5454085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e7/5f/main.PMC5454085.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2017.04.007 .,OADS,/arxiv_data1/oa_pdf/e7/5f/main.PMC5454085.pdf
Available at: http://www.prisma-statement.org/ .,Non-OADS,/arxiv_data1/oa_pdf/e7/5f/main.PMC5454085.pdf
Tools like quantum dots are commonly used in plant pathology successfully for http://dx.doi.org/10.1016/j.btre.2017.03.002 Received 22 December 2016; Received in revised form 15 March 2017; Accepted 16 March 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Khan, A. Zaidi, A.S. Ahmed, F. Ahmed, E. Ahmad, A. Sherwani, M. Owais, A. Azam, Antibacterial and cytotoxic e ﬃcacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain ofStenotrophomonas maltophilia , PLoS One 8 (2013) e59140, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Singh, Biofabricated silver nanoparticles act as a strong fungicide against Bipolaris sorokiniana causing spot blotch disease in wheat, PLoS One 9 (2014) e97881, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"2015 (2015), http://dx.doi.org/10.1155/2015/ 218904 (Article ID 218904, 10 pages).",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
Available from: http://www.fao.org/ag/agl/agll/nrdb/links.jsp?,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"3 (2013) 2013, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Singh, Biofabricated silver nanoparticles act as a strong fungicide against Bipolaris sorokiniana causing spot blotch disease in wheat, PLoS One 9 (2014) e97881, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"3 (2016) 00065, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Singh, Biofabricated silver nanoparticles act as a strong fungicide against Bipolaris sorokiniana causing spot blotch disease in wheat, PLoS One 9 (2014) e97881, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"2016 (2016), http://dx.doi.org/10.1155/2016/1957612 (Article ID 1957612, 7 pages).",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"224 (2013) 1668, http://dx.doi.org/10.1007/s11270-013-1668-0 .",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Jones, A Nanotech Revolution in Agriculture and the Food Industry, Information systems for Biotechnology, Blacksburg, VA, 2006 Available from: http://www.isb.vt.edu/articles/jun0605.html .",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"36 (2013) 273 –283, http://dx.doi.org/10.1007/s00449-012-0782-5 .",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
[152] http://www.bccresearch.com/market-research/nanotechnology/ 2011nanotechnologyreview-nan047c.html .,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
[157] http://www.bccresearch.com/market-research/nanotechnology/2014- nanotechnology-research-review-report-nan047f.html .,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Stacey, M.J. McLaughlin, Fate of zinc oxide nanoparticles coated onto macronutrient fertilizers in analkaline calcareous soil, PLoS One 10 (2015), http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
[164] http://www.geohumus.com/us/products.html .,Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"Adams, E ﬀects of functionalized and raw multi-walled carbon nanotubes on soil bacterial commu-nity composition, PLoS One 10 (2015) (2015) e0123042, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
"(2016), http://dx.doi.org/10.1016/j.jsps.2016.09.",OADS,/arxiv_data1/oa_pdf/02/78/main.PMC5454086.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/9b/main.PMC5454124.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.05.021 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/25/9b/main.PMC5454124.pdf
Available  at:  http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/25/9b/main.PMC5454124.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.05.003,Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3 8–46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8b/59/main.PMC5454129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/5e/main.PMC5454130.pdf
E-mail address: c.teunissen@vumc.nl http://dx.doi.org/10.1016/j.dadm.2017.04.008 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/5e/main.PMC5454130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/5e/main.PMC5454130.pdf
"Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2017.04.008 .References [1]Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, et al.",OADS,/arxiv_data1/oa_pdf/aa/5e/main.PMC5454130.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/40/main.PMC5454131.pdf
E-mail address: plao@wisc.edu http://dx.doi.org/10.1016/j.dadm.2017.05.001 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/27/40/main.PMC5454131.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2017.05.001 .,OADS,/arxiv_data1/oa_pdf/27/40/main.PMC5454131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/c8/main.PMC5454132.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.05.002 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/c8/main.PMC5454132.pdf
http://dx.doi.org/10.1016/ j.ttbdis.2017.02.005 .,OADS,/arxiv_data1/oa_pdf/4b/c8/main.PMC5454132.pdf
http://dx.doi.org/10.1645/16-99 ([Epub ahead of print]).,Non-OADS,/arxiv_data1/oa_pdf/4b/c8/main.PMC5454132.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/ec/main.PMC5454133.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/ec/main.PMC5454133.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/a6/ec/main.PMC5454133.pdf
Published by Elsevier Ireland Ltd. Thi s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Atrial ﬂutter Cavotricuspid isthmus ablationAtrial ﬁbrillation HATCHCHA 2DS2VASc 1.,Non-OADS,/arxiv_data1/oa_pdf/08/9c/main.PMC5454134.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.006 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/08/9c/main.PMC5454134.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/9c/main.PMC5454134.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/08/9c/main.PMC5454134.pdf
These packages are freely avail- able at http://cran.r-project.org .,Non-OADS,/arxiv_data1/oa_pdf/08/9c/main.PMC5454134.pdf
e00308 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
"The theory features the needs forautonomy (the need to feel ownership of one ’s behavior), competence (need for Article No~e00308 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
"In contrast, Article No~e00308 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
"For the first four indicators, a lower Article No~e00308 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Although Article No~e00308 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This study makes some significant contributions to the literature in the use of LPA models incorporating the use of “distal outcome ”as covariates within a LPA Article No~e00308 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
Article No~e00308 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00308 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c2/main.PMC5454135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: NT-proBNPMarfan syndromeDiastolic function Heart failure Cardiomyopathy 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/97/main.PMC5454136.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.003 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/97/main.PMC5454136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/97/main.PMC5454136.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b1/97/main.PMC5454136.pdf
"Previous studies have focused on the potential role of the advanced diﬀusion ( Arzoumanian et al., 2003) and functional ( Smyser et al., http://dx.doi.org/10.1016/j.nicl.2017.05.023 Received 17 August 2016; Received in revised form 7 May 2017; Accepted 25 May 2017⁎Corresponding author at: ITAB —Institute of Advanced Biomedical Technologies, University “G.",Non-OADS,/arxiv_data1/oa_pdf/f2/f5/main.PMC5454138.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f2/f5/main.PMC5454138.pdf
(Cell Mol Gastroenterol Hepatol 2017;4:161 –164; http://dx.doi.org/ 10.1016/j.jcmgh.2017.04.005 ) Warring Parties: Four Independent Hypotheses for Barrett ’s Norman Barrett ’sﬁrst reference to the eponymous metaplasia as “columnar lined esophagus ”invited specula- tion that Barrett ’s arose from the proximal migration of gastric epithelia.,Non-OADS,/arxiv_data1/oa_pdf/d4/5c/main.PMC5454139.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/5c/main.PMC5454139.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2017.04.005164 Point-Counterpoint Cellular and Molecular Gastroenterology and Hepatology Vol.,OADS,/arxiv_data1/oa_pdf/d4/5c/main.PMC5454139.pdf
e00307 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
It only becomes of interest in the event that a resultant of significant Article No~e00307 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
The subtraction was carried out in the sense: wacceptor_atom −wdonor_atom (acceptor Article No~e00307 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
"(residue range)Resolution Å Secondary structure contentVector sum of SS, BS and BB hydrogen bonds (Å)Figure 1 Histone H3 1kx5e 1.94 49% α/0%β -2.695 1 2 Haemagglutinin Ha34 1ybia 1.50 2% α/48% β -0.630 2 3 GroEl chaperone 1xckn (2 –136) 2.92 68% α/5%β -2.872 3a 1xckn (141 –408) 41% α/23% β/2% 3 10 0.000 3b 1xckn (412 –515) 57% α/8%β -3.281 3c 4 Insulin receptor tyrosine kinase 2auha 3.2 34% α/16% β/5% 3 10 -0.870 4 2b4 sb 2.0 34% α/18% β/5% 3 10 -0.998 5 T7 RNA Polymerase 1bpx (1 –139) 2.4 68% α/9%β/2% 3 10 -2.836 5a 1bpx (140 –326) 30% α/29% β/2% 3 10 0.452 5b 6 Glutamate receptor subunit 2 1fw0a 1.9 34% α-helix/18% β-strand 0.000 6 7 Pokeweed lectin C 1ulkb 1.8 10% α/10% β/12% 3 10 -2.708 7 8 Metabotrope glutamate receptor 1ewka (1 –89) 2.2 28% α/17% β/3% 3 10 -2.807 8a 1ewka (90 –448) 34% α/18% β/3% 3 10 -2.688 8b 9 THP type 1 alpha 1 collagen fragment 2llp NMR collagen triple helix -2.794 9a 9b 10 Bovine beta-lactogobulin 1beb 1.8 10% α/42% β 2.303 10a 10b 1beb with Crystal waters removed and replaced with simulation waters then minimizedMOD -0.632 10c 1beb after MD dehydration experiment (see text) MOD -6.892 10d 11 80 residue random sequence α-helix MOD all α -5.464 11 12 80 residue random sequence β-strand MOD all β -8.479 12 13 80 residue random sequence with random secondary structure MOD Arbitrary sequence of α,β,π and 3 –10-16.626 13a Same as the above but in compact “quasi-fold ”(see text) MOD Compact form, prominent 3–10-2.631 13b 14 Prion protein in misfolded amyloid state (structure 31 from NMR ensemble)2rnm NMR all β 2.903 14 Article No~e00307 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
"Cumulative vector sums BB (red color), BS (green) and SS (blue) (BS and SS enhanced fivefold for clarity) for pokeweed lectin C. Article No~e00307 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
4. http://www.rwgrayprojects.com/rbfnotes/fpapers/tensegrity/tenseg01.html .,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
http://www.scribd.com/doc/ 146497147/Art-and-Ideas-Kenneth-Snelson .,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
Article No~e00307 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00307 2405-8440/© 2017 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f9/04/main.PMC5454140.pdf
e00309 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
"Additionally and remarkably, wounding the skin can also induce epidermal cells to assume a HF Article No~e00309 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
"1 E), we determined gene Article No~e00309 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Group Wounded Injection (n = 10 each) Outcome on PD21 (n = 8 each) a PD3Etoposide Protection from hair loss at wound siteb Cyclophosphamide c Cyclophosphamide/doxorubicin d No injection No hair loss e PD8Etoposide Total alopecia on trunkf Cyclophosphamide g Cyclophosphamide/doxorubicin h PD11Etoposide Total alopecia on trunki Cyclophosphamide j Cyclophosphamide/doxorubicink UnwoundedEtoposide Total alopecia on trunkl Cyclophosphamide m Cyclophosphamide/doxorubicin Article No~e00309 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Images were captured using a Keyence Article No~e00309 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Group Injected Cytokine/growth factor (PD3) Chemotherapy Outcome 1 IFN- γ Etoposide Alopecia 2 TNF- α Etoposide Alopecia 3 EGF Etoposide Alopecia 4 FGF Etoposide Alopecia 5 TGF- β Etoposide Alopecia 6 PBS (vehicle) Etoposide Alopecia 7 IL-1βEtoposide Local protection of hair loss8 Cyclophosphamide 9 Cyclophosphamide/doxorubicin 10 No injection No chemotherapy Normal hair phenotype Article No~e00309 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
"These results suggested that wounding on PD3had significant impact on the progression of HF morphogenesis, causing a delay by Article No~e00309 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
IL-1 βprovided broad protection from CIA in neonatal rat skin We next tested whether IL-1 βor a number of carefully selected cytokines/growth factors which were previously shown to exhibit hair growth-inhibitory properties Article No~e00309 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
"4 F–H), IL-1 βtreated skin showed a 2-fold increase in the percentage of degranulated mast cells, and the increase was statistically significant Article No~e00309 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Loss of protection from CIA in Article No~e00309 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Such manipulation may provide Article No~e00309 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
Article No~e00309 22 http://dx.doi.org/10.1016/j.heliyon.2017.e00309 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9a/main.PMC5454141.pdf
"Moreover, administration of IGF-II also rescued spine formation and excitatory synaptic function in the hippocampus of a mouse model of Alzheimer's disease [12] and can modulate memory processes, likely acting at http://dx.doi.org/10.1016/j.redox.2017.05.012 Received 4 May 2017; Accepted 23 May 2017⁎Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"The ﬁnal colour reaction was developed using nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP).The Western blots were digitised using a ﬂatbed scanner (HP Scanjet 5500c, Hewlett-Packard, Madrid, Spain) and analysed using ImageJsoftware (US National Institute of Health; http://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.05.012 .,OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Harris, M. Westwood, Biology and signi ﬁcance of signalling pathways activated by IGF-II, Growth Factors 30 (2012) 1 –12,http://dx.doi.org/10.3109/ 08977194.2011.640325 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"24 (2014) 1947 –1953, http://dx.doi.org/10.1016/j.euroneuro.2014.01.020 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"33 (2012) 230 –251, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
12 (1992) 1558 –1566 http://www.ncbi.nlm.nih.gov/pubmed/1313498 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"44 (2004) 117 –140, http://dx.doi.org/10.1016/j.brainresrev.2003.11.002 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
35 (2007) 329 –345 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17917122 .,OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"9 (2011) 103, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"(2016), http://dx.doi.org/10.1007/s12035-016-9849-7 .E.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"32 (2012)5688 –5703, http://dx.doi.org/10.1523/JNEUROSCI.0111-12.2012 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"6 (2014) 1246 –1262, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"33 (2013) 9408 –9419, http://dx.doi.org/10.1523/ JNEUROSCI.2700-12.201333/22/9408 (pii).",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"8 (2015) 69,http://dx.doi.org/10.3389/fnmol.2015.00069 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"1622 (2015) 466 –473, http://dx.doi.org/10.1016/ j.brainres.2015.07.002 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Acta 1842 (2014) 1041 –1051, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Zhou, Correlation between mitochondrial membrane potential and neurotoxic e ﬀect of corticosterone on primary cultured hippocampal cells, Sheng Li Xue Bao 53 (2001) 469 –472 〈http://www.ncbi.nlm.nih.gov/ pubmed/11930228 〉.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"87 (2007) 873 –904, http://dx.doi.org/10.1152/ physrev.00041.2006 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
J. Neurosci.11 (1999) 2465 –2473 http://www.ncbi.nlm.nih.gov/pubmed/10383636 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Mattson, M. Gleichmann, A. Cheng, Mitochondria in neuroplasticity and neurological disorders, Neuron 60 (2008) 748 –766, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Mattson, Mitochondria and neuroplasticity, ASN Neuro 2 (2010) e00045, http://dx.doi.org/10.1042/AN20100019 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"3 (2004) 205 –214, http://dx.doi.org/10.1038/ nrd1330 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Wong-Riley, Histochemical localization of cytochrome oxidase in the hippocampus: correlation with speci ﬁc neuronal types and a ﬀerent pathways, Neuroscience 7 (1982) 2337 –2361 http://www.ncbi.nlm.nih.gov/ pubmed/6294558 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"56 (1999) 8 –20,http://dx.doi.org/10.1002/(SICI)1097- 4547(19990401)56:1<8::AID-JNR2>3.0.CO;2-G .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"38 (2015) 468 –474, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"(2016), http://dx.doi.org/10.1016/j.freeradbiomed.2016.11.045 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Arnold, Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain, Synapse 65 (2011) 763 –770, http://dx.doi.org/10.1002/syn.20900 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Morrison, The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course, Neuron 79 (2013) 16 –29,http://dx.doi.org/ 10.1016/j.neuron.2013.06.028 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"102 (2016) 274 –286, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"2016 (2016) 6391686, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"34 (2011) 326 –337, http://dx.doi.org/10.1016/j.tins.2011.03.004 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"14 (2013) 144, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"13 (2012) 58, http://dx.doi.org/10.1186/1471-2202-13-58 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"13 (2012) 110, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
59 (2003)145 –146http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=14649879 .,OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"462 (2011) 693 –708, http://dx.doi.org/10.1007/ s00424-011-1012-8 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"33 (2013) 12122 –12135, http://dx.doi.org/10.1523/ JNEUROSCI.0131-13.2013 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"4 (2001)711 –717, http://dx.doi.org/10.1038/89498 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"(2014), http://dx.doi.org/10.3791/ 50557 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"22 (2005) 2451 –2461, http://dx.doi.org/10.1111/j.1460-9568.2005.04437.x .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"83 (2009) 397 –403, http://dx.doi.org/10.1007/s00204-008- 0360-4 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"3 (2002) 453 –462, http://dx.doi.org/10.1038/ nrn849 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Sche ﬀ, A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI, J.Neurotrauma 25 (2008) 513 –526, http://dx.doi.org/10.1089/neu.2007.0451 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"1385 (2011) 26 –37,http://dx.doi.org/10.1016/j.brainres.2011.02.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Lavidis, Reactive nitrogen species contribute to the rapid onset of redox changes induced by acute immobilization stress in rats, Stress 17 (2014) 520 –527, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"87 (2009) 440 –447, http://dx.doi.org/10.1139/y09-027 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"[61] A. Za ﬁr, N. Banu, Modulation of in vivo oxidative status by exogenous corticos- terone and restraint stress in rats, Stress 12 (2009) 167 –177, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"9 (2011), http://dx.doi.org/10.1186/1479-5876-9-123 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"14 (2015) 1191, http://dx.doi.org/10.4314/tjpr.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Cortazar, Low doses of insulin-like growth factor I improve insulin resistance,lipid metabolism, and oxidative damage in aging rats, Endocrinology 149 (2008) 2433 –2442, http://dx.doi.org/10.1210/en.2007-1190 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Cortazar, Low doses of insulin-like growth factor-I induce mitochondrialprotection in aging rats, Endocrinology 149 (2008), http://dx.doi.org/10.1210/ en.2007-1563 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Aging 25 (2004) 63 –69,http://dx.doi.org/10.1016/s0197-4580(03)00117-9 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"73 (2014) 1 –11,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"56 (2015) 263 –272, http://dx.doi.org/10.1007/s12031- 015-0516-7 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"6 (2015) 183 –197, http://dx.doi.org/10.1016/j.redox.2015.07.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"11 (2017) 592 –599, http://dx.doi.org/10.1016/j.redox.2016.12.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"100 (2016) 108 –122, http://dx.doi.org/10.1016/j.freeradbiomed.2016.04.200 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
(2000) 261 –272http://www.ncbi.nlm.nih.gov/pubmed/ 11205145 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Acta 1783 (2008)994 –1002, http://dx.doi.org/10.1016/j.bbamcr.2008.02.016 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"13 (2012) 225 –239, http://dx.doi.org/ 10.1038/nrn3209 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"45 (2008) 443 –452, http://dx.doi.org/10.1016/j.freeradbiomed.2008.04.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"[76] A. Boveris, A. Navarro, Brain mitochondrial dysfunction in aging, IUBMB Life 60 (2008) 308 –314http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=18421773 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"181 (2011) 447 –456, http://dx.doi.org/10.1007/s00360-011-0566-2 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"77 (2016) 400 –406, http://dx.doi.org/10.1002/ddr.21332 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"100 (2016) 1 –4,http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Anderson, Chronic corticosterone a ﬀects brain weight, and mitochondrial, but not glial volume fraction in hippocampal area CA3, Neuroscience 124 (2004)429 –438, http://dx.doi.org/10.1016/j.neuroscience.2003.11.031 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"100 (2016) 81 –85,http://dx.doi.org/ 10.1016/j.freeradbiomed.2016.06.005 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"45(2013) 709 –715, http://dx.doi.org/10.1055/s-0033-1345119 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
212 (2007) 169 –175http://www.ncbi.nlm.nih.gov/pubmed/17438209 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"20 (2014)353 –371, http://dx.doi.org/10.1089/ars.2012.4774 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"1 (2013) 80 –85,http://dx.doi.org/10.1016/j.redox.2013.01.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"1 (2006) 2916 –2921, http://dx.doi.org/10.1038/nprot.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"(2011), http://dx.doi.org/10.3791/3143 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
21 (2001)RC167 http://www.ncbi.nlm.nih.gov/pubmed/11567078 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
22 (2002) 775 –781 http://www.ncbi.nlm.nih.gov/pubmed/11826107 .,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"1237 (2008) 124 –135, http://dx.doi.org/10.1016/j.brainres.2008.08.046S0006- 8993(08)02086-6 (pii).",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Baker, S. Kar, Leu27 insulin-like growth factor-II, an insulin-like growth factor-II analog, attenuates depolarization-evoked GABArelease from adult rat hippocampal and cortical slices, Neuroscience 170 (2010)722 –730, http://dx.doi.org/10.1016/j.neuroscience.2010.07.026 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Alberini, A critical role for IGF-II in memory consolidation and enhancement, Nature 469 (2011) 491 –497, http://dx.doi.org/ 10.1038/nature09667 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Ago, E. Takano, A. Fukada, K. Takuma, T. Matsuda, Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice, Psychopharmacology 225 (2012) 543 –551, http://dx.doi.org/10.1007/s00213-012-2841-7 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Alberini, Enhancement of memories by systemic administration of insulin-like growth factor II, Neuropsychopharmacology (2014), http://dx.doi.org/10.1038/npp.2014.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Bioessays 26 (2004) 445 –453, http://dx.doi.org/10.1002/bies.20012 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Chapman, Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons, Neuron 70 (2011) 847 –854, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"23 (2014) 481 –492, http://dx.doi.org/10.3727/096368914X678490 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"2016 (2016) 8725354, http://dx.doi.org/10.1155/2016/8725354 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"55 (2016) 73–75,http://dx.doi.org/10.3233/JAD-160878 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"63 (2013) 482 –491, http://dx.doi.org/10.1016/j.neuint.2013.08.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"(2016), http://dx.doi.org/10.1007/s12035-016-0129-3 .",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Colicos, C. Sala, A. El-Husseini, A preformed complex of postsynaptic proteins is involved in excitatory synapsedevelopment, Neuron 49 (2006) 547 –562, http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"84 (2008) 263 –283, http://dx.doi.org/10.1016/j.pneurobio.2007.10.011 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
12 (2000) 1949 –1960 http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Aging44 (2016) 9 –21,http://dx.doi.org/10.1016/j.neurobiolaging.2016.04.006 .",OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"67 (2002) 646 –663, http://dx.doi.org/10.1002/jnr.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
"Lehtinen, H. Umemori, Retrograde ﬁbroblast growth factor 22 (FGF22) signaling regulates insulin-like growth factor 2 (IGF2) expression for activity-dependent synapse stabilization inthe mammalian brain, Elife 5 (2016), http://dx.doi.org/10.7554/eLife.12151 .E.",Non-OADS,/arxiv_data1/oa_pdf/56/be/main.PMC5454142.pdf
CGD patients predominantly show an http://dx.doi.org/10.1016/j.redox.2017.04.026 Received 8 February 2017; Received in revised form 19 April 2017; Accepted 20 April 2017⁎Correspondence to: Dept.,Non-OADS,/arxiv_data1/oa_pdf/21/27/main.PMC5454143.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/21/27/main.PMC5454143.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.04.026 .,OADS,/arxiv_data1/oa_pdf/21/27/main.PMC5454143.pdf
e00311 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
"Suppose that s is an another scale factor satisfying s≠a, we have that Article No~e00311 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Here a bi-directional smoothness method is proposed: ^xi¼1 m∑iþm/C01 k¼ixk;~xi¼1 m∑i k¼i/C0mþ1^xk (12) In this study we let m = 5; Article No~e00311 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
"2 , the isolated peak P1 is reproduced Article No~e00311 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
The relative errors of the estimated parameters with A = 60. δ 2 3 4 5 10 20 40 80 160 320 ^σ2.089 3.06 4.05 5.04 10.03 20.03 40.05 80.09 160.25 321.1 EðσÞð%Þ4.4 1.97 1.15 0.76 0.27 0.14 0.113 0.116 0.156 0.343 ^A57.64 58.93 59.39 59.61 59.9 59.98 59.99 60.02 60.07 60.3 EðAÞð%Þ4.4 1.783 1.017 0.65 0.167 0.003 0.002 0.003 0.117 0.5 Article No~e00311 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
P1 P2 P3 P4 P5 P6 P7 σ5 09 1 02 52 52 09 0 A140 100 100 90 140 60 60 ^σ50.0577 8.9517 9.9624 24.5999 24.8296 19.9227 88.6625 EðσÞð%Þ0.1154 0.5367 0.376 1.6604 0.6815 0.39 1.4861 Article No~e00311 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
P1 P2 P3 P4 P5 P6 P7 True 17546 2256 2507 5640 8773 3008 13536 WGM 17567 2194 2458 5319 8542 2929 12913 E(W)(%) 0.1 2.7 2 5.7 2.6 2.6 4.6 GMM 17647 2383 2625 6053 8452 3394 11576E(G) 0.5 5.6 4.7 7.3 3.7 12.8 14.5 SNIP-G 17089 2197 2458 5467 8344 2351 11341 E(S)(%) 2.6 2.7 2 3.1 4.9 21 16 Article No~e00311 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Sample Number No.1 No.2 No.3 No.4 No.5 No.6 No.7 Content(mg/kg) 9.9923 30.7566 48.8089 61.4237 73.6556 78.6347 89.2233 Article No~e00311 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
7 WGM 138.92 332.08 511.45 641.8181 783.03 838.56 945.41 GMM 171.38 344.72 526.2 618.7621 725.65 775.64 892.32 SNIP-G 155.36 294.15 498.87 628.421 739.65 848.29 966.42 Article No~e00311 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
6 Actual content 30.7566 61.4237 78.6347 WGM(E(W)) 31.3749(2.01%) 60.5523(1.42%) 78.7086(0.57%) GMM(E(G)) 34.0505(10.71%) 61.0435(0.62%) 76.4961(2.72%) SNIP-G(E(S)) 28.0381(8.84%) 59.7937(2.65%) 80.6841(2.61%) Article No~e00311 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
Article No~e00311 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00311 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/7a/main.PMC5454144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Drug eluting stentsBifurcation lesionsSide branch 1.,Non-OADS,/arxiv_data1/oa_pdf/07/d0/main.PMC5454145.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.06.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/d0/main.PMC5454145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/d0/main.PMC5454145.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/07/d0/main.PMC5454145.pdf
We anticipate that this information will serve as a useful guide for educators tasked with teaching students http://dx.doi.org/10.1016/j.onehlt.2017.04.001 Received 13 January 2017; Received in revised form 14 April 2017; Accepted 25 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/e5/27/main.PMC5454146.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/27/main.PMC5454146.pdf
"[6] Deputy Director General (Operations), Rome Declaration on World Food Security and World Food Summit Plan of Action, Available at: http://www.fao.org/docrep/ 003/w3613e/w3613e00.htm , (1996) (Accessed April 10, 2017).",Non-OADS,/arxiv_data1/oa_pdf/e5/27/main.PMC5454146.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Animal modelCoronavirus (CoV)Emerging pathogenMiddle East respiratory syndrome (MERS)Reservoir Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.03.001 2352-7714/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
"[5] World Health Organization, WHO, http://www.who.int/csr/don/2016_ 2014 (Accessed on December 15, 2016).",Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
"[7] World Health Organization, WHO, http://www.who.int/emergencies/mers-cov/en/ 2016 (Accessed on December 15, 2016).",Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
"[8] World Health Organization, WHO, https://www.cdc.gov/vhf/ebola/outbreaks/2014- west-africa/ 2014 (Accessed on December 15, 2016).",Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
(2016 Oct 27) http://dx.doi.org/10.1002/rmv.,OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
"15 (2017 Feb) 23(2), http://dx.doi.org/10.3201/eid2302.161239 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/0a/3f/main.PMC5454147.pdf
The authors would like to apologise for any inconvenience caused.IJC Heart & Vasculature 12 (2016) 95 DOI of original article: http://dx.doi.org/10.1016/j.ijchv.2014.06.008 .,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/main.PMC5454148.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.002 2352-9067/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/main.PMC5454148.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ) Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/main.PMC5454148.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/80/main.PMC5454149.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.02.003 2352-7714/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/31/80/main.PMC5454149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/80/main.PMC5454149.pdf
"Furthermore, signi ﬁ- cant organic stenosis is an important factor in VSA patients because pre- vious studies showed that VSA patients with signi ﬁcant organic stenosisIJC Heart & Vasculature 12 (2016) 85 –87 http://dx.doi.org/10.1016/j.ijcha.2016.07.008 2352-9067/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2f/19/main.PMC5454150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/19/main.PMC5454150.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/2f/19/main.PMC5454150.pdf
"Literature review In common with other Escherichia species, E. fergusonii is a rod- http://dx.doi.org/10.1016/j.onehlt.2017.05.001 Received 9 August 2016; Received in revised form 25 March 2017; Accepted 3 May 2017⁎Correspondence author.",Non-OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
"172 (1 –2) (2014) 7 –12,http://dx.doi.org/10.1016/j.vetmic.2014.04.",OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
"102 (7) (2012) 607 –608, http://dx.doi.Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
"60 (2016) 4414 –4415, http://dx.doi.org/10.1128/AAC.00548-16 .",Non-OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
"10 (2012) 917 –934, http://dx.doi.org/10.1586/eri.12.78 .",Non-OADS,/arxiv_data1/oa_pdf/e5/30/main.PMC5454151.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MTRR gene rs326119Congenital heart diseaseHomocysteineCobalamin 1.,Non-OADS,/arxiv_data1/oa_pdf/49/be/main.PMC5454152.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.0042352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/be/main.PMC5454152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/be/main.PMC5454152.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/49/be/main.PMC5454152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: Arch vessel anomaliesCHARGE syndromeCHD7 gene Feeding problemsCongenital heart defectsAberrant subclavian artery 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/e6/main.PMC5454153.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.0152352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/e6/main.PMC5454153.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/e6/main.PMC5454153.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/a5/e6/main.PMC5454153.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary ﬂow IsovueVisipaque Iodixanol IopamidolCanineDogsIntravenous 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/main.PMC5454155.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/main.PMC5454155.pdf
com/ijc-heart-and-vasculature http://dx.doi.org/10.1016/j.ijcha.2016.05.014 2352-9067/© 2016 Published by Elsevier Ireland Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/main.PMC5454155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/main.PMC5454155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary artery diseasePercutaneous coronary interventionDrug-eluting stentChronic total coronary occlusion 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/main.PMC5454156.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/main.PMC5454156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/main.PMC5454156.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/main.PMC5454156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Echocardiography Right ventricle Right ventricular functionMagnetic resonance imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/81/main.PMC5454157.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.007 2352-9067/Crown Copyright © 2016 Published by Elsevier Ireland Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/81/main.PMC5454157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/81/main.PMC5454157.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/ff/81/main.PMC5454157.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.010 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/53/main.PMC5454158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/53/main.PMC5454158.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/87/53/main.PMC5454158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Strain Strain rateAppendageThrombusSinus rhythmAtrial ﬁbrillation 1.,Non-OADS,/arxiv_data1/oa_pdf/71/e4/main.PMC5454159.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.003 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/e4/main.PMC5454159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/e4/main.PMC5454159.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/71/e4/main.PMC5454159.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Xenotransplantation Public health DiabetesPigsVirus safetyPorcine viruses Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/14/27/main.PMC5454160.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.02.002 2352-7714/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/14/27/main.PMC5454160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/27/main.PMC5454160.pdf
References [1]https://www.unos.org/data/ .,OADS,/arxiv_data1/oa_pdf/14/27/main.PMC5454160.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
"1Present address: 207/435 Coronation Drive, Auchen ﬂower, QLD, 4066. http://dx.doi.org/10.1016/j.onehlt.2017.03.002 2352-7714/Crown Copyright © 2017 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
(http://www9.health.gov.au/cda/Source/CDA-index.cfm ).,OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
( http://stat.abs.gov.au/ itt/r.jsp?RegionSummary&region=312&dataset=ABS_NRP9_ASGS&geoconcept= REGION&datasetASGS=ABS_NRP9_ASGS&d atasetLGA=ABS_NRP9LGA&regionLGA= REGION&regionASGS=REGION ).,OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
2016 ( http://www.socscistatistics.com/tests/spearman/Default.aspx ).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
2 (7) (2011) 1 –10http://www.webmedcentral.com (20th December 2014).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/main.PMC5454161.pdf
Published by Elsevier Ireland Ltd. Thi s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EndocarditisBacteremiaAntibiotic prophylaxisDental care 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/02/main.PMC5454162.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/02/main.PMC5454162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/02/main.PMC5454162.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/c7/02/main.PMC5454162.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.010 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/48/main.PMC5454163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/48/main.PMC5454163.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/67/48/main.PMC5454163.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary artery disease Risk factors Aorto-ostial disease 1.,Non-OADS,/arxiv_data1/oa_pdf/71/f2/main.PMC5454164.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.016 2352-9067/© 2016 Published by Elsevier Ireland Ltd.,Non-OADS,/arxiv_data1/oa_pdf/71/f2/main.PMC5454164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/f2/main.PMC5454164.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/71/f2/main.PMC5454164.pdf
"The recent development of advanced, PCR-based techniques capable http://dx.doi.org/10.1016/j.onehlt.2017.04.002 Received 2 November 2016; Received in revised form 12 April 2017; Accepted 25 April 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"Geiger, A. Loukas, D. Diemert, et al., Soil- transmitted helminth infections: ascariasis, trichuriasis, and hookworm, Lancet 367 (2006) 1521 –1532, http://dx.doi.org/10.1016/S0140-6736(06)68653-4 .",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"[3] R. Traub, R. Hobbs, P. Adams, J. Behnke, P. Harris, R. Thompson, A case of mistaken identity– reappraisal of the species of canid and felid hookworms (Ancylostoma ) present in Australia and India, Parasitology 134 (2007) 113 –119, http://dx.doi.org/10.1017/S0031182006001211 .",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"86 (4) (2012) 624 –634, http://dx.doi.org/10.4269/ajtmh.2012.11-0413 .",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"Gasser, Genetic characterization of selected parasites from people with histories of gastrointestinal disorders using a mutation scanning-coupled approach,Electrophoresis (2013), http://dx.doi.org/10.1002/elps.201300100 .",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"2 (2013) 173 –177, http://dx.doi.org/ 10.1016/j.ijppaw.2013.04.003 .",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"45 (2014) 167 –184, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"2 (2016), http://dx.doi.org/10.1080/23311843.2016.1214228 .",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"181 (1) (2011) 69 –73,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"155 (2008) 67 –73,http://dx.doi.org/10.1016/j.vetpar.2008.05.001 .",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"http://www.physics.csbsju.edu/stats/ , (1996) Accessed 10.05.16).",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"[24] Australian Bureau of Statistics, Mossman Gorge (ILOC30200303) Indigenous Proﬁle.http://www.censusdata.abs.gov.au/census_services/getproduct/census/ 2011/quickstat/ILOC30200303?opendocument&navpos=220 , (2011) (Accessed 29.04.16).",Non-OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011/quickstat/ILOC30801502?opendocument&navpos=220 , (2011) (Accessed 29.04.16).",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011/ quickstat/ILOC30201101?opendocument&navpos=220 , (2011) (Accessed 29.04.16).",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
"21 (2015) 426 –432, http://dx.doi.org/10.1016/j.cmi.2015.01.004 .F.A.",OADS,/arxiv_data1/oa_pdf/f1/6c/main.PMC5454165.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Wesselsbron virusRodentsBlack ratEastern Senegal 1.,Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.02.001 2352-7714/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
"107 (3) (2013 Mar) 200 –203, http://dx.doi.org/10.1093/ trstmh/trs095 .",Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
"46 (4) (Feb 15 2008) 516 –522, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
"14 (Jul 19 2015) 281, http://dx.doi.org/10.1186/s12936-015- 0808-y .",Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
"13 (5) (2013 May) 330 –336, http://dx.doi.org/10.1089/vbz.2012.1181 (Epub 2013 Mar 8).",Non-OADS,/arxiv_data1/oa_pdf/04/91/main.PMC5454166.pdf
Published by Elsevier Ireland Ltd. Thi s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Transcatheter aortic valve implantationCoreValve®Evolut R ™ Paravalvular leak 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.06.002 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"References [1]M. Abdel-Wahab, J. Mehilli, C. Frerker, F.J. Neumann, T. Kurz, R. Tolg, D. Zachow, E. Guerra, S. Massberg, U. Schafer, M. El-Mawardy, G. Richardt, Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial, JAMA 311 (2014)1503 –1514, http://dx.doi.org/10.1001/jama.2014.3316.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"2 (2009) 821 –827, http://dx.doi.org/10.1016/j.jcin.2009.07.003.",OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"4 (2011) 851 –858, http://dx.doi.org/10.1016/j.jcin.2011.03.019.",OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"42 (2012) S45 –S60, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"[5]N. Piazza, G. Martucci, K. Lachapelle, B. de Varennes, L. Bilodeau, J. Buithieu, D.Mylotte, First-in-human experience with the Medtronic CoreValve Evolut R, EuroIntervention 9 (2014) 1260 –1263, http://dx.doi.org/10.4244/EIJV9I11A215.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"63 (2014) 1972 –1981, http://dx.doi.org/10.1016/j.jacc.2014.02.",OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"Mohr, G. Schuler, Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation, Europace 14 (2012) 1759 –1763, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"59 (2012) 1134 –1141, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"33 (2012) 2451 –2496, http://dx.doi.org/10.1093/eurheartj/ehs109.",Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
"195 (2015) 171 –175, http://dx.doi.org/10.1016/j.ijcard.2015.",OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5454167.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Muscle vasodilatationForearm vascular conductanceExerciseGenetic polymorphism Alpha-adrenergic receptor Endothelial nitric oxide synthaseBradykinin B2 receptorCardiovascular genetics 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/62/main.PMC5454168.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.10.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/62/main.PMC5454168.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/62/main.PMC5454168.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/1b/62/main.PMC5454168.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.009 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC5454169.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC5454169.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC5454169.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.09.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/b6/main.PMC5454170.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/b6/main.PMC5454170.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/ae/b6/main.PMC5454170.pdf
Published by Elsevier Ireland Ltd. Th is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Comprehensive cardiac rehabilitationCardiovascular diseaseSimple non-invasive testsArterial pressure volume indexAc o e f ﬁcient of variation of the R –R interval 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/main.PMC5454171.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.004 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/main.PMC5454171.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/main.PMC5454171.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/bc/c1/main.PMC5454171.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MERS Coronavirus InterventionReviewDromedary camel Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/main.PMC5454172.pdf
http://dx.doi.org/10.1016/j.onehlt.2016.12.001 2352-7714/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/main.PMC5454172.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/d4/main.PMC5454172.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pericardial diseaseCompressionTamponadeConstrictionPredictors Diagnostic accuracy 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5454173.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.005 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5454173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5454173.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/7c/61/main.PMC5454173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cardiac amyloidosisEchocardiographyCardiac magnetic resonance imaging Regression TreatmentSurvival 1.,Non-OADS,/arxiv_data1/oa_pdf/45/e6/main.PMC5454174.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.12.002 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/45/e6/main.PMC5454174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/e6/main.PMC5454174.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/45/e6/main.PMC5454174.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Tako-tsuboStress cardiomyopathyCardiac magnetic resonanceInfarct quantitationLate gadolinium enhancement Speckle tracking strain echocardiography 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/main.PMC5454175.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.009 2352-9067/Crown Copyright © 2016 Published by Elsevier Ireland Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/main.PMC5454175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/main.PMC5454175.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/c5/a9/main.PMC5454175.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.07.003 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/4d/main.PMC5454176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4d/main.PMC5454176.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/af/4d/main.PMC5454176.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DipyridamoleMyocardial perfusion scanAdverse effects 1.,Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.002 2352-9067/© 2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"60 (2012) e44 –e164, http://dx.doi.org/10.1016/j.jacc.2012.07.013 .",OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"Imaging 32 (2005) 855 –897, http://dx.doi.org/10.1007/s00259-005-1779-y .",Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"53 (2009) 2201 –2229, http://dx.doi.org/10.1016/j.jacc.2009.02.013 .",OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"38 (2010) 149 –152, http://dx.doi.org/10.2967/jnmt.109.072629 .",Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"38 (2010) 163 –171, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"330 (1994) 1782 –1788, http://dx.doi.org/10.1056/NEJM199406233302503 .",Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"7 (2000) 439–446, http://dx.doi.org/10.1067/mnc.2000.108030 .",Non-OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
"23 (2014) 89–95,http://dx.doi.org/10.4274/mirt.85057 .19 S.-D. Lee et al.",OADS,/arxiv_data1/oa_pdf/00/01/main.PMC5454177.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary angiographyTransradial catheterizationRadial artery occlusion Access site complications 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/60/main.PMC5454178.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.12.003 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/60/main.PMC5454178.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/60/main.PMC5454178.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/8e/60/main.PMC5454178.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MERS-CoVSerologyNeutralizing antibodiesDromedary camelsMaliMiddle East respiratory syndrome coronavirus Emerging Zoonotic infection 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/64/main.PMC5454179.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.03.003 2352-7714/© 2017 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/f1/64/main.PMC5454179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/64/main.PMC5454179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary artery tortuosityGenderExtent scoreGensini score 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/7e/main.PMC5454180.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.11.0052352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/7e/main.PMC5454180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/7e/main.PMC5454180.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/fc/7e/main.PMC5454180.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Coronary calci ﬁcation CMR Coronary CTExertional angina and myocardial perfusion 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/1a/main.PMC5454181.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.12.001 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/1a/main.PMC5454181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/1a/main.PMC5454181.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/f4/1a/main.PMC5454181.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Conservation medicine Zoonoses Animal healthGlobal health The increasingly international work of both public health institu- tions (such as governments, non-governmental organizations, non- proﬁt organizations, and/or schools of public health and medicine) and accredited zoos, including over 200 zoological facilities in North America accredited by the Association of Zoos and Aquariums (AZA) and 300 member facilities in the European Association of Zoos and Aquaria, re ﬂects the reality that our world is shrinking [1].",Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
http://dx.doi.org/10.1016/j.onehlt.2016.11.003 2352-7714/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003467 .,Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
"[16] The Zoo Animal Health Network, http://www.zooanimalhealthnetwork.org/WNV .",Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
"[17] The Zoo Animal Health Network, http://www.zooanimalhealthnetwork.org/ai/ .",Non-OADS,/arxiv_data1/oa_pdf/70/ff/main.PMC5454182.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: One HealthOne medicine Multi-disciplinary research Biosolids Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
http://dx.doi.org/10.1016/j.onehlt.2017.03.004 2352-7714/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
"[2] World Health Organization, WHO publishes list of top emerging diseases likely to cause major epidemicsAvailable from: http://www.who.int/medicines/ebola-treat- ment/WHO-list-of-top-emerging-diseases/en/ 2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
"[9] Global Health Observatory [Internet], Available from: http://apps.who.int/gho/data/ node.home .",OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
"[16] University of Washington, Ebola and One HealthAvailable from: http://deohs.wash- ington.edu/cohr/ebola-and-one-health 2016.",Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
"[34] One Health Commission, World Health through CollaborationAvailable from: https://www.onehealthcommission.org 2016.",Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
One Health 2013 [Available from: https://www.cdc.gov/onehealth/ .50 J. Lebov et al.,Non-OADS,/arxiv_data1/oa_pdf/5a/22/main.PMC5454183.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ProGlide Vascular closureCostCardiac catheterization 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/4d/main.PMC5454184.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.09.002 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/4d/main.PMC5454184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/4d/main.PMC5454184.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/1a/4d/main.PMC5454184.pdf
"For a national comparison of per patient costs, refer tohttp://www.ahaonlinestore.com/ProductDisplay.asp?ProductID= 637.",Non-OADS,/arxiv_data1/oa_pdf/1a/4d/main.PMC5454184.pdf
"Published by Elsevier Ireland Ltd. Thi s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pulmonary hypertension by echoPulmonary pressure by echocardiographyTricuspid Regurgitation VmaxPulmonary acceleration time Pulmonary vascular resistance by echo Pulmonary hypertension (PHT) is a pathological haemodynamic condition de ﬁned as an increase in mean pulmonary arterial pressure (mPAP) ≥25mmHg at rest, assessed using gold standard investigation by right heart catheterisation [1].",Non-OADS,/arxiv_data1/oa_pdf/da/08/main.PMC5454185.pdf
http://dx.doi.org/10.1016/j.ijcha.2016.05.011 2352-9067/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/08/main.PMC5454185.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/08/main.PMC5454185.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/da/08/main.PMC5454185.pdf
"[25] D. Dawson, J. Grapsa, P. Nihoyannopoulos, et al., Protocol for the assessment of patients with suspected pulmonary hypertension, British Society of Echocardiography, 2011 (Online article, URL- http://www.bsecho.org/guideline-protocol-for-assessment- of-patients-with-suspected-pulmonary-hypertension/ ).",Non-OADS,/arxiv_data1/oa_pdf/da/08/main.PMC5454185.pdf
GSE74129; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token =kvkhuoounnyhnkn&acc =GSE74129).,OADS,/arxiv_data1/oa_pdf/77/eb/icb20172a.PMC5454315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ rThe Author(s) 2017 The Supplementary Information that accompanies this paper is available o n the Immunology and Cell Biology website (http://www.nature.com/icb).Myeloid S100 proteins reduce lung in ﬂammation YH i r o s h i m a et al 472 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/77/eb/icb20172a.PMC5454315.pdf
"Read counts were associatedto each gene (based on UCSC-derived mm9 GTF gene annotations), usingthe featureCounts software 42(http://bioinf.wehi.edu.au/featureCounts/) setting the options -T 2 -p -P. Absolute gene expression was de ﬁned determining reads per kilobase per million mapped reads (RPKM) as previously described,43deﬁning total library size as the number of reads mapping to exons only.",OADS,/arxiv_data1/oa_pdf/8c/c8/onc2016443a.PMC5454316.pdf
"47,48 Data availability The NGS datasets used in this work are available on the GEO archive underthe accession code GSE80195 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE80195).",OADS,/arxiv_data1/oa_pdf/8c/c8/onc2016443a.PMC5454316.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)p53-regulated transcription in Myc-driven lymphomas C Tonelli et al 2929 Oncogene (2017) 2921 –2929",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/onc2016443a.PMC5454316.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)The role of cancer-FOXP3 in PDAC X Wang et al 3058 Oncogene (2017) 3048 –3058",Non-OADS,/arxiv_data1/oa_pdf/d3/63/onc2016458a.PMC5454319.pdf
Available from: http://cw.routledge.com/textbooks/ 9780415537902/data/case/7_Radiography.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/a5/JMRS-64-146.PMC5454320.pdf
J Med Radiat Sci 2017. https://doi.org/10.1002/jmrs.186.,Non-OADS,/arxiv_data1/oa_pdf/e2/3d/JMRS-64-79.PMC5454321.pdf
J Med Radiat Sci 2017. https://doi.org/10.1002/jmrs.189.,Non-OADS,/arxiv_data1/oa_pdf/e2/3d/JMRS-64-79.PMC5454321.pdf
Available from: http://www.radher.jp/J- RIME/report/DRLhoukokusyoEng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/20/JMRS-64-82.PMC5454333.pdf
2016; https://www.nccn.org/profes-sionals/physician_gls/f_guidelines.asp.Genetic Testing Positive Follow NCCN management  recommendations for the  syndrome identified Negative Management should be  based on the patient’s  personal and family history  Variant of Unknown  Significance Should be treated like a  negative result- management should be  based on the patient's  personal and family history Figure 1 Clinical management recommendations based on the three possible results from genetic testing.Hereditary Gastrointestinal Panel Testing Maga et al.,Non-OADS,/arxiv_data1/oa_pdf/5b/97/ctg201719a.PMC5454385.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2017Network Meta-analysis Drug 1 Drug 3Drug 4 Drug 2Drug 1 Drug 2 Drug 3 Drug 1 Drug 4Drug 2Traditional Pairwise Meta-analysis Figure 1 Differences between traditional meta-analyses and network meta- analyses.",Non-OADS,/arxiv_data1/oa_pdf/81/ce/ctg201720a.PMC5454386.pdf
"22In order to detect joint areas of demyelination causing cer- tain symptoms, images have to be brought into a stan-dard space; this was achieved by spatially normalizing alldemyelination load masks using the spatial deformationﬁeld generated by spatially normalizing high-resolutionT1 3D datasets to MNI space, applying segmentationfunctionality available within the statistical parametricmapping (SPM12) software (http://www.fil.ion.ucl.ac.uk/ spm/software/spm12/).",Non-OADS,/arxiv_data1/oa_pdf/84/47/ACN3-4-403.PMC5454396.pdf
http://www.mdsabstracts.org/abstract/utilizing-remote-blood-pressure-monitoring-in-a-phase-iii- clinical-drug-trial-for-parkinsons-disease/.,Non-OADS,/arxiv_data1/oa_pdf/4f/23/ACN3-4-360.PMC5454402.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/Roles of intestinal epithelial cells R Okumura and K Takeda 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/bf/e1/emm201720a.PMC5454438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Microbiota in chronic in ﬂammatory diseases DK i m et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/b6/a4/emm201724a.PMC5454439.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)miR-200a-3p desensitizes Hep3B cells to 5-FU HL e e et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/3f/ab/emm201733a.PMC5454440.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/Microbiota in T-cell responses NL e ea n dW - UK i m 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/af/78/emm201736a.PMC5454441.pdf
"The results were analyzed using ImageJ software (http://rsb.info.nih.gov/ij/, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/51/f9/emm201741a.PMC5454443.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)TMEM119 and tumorigenesis of osteosarcoma Z-H Jiang et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/51/f9/emm201741a.PMC5454443.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Helicobacter pylori -derived extracellular vesicles H-I Choi et al 13 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/63/23/emm201747a.PMC5454444.pdf
Luciferase-reporter gene assay The target gene of miR-124 was predicted by the online softwareTargetscan 7.1 (http://www.targetscan.org/vert_71/).,OADS,/arxiv_data1/oa_pdf/cf/70/emm201748a.PMC5454445.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Lentivirus-mediated miR-124-modi ﬁed BMSCs and SCI J-L Song et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/cf/70/emm201748a.PMC5454445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Engulfment signals and the phagocytic machinery S-Y Park and I-S Kim 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d3/d9/emm201752a.PMC5454446.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Editorial 2 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/53/a5/emm201755a.PMC5454447.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Transcriptome analyses of CTE J-S Seo et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/57/29/emm201756a.PMC5454448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Carbonic anhydrases in skin wounds H Barker et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/3b/5a/emm201760a.PMC5454449.pdf
"Function predictionof the mutant FKBP51 was performed using PloyPhen-2(http://genetics.bwh.harvard.edu/pph2/) and PyMol (DeLano Scienti ﬁc LLC, San Carlos, CA, USA).",OADS,/arxiv_data1/oa_pdf/03/e4/emm201764a.PMC5454451.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/A novel FKBP5 mutation is associated with PDB BL u et al 13 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/03/e4/emm201764a.PMC5454451.pdf
Available  from: http://www.chinacdc.cn.,Non-OADS,/arxiv_data1/oa_pdf/cb/dd/CMJ-130-1320.PMC5455042.pdf
Available from: http://www.nhfpc.gov.cn/jkj/s3578/201503/ bfb58052642b4a9e93e5de254a1b55fd.shtml.,Non-OADS,/arxiv_data1/oa_pdf/cb/dd/CMJ-130-1320.PMC5455042.pdf
"The data on PubMed  (http://www.ncbi.nlm.nih.gov/pubmed/, last accessed on  January 6, 2017) show that in the past 16 years, an increasing  number of IR articles have been published by Chinese  interventionists [ Figure  2a].",Non-OADS,/arxiv_data1/oa_pdf/9c/3c/CMJ-130-1371.PMC5455048.pdf
"[20] We searched the National Natural Science Foundation of  China (NSFC, http://www.nsfc.gov.cn/, last accessed on  January 6, 2017), which was set up by the Chinese Central  Government, and is the most common research foundation for  medical scientists.",Non-OADS,/arxiv_data1/oa_pdf/9c/3c/CMJ-130-1371.PMC5455048.pdf
"In the past 10 years, the  number of national continuing medical education programs  has increased from 19 to 121 (http://cmegsb.cma.org.cn/,  last accessed on January 6, 2017), with an annual growth  of 20% [ Figure  2d].",Non-OADS,/arxiv_data1/oa_pdf/9c/3c/CMJ-130-1371.PMC5455048.pdf
"Vienna, Austria: R Foundation for Statistical Computing.Available at http://www.R-project.org Rajimehr, R., Vaziri-Pashkam, M., Afraz, S.-R., & Esteky, H. (2004).",Non-OADS,/arxiv_data1/oa_pdf/df/13/i1534-7362-17-5-18.PMC5455068.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/ licenses/by-nc-nd/4.0/ =$ DOI: 10.1200/JOP.2016.011486 ; published online ahead of print at jop.ascopubs.org on September 6, 2016.A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs Derrick S. Haslem, S. Burke Van Norman, Gail Fulde, Andrew J. Knighton, Tom Belnap, Allison M. Butler, Sharanya Rhagunath, David Newman, Heather Gilbert, Brian P. Tudor, Karen Lin, Gary R. Stone, David L. Loughmiller, Pravin J. Mishra, Rajendu Srivastava, James M. Ford, and Lincoln D. Nadauld QUESTION ASKED: What are the clinical outcomes and health care –associated costs in patients with advanced cancer who receive precision cancer medicine?",Non-OADS,/arxiv_data1/oa_pdf/e0/6f/JOP.2016.011486.PMC5455156.pdf
"2RP is exceptionally heterogeneous, with more than 100 genetic causes alreadydescribed (RetNet: https://sph.uth.edu/retnet/, in the publicdomain).",Non-OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"Targeted-Capture Retinal Panels G e n o m i cD N Af r o me a c ha v a i l a b l ef a m i l ym e m b e rw a sanalyzed for the presence of mutations in retinal disease genes listed in RetNet (https://sph.uth.edu/retnet/, accessed June 1,2016) using a targeted-capture NGS research protocol.",Non-OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"The Exome Aggregation Consortium (ExAC) data set (http://exac.broadinstitute.org/, in the public domain) and 1000 Genomes Database (http://www.1000genomes.org/, in the public domain) (both accessed December 12, 2016) were searched for the presence of the SAG p.Cys147Phe mutation.",OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"Variant Effect Predictor (http://www.ensembl.org/info/docs/ tools/vep/index.html, in the public domain), which aggregates a number of different pathogenicity prediction algorithmsincluding SIFT, PolyPhen-2, and Condel, predicted the pathoge- nicity of the SAG p.Cys147Phe mutation.",OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"Additional analyses using PROVEAN (http://provean.jcvi.org/, in the public domain) and MutationTaster (http://www.mutationtaster.org/, in the public domain) also were used.",OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"Multiple sequences were aligned using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/ clustalo/, in the public domain).",OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"In databases ofhealthy control populations (e.g., ExAC, 1000Genomes), this variant appears once only, at a frequency of 1 per 120,594alleles overall, and in 1 per 11,566 Hispanic alleles (ExACdatabase accessed December 14, 2016; http://exac.broadinstitute.org/).",Non-OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"This is borne out by an earlier study of families with adRP from the Northeastern region of the United States,22where the Hispanic population is signiﬁcantly smaller than in Texas or California and is also primarily of Caribbean and South American origin (U.S. Census Bureau Report C2010BR-04: http://www.census.",Non-OADS,/arxiv_data1/oa_pdf/ba/a1/i1552-5783-58-5-2774.PMC5455168.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncomme rcial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 34:1915–1918 (June 1, 2017) Mary Ann Liebert, Inc.DOI: 10.1089/neu.2015.4179 1915",Non-OADS,/arxiv_data1/oa_pdf/78/0c/neu.2015.4179.PMC5455214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/f8/sfw147.PMC5455215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/60/sfw135.PMC5455253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/9c/sfw111.PMC5455255.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org .Conflict of interest statement None declared.,Non-OADS,/arxiv_data1/oa_pdf/d3/9c/sfw111.PMC5455255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/aex118.PMC5455256.pdf
Available from https://www.nice.org.uk/guidance/cg174 (accessed 20 November 2016) 2.,Non-OADS,/arxiv_data1/oa_pdf/b8/3a/aex118.PMC5455256.pdf
Available from http://www.bapen.org.uk/ pdfs/bapen_pubs/giftasup.pdf (accessed 20 November 2016) 3.,Non-OADS,/arxiv_data1/oa_pdf/b8/3a/aex118.PMC5455256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/sfw129.PMC5455257.pdf
"For example, the Academia and Industrycollaboration for Digital PATHology (AIDPATH, http://aidpath.eu/) is an international effort focused on interoperability of digi-tal pathology applications across multiple projects, institutionsand disciplines ( Table 1 ).Pharmaceutical industry-sponsored clinical trials have worked with the digital pathology industry, applying previouslyunderused software to create methodologies that improve reli-ability and reproducibility of data collection [ 6].",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/sfw129.PMC5455257.pdf
"Wikipedia, https://en.wikipedia.org/wiki/Standardization (August 2016, date last accessed) 8.",Non-OADS,/arxiv_data1/oa_pdf/6e/0b/sfw129.PMC5455257.pdf
[cited 1986]; Available  from: URL:   http://www.who.int/healthpromotion/conferences/p revious/ottawa/en/index4.html   20.,Non-OADS,/arxiv_data1/oa_pdf/11/6a/ARYA-12-281.PMC5455327.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by- nc-nd/4.0/ INTRODUCTION For postmenopausal women with clinical stage II or III estrogen receptor (ER) –positive breast cancer, neoadjuvant aromatase inhibition (AI) isan underused and low-toxicity alternative to chemotherapy for increasing breast conservationrates.",Non-OADS,/arxiv_data1/oa_pdf/8b/d3/JCO.2016.69.4406.PMC5455353.pdf
"Available at: http://eyewiki.aao.org/Optical_Coherence_Tomography, Accessed February 15, 2017.",Non-OADS,/arxiv_data1/oa_pdf/dd/f3/i1552-5783-58-6-BIO1.PMC5455411.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by- nc-nd/4.0/ INTRODUCTION Since the discovery of the testosterone dependence of prostate cancer in the 1940s,1medical or surgical castration has been a ﬁrst-line treatment of ad- vanced prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/b3/b6/JCO.2016.69.5304.PMC5455459.pdf
"Eur J Cancer 51:101-111, 2015 9.Socialstyrelsen: National Board of Health and Welfare: The Prescribed Drug Register [in Swedish], 2008.http://www.nepi.net/Socialstyre lsens-laekemedelsregister.",Non-OADS,/arxiv_data1/oa_pdf/b3/b6/JCO.2016.69.5304.PMC5455459.pdf
"Int J Epidemiol 42:956-967, 2013 11.Nationella prostatacancerregistret: RATTEN Online Reporting System [in English], 2015. http:// www.npcr.se12.Statistics Sweden: Longitudinal integration database for health insurance and labour marketstudies (LISA by Swedish acronym) [in Swedish].http://www.scb.se 13.Berglund A, Garmo H, Tishelman C, et al: Comorbidity, treatment and mortality: A populationbased cohort study of prostate cancer in PCBaSeSweden.",OADS,/arxiv_data1/oa_pdf/b3/b6/JCO.2016.69.5304.PMC5455459.pdf
fda.gov/Drugs/DrugSafety/ucm383904.htm 18.American Cancer Society: Cancer facts & ﬁgures 2016. http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/b3/b6/JCO.2016.69.5304.PMC5455459.pdf
"N Engl J Med 372:724-734,2015 8.National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology:Breast cancer version 2.2016. http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#site 9.Cardoso F, Costa A, Norton L, et al: ESO- ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).",Non-OADS,/arxiv_data1/oa_pdf/f0/a8/JCO.2016.67.4887.PMC5455677.pdf
"http://ec.europa.eu/health/ documents/community-reg ister/2014/20140630129157/ anx_129157_en.pdf 32.Baselga J, Cort ´es J, Kim SB, et al: Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f0/a8/JCO.2016.67.4887.PMC5455677.pdf
Sample size calculations were performed with East 5 software package (Cytel; http://www.cytel.com/ ) comparing two groups.,OADS,/arxiv_data1/oa_pdf/f0/a8/JCO.2016.67.4887.PMC5455677.pdf
http://ctep.cancer.gov .,Non-OADS,/arxiv_data1/oa_pdf/f0/a8/JCO.2016.67.4887.PMC5455677.pdf
"Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by- nc-nd/4.0/ INTRODUCTION A fusion gene comprising the echinoderm microtubule-associated protein-like 4 ( EML4 ) gene and the anaplastic lymphoma kinase ( ALK) gene has been identi ﬁed as an oncogenic driver mutation in non –small-cell lung cancer (NSCLC).1 ALK-positive disease is a distinct subset of NSCLC, occurring in approximately 5% of patients withadvanced adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/f8/e9/JCO.2016.70.5749.PMC5455704.pdf
http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/f8/e9/JCO.2016.70.5749.PMC5455704.pdf
"Oncolo-gist 19:e5-e11, 2014 5.Pharmaceuticals and Medical Devices Agency: Report on the Deliberation Results (Crizotinib), 2012. https://www.pmda.go.jp/ ﬁles/000153949.pdf 6.Solomon BJ, Mok T, Kim DW, et al: First-line crizotinib versus chemotherapy in ALK-positive lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/f8/e9/JCO.2016.70.5749.PMC5455704.pdf
"http://www.clinicaltrials.jp/user/cteList_e.jsp# 15.Shaw AT, Kim DW, Nakagawa K, et al: Cri- zotinib versus chemotherapy in advanced ALK-posi- tive lung cancer.",OADS,/arxiv_data1/oa_pdf/f8/e9/JCO.2016.70.5749.PMC5455704.pdf
"It may also http://dx.doi.org/10.1016/j.ssmph.2016.10.008 Received 9 August 2016; Received in revised form 17 October 2016; Accepted 17 October 2016⁎Correspondence to: Dornsife School of Public Health, Drexel University, Department of Epidemiology and Biostatistics, 3215 Market Street, 5th Floor, Philadelphia, PA 19104, USA.",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"〈http://www.epi.org/publication/the_state_of_working_ americas_wealth_2011/ 〉 Avendano, M., & Glymour, M. M. (2008).",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Journal of Epidemiology Community Health , 59(7), 542– 545. http://dx.doi.org/10.1136/jech.2004.021147 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Retrieved from 〈http://www.bls.gov/data/ 〉 Carter, K. N., Blakely, T., Collings, S., Imlach Gunasekara, F., & Richardson, K. (2009).",OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Journal of Epidemiology & Community Health , 63(3), 221– 226. http://dx.doi.org/10.1136/jech.2008.079483 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"International Journal of Epidemiology , 31(2), 359– 367. http://dx.doi.org/10.1093/ije/31.2.359 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Journal of the American Association of Nurse Practitioners, 27(8), 457– 465. http://dx.doi.org/10.1002/2327-6924.12215 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/10.1016/S0140-6736(11)60827-1 .,OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"American Journal of Epidemiology , 166(8), 966– 974. http://dx.doi.org/10.1093/aje/kwm155 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Annals of the New York Academy of Sciences , 896(1), 335– 337. http://dx.doi.org/10.1111/j.1749-6632.1999.tb08133.x .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/ 10.1542/peds.2016-0340 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/10.1016/S0140-6736(07)60368-7 .,OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/10.2337/dc06-0022 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/10.1177/0002716213497452 .,Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"American Journal of Preventive Medicine , 33(3), 250– 264. http://dx.doi.org/10.1016/j.amepre.2007.04.033 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Journal of Epidemiology and Community Health , 67(5), 439– 445. http://dx.doi.org/10.1136/jech-2012-200999 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Annals of Epidemiology , 19(3), 202– 209. http://dx.doi.org/10.1016/j.annepidem.2008.12.005 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"International Journal of Methods in Psychiatric Research , 21(2), 88 –97.http://dx.doi.org/10.1002/mpr.1349.R Core Team (2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
http://dx.doi.org/10.1016/S0140-6736(12)60072-5 .,OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Social Psychiatry and Psychiatric Epidemiology , 46(7), 549– 558. http://dx.doi.org/10.1007/s00127-010-0221-3 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Academic Emergency Medicine , 21(5), 510– 519. http://dx.doi.org/10.1111/acem.12369.",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Journal of Statistical Software , 64(8) (Retrieved from) 〈http://www.jstatsoft.org/v64/i08 〉.",OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Social Science & Medicine , 124, 85 –93.http://dx.doi.org/10.1016/j.socscimed.2014.11.027 .",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"Social Science & Medicine , 130, 234– 241. http://dx.doi.org/10.1016/j.socscimed.2015.02.028 .F.",Non-OADS,/arxiv_data1/oa_pdf/7d/a6/main.PMC5455782.pdf
"MeSH Keywords:  Apoptosis • Endothelial Cells • MAP Kinase Kinase 7  Abbreviations:  EOCs  – endothelial outgrowth cells; ADMA  – asymmetric dimethylarginine; JNK – c-Jun N-terminal pro - tein kinase; EPCs – endothelial progenitor cells  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904718Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Neurology, The Second Hospital of Tianjin Medical University,  Tianjin, P.R.",Non-OADS,/arxiv_data1/oa_pdf/d2/7c/medscimonit-23-2535.PMC5455802.pdf
"MeSH Keywords:  Lupus Erythematosus, Systemic • Myositis • Prevalence • Risk Factors  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902016Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Epidemiology and Biostatistics, School of Public Health,   Anhui Medical University, Hefei, Anhui, P.R.",Non-OADS,/arxiv_data1/oa_pdf/05/e0/medscimonit-23-2543.PMC5455803.pdf
"MeSH Keywords:  Diethylpropion • Lupus Nephritis • TNF Receptor-Associated Factor 6  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/900667Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Emergency, Linyi People’s Hospital, Linyi, Shandong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/29/2e/medscimonit-23-2550.PMC5455804.pdf
"MeSH Keywords:  Intra-Abdominal Fat • Mesenteric Vascular Occlusion • Panniculitis, Peritoneal • Torsion Abnormality  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903574Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Emergency Medicine, Taoyuan Armed Forces General Hospital,  National Defense Medical Center, Taoyuan, Taiwan 2 Department of Surgery, Taoyuan Armed Forces General Hospital, National  Defense Medical Center, Taoyuan, Taiwan 3 Department of Radiology, Taoyuan Armed Forces General Hospital, National  Defense Medical Center, Taoyuan, TaiwanISSN 1941-5923 © Am J Case Rep, 2017; 18: 589-592 DOI: 10.12659/AJCR.903574 589 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/76/94/amjcaserep-18-589.PMC5455808.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/18/31/10.1177_2325967117S00177.PMC5455837.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/18/31/10.1177_2325967117S00177.PMC5455837.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/0b/79/10.1177_2325967117S00190.PMC5455838.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0b/79/10.1177_2325967117S00190.PMC5455838.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/49/0d/10.1177_2325967117S00165.PMC5455845.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/49/0d/10.1177_2325967117S00165.PMC5455845.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/28/3e/10.1177_2325967117S00172.PMC5455846.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/28/3e/10.1177_2325967117S00172.PMC5455846.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/e2/2f/10.1177_2325967117S00166.PMC5455847.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e2/2f/10.1177_2325967117S00166.PMC5455847.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/8d/e6/10.1177_2325967117S00160.PMC5455848.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8d/e6/10.1177_2325967117S00160.PMC5455848.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/8a/eb/10.1177_2325967117S00198.PMC5455849.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8a/eb/10.1177_2325967117S00198.PMC5455849.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/c1/a1/10.1177_2325967117S00191.PMC5455851.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c1/a1/10.1177_2325967117S00191.PMC5455851.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/eb/65/10.1177_2325967117S00186.PMC5455852.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/eb/65/10.1177_2325967117S00186.PMC5455852.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/a1/3c/10.1177_2325967117S00178.PMC5455853.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a1/3c/10.1177_2325967117S00178.PMC5455853.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/65/61/10.1177_2325967117S00170.PMC5455854.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/65/61/10.1177_2325967117S00170.PMC5455854.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/e5/9a/10.1177_2325967117S00195.PMC5455855.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e5/9a/10.1177_2325967117S00195.PMC5455855.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/a9/3c/10.1177_2325967117S00192.PMC5455857.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a9/3c/10.1177_2325967117S00192.PMC5455857.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/98/6d/10.1177_2325967117S00194.PMC5455858.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/98/6d/10.1177_2325967117S00194.PMC5455858.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/89/7f/10.1177_2325967117S00200.PMC5455859.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/89/7f/10.1177_2325967117S00200.PMC5455859.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/55/03/10.1177_2325967117S00202.PMC5455860.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/55/03/10.1177_2325967117S00202.PMC5455860.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/d0/f6/10.1177_2325967117S00171.PMC5455861.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d0/f6/10.1177_2325967117S00171.PMC5455861.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/8b/8b/10.1177_2325967117S00156.PMC5455862.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8b/8b/10.1177_2325967117S00156.PMC5455862.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/84/00/10.1177_2325967117S00205.PMC5455863.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/84/00/10.1177_2325967117S00205.PMC5455863.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/26/17/10.1177_2325967117708286.PMC5455864.pdf
http://www.nrmp.org/wp-content/ uploads/2016/04/Main-Match-P rogram-Results-2012-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/26/17/10.1177_2325967117708286.PMC5455864.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/10.1177_2325967117S00207.PMC5455876.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/5b/00/10.1177_2325967117S00207.PMC5455876.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/6c/4d/10.1177_2325967117S00199.PMC5455877.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6c/4d/10.1177_2325967117S00199.PMC5455877.pdf
"https://doi.org/10.1177/1758834017699772   https://doi.org/10.1177/1758834017699772 Therapeutic Advances in Medical OncologyTher Adv Med Oncol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/2f/e0/10.1177_1758834017699772.PMC5455879.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav journals.sagepub.com/home/tam 441 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License   (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).We read with interest the article on a recent ret- rospective analysis from The Ohio State University, which reported that a modified regi-men of nab-paclitaxel plus gemcitabine (biweekly [q2w]) in patients with metastatic pancreatic cancer was associated with an acceptable toxicity profile and appeared to be relatively effective.",Non-OADS,/arxiv_data1/oa_pdf/2f/e0/10.1177_1758834017699772.PMC5455879.pdf
"ECOG  performance status, http://ecog-acrin.org/resources/ ecog-performance-status (2016, accessed 15 November 2016).",OADS,/arxiv_data1/oa_pdf/2f/e0/10.1177_1758834017699772.PMC5455879.pdf
"https://doi.org/10.1177/1758834017702820   https://doi.org/10.1177/1758834017702820 Therapeutic Advances in Medical OncologyTher Adv Med Oncol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/13/69/10.1177_1758834017702820.PMC5455880.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav journals.sagepub.com/home/tam 387 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License   (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction With 1.6 million deaths expected annually, lung cancer is the most common cause of cancer-related death worldwide in both men and women.",Non-OADS,/arxiv_data1/oa_pdf/13/69/10.1177_1758834017702820.PMC5455880.pdf
"https://doi.org/10.1177/1758834017704329   https://doi.org/10.1177/1758834017704329 Therapeutic Advances in Medical Oncology journals.sagepub.com/home/tam 405 Ther Adv Med Oncol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/d2/10.1177_1758834017704329.PMC5455881.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License   (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Pretest probability is used in medicine on a daily basis.",Non-OADS,/arxiv_data1/oa_pdf/40/d2/10.1177_1758834017704329.PMC5455881.pdf
"https://doi.org/10.1177/1758834017708742   https://doi.org/10.1177/1758834017708742 Therapeutic Advances in Medical Oncology journals.sagepub.com/home/tam 431 Ther Adv Med Oncol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ed/24/10.1177_1758834017708742.PMC5455883.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License   (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Cervical cancer is the fourth most common cause of cancer-related deaths in women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ed/24/10.1177_1758834017708742.PMC5455883.pdf
"https://doi.org/10.1177/1758834017709238   https://doi.org/10.1177/1758834017709238 Therapeutic Advances in Medical OncologyTher Adv Med Oncol 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9f/98/10.1177_1758834017709238.PMC5455884.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav journals.sagepub.com/home/tam 445 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License   (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Reply to Von Hoff and Renschler’s Letter to  the Editor re: Ahn et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/98/10.1177_1758834017709238.PMC5455884.pdf
Ther Adv Med Oncol  https://doi.org/10.1177/1758834016676011 We have reviewed with great interest the letter by  Von Hoff and Renschler.,Non-OADS,/arxiv_data1/oa_pdf/9f/98/10.1177_1758834017709238.PMC5455884.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/86/ae/10.1177_2325967117708190.PMC5455885.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/2a/9b/10.1177_2325967117S00201.PMC5455886.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2a/9b/10.1177_2325967117S00201.PMC5455886.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/61/76/10.1177_2325967117S00169.PMC5455887.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/61/76/10.1177_2325967117S00169.PMC5455887.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/31/e8/10.1177_2325967117S00162.PMC5455889.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/31/e8/10.1177_2325967117S00162.PMC5455889.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/6b/e0/10.1177_2325967117S00196.PMC5455890.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6b/e0/10.1177_2325967117S00196.PMC5455890.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/55/7a/10.1177_2325967117S00176.PMC5455891.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/55/7a/10.1177_2325967117S00176.PMC5455891.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/c7/af/10.1177_2325967117S00188.PMC5455892.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c7/af/10.1177_2325967117S00188.PMC5455892.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/da/fd/10.1177_2325967117S00181.PMC5455893.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/da/fd/10.1177_2325967117S00181.PMC5455893.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/7f/f4/10.1177_2325967117S00163.PMC5455894.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7f/f4/10.1177_2325967117S00163.PMC5455894.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/10.1177_2325967117S00161.PMC5455895.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/10.1177_2325967117S00161.PMC5455895.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/e1/40/10.1177_2325967117S00197.PMC5455903.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e1/40/10.1177_2325967117S00197.PMC5455903.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/d5/d2/10.1177_2325967117S00203.PMC5455942.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d5/d2/10.1177_2325967117S00203.PMC5455942.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/10.1177_2325967117S00164.PMC5455943.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/10.1177_2325967117S00164.PMC5455943.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/b9/cd/10.1177_2325967117S00157.PMC5455944.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b9/cd/10.1177_2325967117S00157.PMC5455944.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/27/78/10.1177_2325967117S00189.PMC5455945.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/27/78/10.1177_2325967117S00189.PMC5455945.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/a9/ff/10.1177_2325967117S00159.PMC5455946.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a9/ff/10.1177_2325967117S00159.PMC5455946.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/24/b6/10.1177_2325967117S00174.PMC5455947.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/24/b6/10.1177_2325967117S00174.PMC5455947.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/10.1177_2325967117S00183.PMC5455948.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/10.1177_2325967117S00183.PMC5455948.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/55/2d/10.1177_2325967117S00158.PMC5455949.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/55/2d/10.1177_2325967117S00158.PMC5455949.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/7a/91/10.1177_2325967117S00167.PMC5455950.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7a/91/10.1177_2325967117S00167.PMC5455950.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ca/68/10.1177_2325967117708307.PMC5455952.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/4b/59/10.1177_2325967117S00175.PMC5455953.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/4b/59/10.1177_2325967117S00175.PMC5455953.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/0d/5b/10.1177_2325967117S00185.PMC5455956.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0d/5b/10.1177_2325967117S00185.PMC5455956.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/25/msx119.PMC5455958.pdf
"All strains are maintained in the Roscoff Culture Collection (RCC), in France (http://roscoff-culture-collection.org/).",Non-OADS,/arxiv_data1/oa_pdf/33/25/msx119.PMC5455958.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/54/21/10.1177_2325967117S00206.PMC5455961.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/54/21/10.1177_2325967117S00206.PMC5455961.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a0/10.1177_2325967117S00180.PMC5455962.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ac/a0/10.1177_2325967117S00180.PMC5455962.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/86/msx096.PMC5455965.pdf
"The source code is available at https://github.com/foxyiris/PhyloFates (last accessed March 3, 2017).",Non-OADS,/arxiv_data1/oa_pdf/cd/86/msx096.PMC5455965.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/ec/msx106.PMC5455966.pdf
Protein sequences were retrieved from Genbank and the http://pristionchus.org databases.,OADS,/arxiv_data1/oa_pdf/e3/ec/msx106.PMC5455966.pdf
"URL: http://www.wormbook.org Susoy V, Ragsdale EJ, Kanzaki N, Sommer RJ.",OADS,/arxiv_data1/oa_pdf/e3/ec/msx106.PMC5455966.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/42/ba/10.1177_2325967117S00184.PMC5455967.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/42/ba/10.1177_2325967117S00184.PMC5455967.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/2b/msx111.PMC5455968.pdf
"Phylogenetic Analyses Sequence alignments were prepared for phylogenetic analysis by stripping sites with >20% missing data and removing tandem repeats using Phobos v. 3.3.12 (http://www.ruhr- uni-bochum.de/spezzoo/cm/cm_phobos.htm; last accessed March 25, 2017).",OADS,/arxiv_data1/oa_pdf/fb/2b/msx111.PMC5455968.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/10.1177_2325967117S00168.PMC5455969.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/4f/7a/10.1177_2325967117S00168.PMC5455969.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/10/47/10.1177_2325967117S00204.PMC5455970.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/10/47/10.1177_2325967117S00204.PMC5455970.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/d6/29/10.1177_2325967117S00179.PMC5455972.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d6/29/10.1177_2325967117S00179.PMC5455972.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/8d/65/10.1177_2325967117S00173.PMC5455973.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8d/65/10.1177_2325967117S00173.PMC5455973.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/11/14/10.1177_2325967117S00193.PMC5455974.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/11/14/10.1177_2325967117S00193.PMC5455974.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/e3/4c/10.1177_2325967117S00182.PMC5455976.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e3/4c/10.1177_2325967117S00182.PMC5455976.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Correspondence to:  HE Hulst  VU University Medical Center, Dept.",Non-OADS,/arxiv_data1/oa_pdf/b6/83/10.1177_1352458517692422.PMC5455978.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to:  B Brochet  Service de Neurologie, CHU de Bordeaux, F-33076 Bordeaux, France.",Non-OADS,/arxiv_data1/oa_pdf/b6/83/10.1177_1352458517692422.PMC5455978.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/11/93/10.1177_2325967117S00208.PMC5455979.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/11/93/10.1177_2325967117S00208.PMC5455979.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
( c) Window of the QTL Oar25 interval (Oarv3.1) extracted from the UCSC genome browser (https://genome-euro.ucsc.edu) and a zoom of the region around the IRF2BP2 gene.,OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
Visualinspection of sequences using the Integrative Genomics Viewer (IGV) software (https://www.broadinstitute.org/igv/) pinpointed an insertion of approximately 1500 bp and locatedwithin the IRF2BP2 gene.,OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
"We identified within the Berrichon du Cher indi-vidual, using the BLAST program (https://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
We also exploited data from the international NextGen project which are publicly available (http://nextgen.epﬂ.ch/).Genome-Wide Identification of the Mutation Underlying Fleece Variation .doi:10.1093/molbev/msx114 MBE 1727,OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
"Wetruly appreciated the involvement of various breed organiza- tions for their assistance in sample collection (France Ge´ne´tique Elevage http://en.france-genetique-elevage.org/, FranceAgriMer http://www.franceagrimer.fr/, le Groupement des Moutons d’Ouessant http://www.mou- tons-ouessant.com/and l’Institut de l’Elevage http://idele.fr/).Demars et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
We also thank the International Sheep Genomics Consortium (http://www.sheephapmap.org /) for providing additional sequences especially for primitive sheep as Ovis Canadensis and Ovis dalli .,Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
"Finally, We thank the different platforms: 1) LABOGENA (http://www.labogena.fr/), especially J.Ogereau and B. Camus, for the genotyping using both Illumina OvineSNP50 Genotyping and Ovine Infinium HD SNP Beadchips, 2) the Get-Plage platform (http://get.geno-toul.fr/) for the NextGen Sequencing using the Illumina HiSeq 3000 system and all the complementary analyses, and 3) IGM Genomics Center (http://igm.ucsd.edu/genomics/) and itsdirector K. Jepsen for the PacBio sequencing service.",Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
"We are also grateful to H. Berge `s of the CNRGV (http://cnrgv.tou- louse.inra.fr/) for their assistance with BAC sequencing anal-yses, C. Klopp from SIGENAE (http://www.sigenae.org/) for his support with bioinformatics analyses and C. Robert for her help with statistical analyses.",Non-OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
Both genotyping data are available at http://genoweb.toulouse.inra.,OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
Sequences have been submitted t o public EMBL-EBI database with accession n /C14PRJEB14418 for the seven whole genome sequencing and to http://genoweb.toulouse.inra.fr/ /C24jdemars/CH243-319B01.fasta for the BAC sequence.,OADS,/arxiv_data1/oa_pdf/b4/6c/msx114.PMC5455980.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/67/msx118.PMC5455981.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/33/msx075.PMC5455982.pdf
"In particular, we looked fora-a n d b-tubulin, myosin, actin, and the actin regulating Arp2/3-complex that consists of seven actin-related proteins( a r p 2 ,a r p 3 ,A R P C 1 ,A R P C 2 ,A R P C 3 ,A R P C 4 ,a n dA R P C 5 ) .Reference alignments and sequences downloaded fromPFAM (http://pfam.xfam.org/), as well as relevant other re-cently published alignments ( Hou et al.",OADS,/arxiv_data1/oa_pdf/e3/33/msx075.PMC5455982.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/e6/msx117.PMC5455983.pdf
To compare the annotated genes in louse endosymbionts we used reciprocal best tBLASTx 2.5.0 þto identify shared genes (scripts for filtering blast results obtained from http://goo.gl/csx730).,OADS,/arxiv_data1/oa_pdf/5c/e6/msx117.PMC5455983.pdf
"Second,BLAST hits were filtered to find only the bidirectional best hitsbetween every possible taxa set (scripts for filtering blast re-sults obtained from http://goo.gl/csx730).",OADS,/arxiv_data1/oa_pdf/5c/e6/msx117.PMC5455983.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/09/c3/10.1177_2325967117S00209.PMC5455999.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/09/c3/10.1177_2325967117S00209.PMC5455999.pdf
"2016 Combined Australian Knee Society and New Zealand Knee & Sport Society Meeting     T h i s 	o p e n ‐ a c c e s s 	a r t i c l e 	i s 	p u b l i s h e d 	a n d 	d i s t r i b u t e d 	u n d e r 	t h e 	 Creative	 Commons	 Attribution	 ‐	 NonCommercial	 ‐	 No	 Derivatives	 License	 (http://creativecommons.org/licenses/by‐nc‐nd/3.0/),	which	perm its	the	noncommercial	use,	distr ibution,	and	reproduction	of	th e	article	in	any	medium,	 provided	the	original	author	and	source	are	credited.",Non-OADS,/arxiv_data1/oa_pdf/e5/0d/10.1177_2325967117S00187.PMC5456000.pdf
"For	 reprints	and	permission	queries,	please	visit	SAGE’s	Web	site	a t	http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e5/0d/10.1177_2325967117S00187.PMC5456000.pdf
"https://doi.org/10.1177/2333794X17711767Global Pediatric Health Volume 4: 1 –3  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17711767 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article In 2012, the American Academy of Pediatrics (AAP)  asserted that neonatal male circumcision provides enough medical benefit to justify continued access to this procedure on an elective basis, and in 2015, the Centers for Disease Control and Prevention (CDC) issued a statement recommending male circumcision for all infants.",Non-OADS,/arxiv_data1/oa_pdf/70/e3/10.1177_2333794X17711767.PMC5456024.pdf
http://www.cdc.gov/nchs/data/hestat/circumcisions/circumcisions.htm.,Non-OADS,/arxiv_data1/oa_pdf/70/e3/10.1177_2333794X17711767.PMC5456024.pdf
http://healthdata.dshs.texas.gov/Population.,Non-OADS,/arxiv_data1/oa_pdf/70/e3/10.1177_2333794X17711767.PMC5456024.pdf
http://www.myhighplains.com/ news/refugee-population-growing-too-quickly-in-ama- rillo.,Non-OADS,/arxiv_data1/oa_pdf/70/e3/10.1177_2333794X17711767.PMC5456024.pdf
"https://doi.org/10.1177/2050313X17711064 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –5 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17711064 journals.sagepub.com/home/sco Introduction It is estimated that there will be approximately 76,380 new  diagnoses and 10,130 deaths due to melanoma in the United States during 2016.",Non-OADS,/arxiv_data1/oa_pdf/1f/20/10.1177_2050313X17711064.PMC5456025.pdf
"Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1975_2013/  2.",Non-OADS,/arxiv_data1/oa_pdf/1f/20/10.1177_2050313X17711064.PMC5456025.pdf
"Molecular profiling of melanoma, https://www.mycancergenome.org/content/disease/mela- noma/ (accessed 15 September 2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/20/10.1177_2050313X17711064.PMC5456025.pdf
"BRAF: genetics home ref-erence, https://ghr.nlm.nih.gov/gene/BRAF#location (accessed 15 September 2016).",OADS,/arxiv_data1/oa_pdf/1f/20/10.1177_2050313X17711064.PMC5456025.pdf
"https://doi.org/10.1177/2333794X17711342Global Pediatric Health Volume 4: 1 –5  © The Author(s) 2017 Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17711342 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Rickets is a serious disorder that may be congenital,  genetic, or acquired secondary to vitamin D deficiency,  with apparent physical features confirmed by radiologi - cal findings and blood tests.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/10.1177_2333794X17711342.PMC5456026.pdf
http://www.medis.or.jp/4_hyojyun/medis-mas - ter/.,Non-OADS,/arxiv_data1/oa_pdf/02/c7/10.1177_2333794X17711342.PMC5456026.pdf
http://www.doh.wa.gov/ portals/1/documents/5500/smallnumbers.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/c7/10.1177_2333794X17711342.PMC5456026.pdf
(Preliminary results in Japanese: http://www.env.go.jp/ chemi/ceh/results/index.html#health.),Non-OADS,/arxiv_data1/oa_pdf/02/c7/10.1177_2333794X17711342.PMC5456026.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AdolescentsDepressionPreventionInternet Cognitive behavioral therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/j.invent.2017.02.003 2214-7829/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1542/ peds.112.2.e119 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1007/s11121-016-0737-1 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1037/a0017391 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
Retrieved from http://www.samhsa.gov/data/sites/default/ ﬁles/NSDUH-FRR1-2014/NSDUH- FRR1-2014.pdf ).,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1111/add.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1002/pon.3075 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1080/10919392.2006.9681199 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1007/s11121-007-0070-9 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1001/archpsyc.61.8.807 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
BMC Psychiatry 10:113. http://dx.doi.org/10.1186/1471-244X-10-113 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
Internet Interventions 6:50 –56.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
"Pew Research Center, Washington, D.C. (April 9, 2015, http://www.pewinternet.org/2015/04/09/teens- social-media-technology-2015/ ).25 E.G.",Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1002/jclp.20531 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
BMC Psychiatry 14:14. http://dx.doi.org/10.1186/1471-244X-14-14 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/j.cpr.2010.08.002 .,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1097/PSY.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
Psychiatry http://dx.doi.org/10.1111/eip.12354 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
"Science and Practice, Clinical Psychology http://dx.doi.org/10.1111/cpsp.12173 .",Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/S0272- 7358(99)00026-4 .,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2011.1503 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1016/S0140-6736(11)60871-4 .,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
30 (1):23 –37.http://dx.doi.org/10.1097/DBP.0b013e3181966c2a .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
51:30 –47.http://dx.doi.org/10.1016/j.cpr.,OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.2196/jmir.1857 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.1007/ s11121-015-0620-5 .,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
http://dx.doi.org/10.2196/jmir.2033 .26 E.G.,Non-OADS,/arxiv_data1/oa_pdf/10/82/main.PMC5456272.pdf
"The full terms of this license are available at https:// www.dovepress.com/terms.php  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License  (http://creativecommons.org/licenses/by-nc/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/bc/1a/nihms-830154.PMC5456281.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php ).",Non-OADS,/arxiv_data1/oa_pdf/bc/1a/nihms-830154.PMC5456281.pdf
Creative Commons At- tribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ INTRODUCTION Adenoid cystic carcinoma (ACC) is a common malignant salivary gland tumor with a recurrencerate of 40% to 50% after curative intent treat-ment.,Non-OADS,/arxiv_data1/oa_pdf/24/ab/JCO.2016.67.5264.PMC5456373.pdf
"https://doi.org/10.1177/1179299X17710944 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Biomarkers in Cancer Volume 9: 1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179299X17710944 Background The incidence of prostate cancer is increasing and accounts for  25% of cancer diagnosis in men in the United Kingdom1 and  8% of all cancer cases worldwide as of 2012.2 The rising inci- dence is partly due to an ageing population and is also second-arily related to routine testing for serum prostate-specific antigen (PSA).",Non-OADS,/arxiv_data1/oa_pdf/f2/04/10.1177_1179299x17710944.PMC5457026.pdf
A TMA of prostate tumour samples was constructed by the  WCB using a semi-automated TMA Master (3DHISTECH; http://www.3dhistech.com/tma_master) and 0.6 mm diameter  cores.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/10.1177_1179299x17710944.PMC5457026.pdf
REfERE nCE s  1. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics- by-cancer-type/prostate-cancer/survival.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/10.1177_1179299x17710944.PMC5457026.pdf
2. http://www.wcrf.org/int/cancer-facts-figures/worldwide-data.,Non-OADS,/arxiv_data1/oa_pdf/f2/04/10.1177_1179299x17710944.PMC5457026.pdf
"https://doi.org/10.1177/1176934317710945 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Evolutionary Bioinformatics Volume 13: 1–15 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176934317710945 Introduction Mitochondria are responsible for aerobic energy production in  eukaryotic cells.1,2 Although most of the proteins of mitochon- dria are coded by nuclear DNA, a number of essential proteins are coded by mitochondrial DNA (mtDNA).",Non-OADS,/arxiv_data1/oa_pdf/97/96/10.1177_1176934317710945.PMC5457027.pdf
"However, CAB85525.1 has been annotated as maturase-like protein (https://www.ncbi.nlm.nih.gov/protein/cab85525.1).",Non-OADS,/arxiv_data1/oa_pdf/97/96/10.1177_1176934317710945.PMC5457027.pdf
"https://doi.org/10.1177/1179546817710934 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Cardiology Volume 11: 1–2 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179546817710934 Case Report A 76-year-old woman with atrial fibrillation, chest pain, dysp- nea, and 1 prior episode of syncope presented to our medical center for pulmonary vein and coronary artery evaluation prior to an ablation procedure.",Non-OADS,/arxiv_data1/oa_pdf/c8/0c/10.1177_1179546817710934.PMC5457028.pdf
"https://doi.org/10.1177/1179552217709456 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Gastroenterology Volume 10: 1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179552217709456 Introduction Gastroesophageal reflux disease (GERD) is a condition that  develops when the reflux of stomach contents causes trouble-some symptoms and/or complications such as heartburn or acid indigestion.",Non-OADS,/arxiv_data1/oa_pdf/a7/0b/10.1177_1179552217709456.PMC5457029.pdf
"Both the treatments were well tolerated with few reports of adverse events.TRiAL ReGiSTRAT iOn: This trial is registered with http://clinicaltrials.gov, number NCT02140073.",Non-OADS,/arxiv_data1/oa_pdf/a7/0b/10.1177_1179552217709456.PMC5457029.pdf
http://www.worldgastroenterology.org/guidelines/global-guidelines/gastroesophageal-reflux-disease/gastroesoph - ageal-reflux-disease-english.,Non-OADS,/arxiv_data1/oa_pdf/a7/0b/10.1177_1179552217709456.PMC5457029.pdf
"March 7, 2014. http://www.ema.europa.eu/docs/ en_GB/document_library/Referrals_document/Domperidone_31/ Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_ Committee/WC500162559.pdf.",Non-OADS,/arxiv_data1/oa_pdf/a7/0b/10.1177_1179552217709456.PMC5457029.pdf
https://www.medicines.org.uk/emc/medicine/18865#POSOLOGY.,Non-OADS,/arxiv_data1/oa_pdf/a7/0b/10.1177_1179552217709456.PMC5457029.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1603266/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/74/0f/1603266.PMC5457030.pdf
"N. Russell, Framing Lorentz symmetry (2004); http://cerncourier.com/cws/article/cern/ 29224.",Non-OADS,/arxiv_data1/oa_pdf/74/0f/1603266.PMC5457030.pdf
"Sun, W. Zhao, S. Lv, D. Liu, C. Li, Y. Zhang, Y. Hu, Y. Xu, L. Zhao, G. Liu, Z. Mao, X. Jia, F. Zhang, S. Zhang, F. Yang, Z. Wang, Q. Peng, H. Weng, X. Dai, Z. Fang, Z. Xu, C. Chen, X. J. Zhou, Electronic Evidence for Type II WeylSemimetal State in MoTe 2, http://arxiv.org/abs/1604.01706 (2016).",OADS,/arxiv_data1/oa_pdf/74/0f/1603266.PMC5457030.pdf
"H. Dil, J. Mesot, H. Ding, M. Shi, Discovery of Weyl semimetal state violating Lorentz invariance in MoTe 2, http://arxiv.org/abs/1604.02116 (2016).",Non-OADS,/arxiv_data1/oa_pdf/74/0f/1603266.PMC5457030.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602705/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/36/1602705.PMC5457031.pdf
"Shock wave database, http://teos.ficp.ac.ru/rusbank/ 46.",OADS,/arxiv_data1/oa_pdf/8c/36/1602705.PMC5457031.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1603170/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/65/c2/1603170.PMC5457032.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/2c/ott-10-2745.PMC5457035.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2745–2750OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2745Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13662 1 neoadjuvant chemotherapy combined with limb  salvage surgery in patients with limb osteosarcoma  of enneking stage ii: a retrospective study guangke Yuan1,2 Jingming chen2 Dongjin Wu1 chunzheng gao1 1Department of Orthopedics,   The second hospital of shandong  University, Jinan, 2Department of  Orthopedics, Yidu central hospital  of Weifang, Weifang, shandong,   People’s republic of chinaObjective:  To explore the effect of neoadjuvant chemotherapy combined with limb salvage  surgery in patients with limb osteosarcoma of Enneking stage II.",Non-OADS,/arxiv_data1/oa_pdf/7d/2c/ott-10-2745.PMC5457035.pdf
"The oncologic outcomes of osteosarcoma are poor because of its high  malignancy and characteristics prone to metastasis.3 The goal of osteosarcoma treatment  is to control the primary tumor and (micro-)metastatic deposits, to maintain maximal  extremity function and to minimalize the treatment-related adverse reactions.4 With the improvement of requirements to quality of life, limb salvage surgery  has become the main way of treatment of limb osteosarcoma with satisfying local correspondence: chunzheng gao Department of Orthopedics, The second  hospital of shandong University, no 247  north Park street, Tianqiao District,  Jinan 250100, shandong Province,  People’s republic of china Tel +86 151 5316 9697 email prfgao@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Yuan et al Running head recto: Neoadjuvant chemotherapy in patients with limb osteosarcoma DOI: http://dx.doi.org/10.2147/OTT.S136621",Non-OADS,/arxiv_data1/oa_pdf/7d/2c/ott-10-2745.PMC5457035.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/2c/ott-10-2745.PMC5457035.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/2c/ott-10-2745.PMC5457035.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/c6/ott-10-2737.PMC5457036.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2737–2738OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2737COrrigendumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13913 2 Fibronectin 1 promotes migration and invasion of papillary thyroid cancer  and predicts papillary thyroid cancer lymph node metastasis [Corrigendum] Xia S, Wang C, Postma EL, Y ang Y, Ni X, Zhan W .",Non-OADS,/arxiv_data1/oa_pdf/16/c6/ott-10-2737.PMC5457036.pdf
The  correct images in Figure 6 are as follows: Journal name: OncoTargets and Therapy Article Designation: Corrigendum Y ear: 2017 Volume: 10 Running head verso: Xia et al Running head recto: Fibronectin 1 promotes migration and invasion of papillary thyroid cancer DOI: http://dx.doi.org/10.2147/OTT.S139132 Figure 6/HQWLYHFWRUKRXUV /HQWLILEURQHFWLQ /HQWLYHFWRUKRXU /HQWLILEURQHFWLQ $ /HQWL YHFWRU/HQWL ILEURQHFWLQ1XPEHURIFHOO      /HQWLYHFWRU  /HQWLILEURQHFWLQ % & /HQWL YHFWRU/HQWL ILEURQHFWLQ1XPEHURIFHOO      /HQWLYHFWRU  /HQWLILEURQHFWLQ  ' (,Non-OADS,/arxiv_data1/oa_pdf/16/c6/ott-10-2737.PMC5457036.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/c6/ott-10-2737.PMC5457036.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/c6/ott-10-2737.PMC5457036.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-12-4073.PMC5457120.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4073–4084International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4073OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S12515 4 In situ preparation of water-soluble ginsenoside  rh2-entrapped bovine serum albumin  nanoparticles: in vitro cytocompatibility studies Priyanka singh1,2 Yeon Ju Kim1 hina singh1 sungeun ahn1 Verónica castro-aceituno1 Deok chun Yang1,2 1Department of Oriental Medicine  Biotechnology, ginseng Bank,   2graduate school of Biotechnology,   college of life sciences, Kyung hee  University, Y ongin, republic of KoreaAbstract:  The present study investigates a simple and convenient one-step procedure for the  preparation of bovine serum albumin (BSA)-Rh2 nanoparticles (NPs) at room temperature.",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-12-4073.PMC5457120.pdf
"Keywords:  bovine serum albumin, ginsenoside Rh2, solubility, stability, cancer, inflammation Introduction Nanotechnology and development of nanoparticle (NP) carriers for the delivery of  poor water-soluble drugs is a considerable area of research and has gained increased  attention.1 Many drug delivery systems have been developed by utilizing organic,  inorganic, and metal-based nanocarriers; however, achieving efficient drug loading  or entrapment in NP carriers, with improved stability and availability of drug in its  active form, is itself a challenging task.2 Thus, there is a continuous need for devel - oping promising drug delivery nanocarriers which can overcome these limitations.3  Among various nanocarriers, biomacromolecular proteins have arisen as potential drug  delivery carriers by overcoming the confines of conventional drug delivery systems correspondence: Priyanka singh;   Yeon Ju Kim Department of Oriental Medicine  Biotechnology, ginseng Bank, college  of life sciences, Kyung hee University,  Yongin 446-701, republic of Korea Tel +82 31 201 2100 Fax +82 31 202 2688 email prnksingh254@gmail.co m;  yeonjukim@khu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Singh et al Running head recto: BSA-Rh2 NPs for stable and enhanced Rh2 delivery DOI: http://dx.doi.org/10.2147/IJN.S125154",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-12-4073.PMC5457120.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-12-4073.PMC5457120.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/bc/ijn-12-4073.PMC5457120.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/ott-10-2761.PMC5457121.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2761–2768OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2761Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13102 2 Efficacy and safety of TACE in combination with  sorafenib for the treatment of TACE-refractory  advanced hepatocellular carcinoma in chinese  patients: a retrospective study Jianbing Wu* An Li* Jiajin Yang* Yanjun lu Jie li Department of Oncology,   The second affiliated hospital  of nanchang University, nanchang,   Jiangxi, People’s Republic of China *These authors contributed  equally to this workBackground:  Transarterial chemoembolization (TACE) and sorafenib (SOR) are well- established treatments for hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/ott-10-2761.PMC5457121.pdf
"1 Mingde road,  nanchang, Jiangxi 330006, People’s  Republic of China Tel +86 135 0791 7177 email hhgwjb@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wu et al Running head recto: TACE and sorafenib for HCC DOI: http://dx.doi.org/10.2147/OTT.S131022",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/ott-10-2761.PMC5457121.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a1/f1/ott-10-2761.PMC5457121.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/f1/ott-10-2761.PMC5457121.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/21/ijn-12-3993.PMC5457122.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3993–4005International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3993OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13518 9 Iron oxide nanoparticles and induced autophagy  in human monocytes Qihong Wu1 rong rong Jin2 Ting Feng1 li liu2 li Yang2 Yuhong Tao3 James M anderson4,5 hua ai2,6 hong li1,3 1Key laboratory of Obstetrics,   gynecology, Pediatric Disease, and  Birth Defects, Ministry of education,   West china second University  hospital, 2National engineering  research center for Biomaterials,   3Department of Pediatrics, West  china second University hospital,   sichuan University, chengdu,   china; 4Department of Biomedical  engineering, 5Department of  Pathology, case Western reserve  University, cleveland, Oh, Us;   6Department of radiology, West  china hospital, sichuan University,   chengdu, chinaAbstract:  Superparamagnetic iron oxide nanoparticles have been widely used in biomedical  applications, but understanding of their interactions with the biological immune system is  relatively limited.",Non-OADS,/arxiv_data1/oa_pdf/9e/21/ijn-12-3993.PMC5457122.pdf
"With monocytes as  mediators of adaptive and innate immunity, they can be either developed into various correspondence: hua ai; hong li 29 Wangjiang road/20 section 3  south renmin road, chengdu,  sichuan 610064/610041, china Tel +86 28 8541 3991; 8550 3602 Fax +86 28 8541 3991; 8550 2930 email huaai@scu.edu.c n;   lhong3985@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wu et al Running head recto: Iron oxide NPs induce autophagy in human monocytes DOI: http://dx.doi.org/10.2147/IJN.S135189",Non-OADS,/arxiv_data1/oa_pdf/9e/21/ijn-12-3993.PMC5457122.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9e/21/ijn-12-3993.PMC5457122.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/21/ijn-12-3993.PMC5457122.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/cd/cia-12-917.PMC5457123.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 917–921Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  917OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S13635 5 effect of small-dose levosimendan on mortality  rates and organ functions in Chinese elderly  patients with sepsis Xin Wang1,* shikui li2,* 1Intensive Care Unit, 2Cardiothoracic  surgery, Daqing Oilfield general  hospital, Daqing, heilongjiang,   People’s republic of China *These authors contributed equally  to this workAim:  As a primary cause of death not only in Western countries but also in the People’s Republic  of China, sepsis is diagnosed as abnormal organ functions as a result of a disordered response to a  severe infection.",Non-OADS,/arxiv_data1/oa_pdf/33/cd/cia-12-917.PMC5457123.pdf
"Keywords:  Chinese elderly, levosimendan, mortality rate, organ function, sepsis, small-dose Introduction Patients with sepsis have a mortality rate of 30%–40% across the world.1 As a primary  cause of death not only in Western countries but also in China, sepsis is diagnosed as  abnormal organ functions as a result of a disordered response to a severe infection.2  Its most severe appearance is septic shock because of circulatory disturbance and  metabolic abnormalities.3 Levosimendan (Qilu Pharmaceutical, Jinan, People’s  Republic of China) is a new kind of calcium-sensitizing agent that has the potential to  improve the cardiovascular function and blood circulation without obviously increas - ing the oxygen demand and impairing the diastolic relaxation.4–6 Moreover, previous  studies have suggested that levosimendan improves the pulmonary, renal, liver, and Correspondence: shikui li Cardiothoracic surgery, Daqing  Oilfield General Hospital, 8 Zhongkang  street, saertu District, Daqing 163001,  heilongjiang, People’s republic of China email i skxw12@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wang and Li Running head recto: Effect of levosimendan on sepsis DOI: http://dx.doi.org/10.2147/CIA.S136355",Non-OADS,/arxiv_data1/oa_pdf/33/cd/cia-12-917.PMC5457123.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/33/cd/cia-12-917.PMC5457123.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/33/cd/cia-12-917.PMC5457123.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/85/ott-10-2751.PMC5457124.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2751–2760OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2751Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13700 0 Pretreatment combination of platelet counts and  neutrophil–lymphocyte ratio predicts survival  of nasopharyngeal cancer patients receiving  intensity-modulated radiotherapy Yu-hsuan lin1 Kuo-Ping chang2 Yaoh-shiang lin2,3 Ting-shou chang2–4 1Department of Otolaryngology, head  and neck surgery, national cheng  Kung University hospital, college  of Medicine, national cheng Kung  University, Tainan, 2Department of  Otolaryngology, head and neck  surgery, Kaohsiung Veterans general  hospital, Kaohsiung, 3Department  of Otolaryngology, head and neck  surgery, national Defense Medical  center, Taipei, 4institute of Public  health, college of Medicine, national  cheng Kung University, Tainan, Taiwan,   republic of chinaBackground:  Increased cancer-related inflammation has been associated with unfavorable  clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/8b/85/ott-10-2751.PMC5457124.pdf
"Keywords:  nasopharyngeal carcinoma, intensity-modulated radiotherapy, inflammation-based  marker, combination of platelet count and neutrophil–lymphocyte ratio, prognosis Introduction Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its  association with the Epstein–Barr virus (EBV) infection, demographic tendencies,  clinical behavior, and treatment.1,2 Although recent epidemiologic studies have found it  to be declining in incidence in several previous endemic areas, it remains unchanged in  southern China, where it has an incidence .20/100,000 person-years.1 Compared with  conventional two-dimensional radiotherapy, the combination of newly developed  intensity-modulated radiotherapy (IMRT) and chemotherapy has been found to extend correspondence: Ting-shou chang Department of Otolaryngology, head  and neck surgery, Kaohsiung Veterans  general hospital, no 386, Ta-chung  1st road, Kaohsiung 813, Taiwan,  republic of china Tel +886 975 58 1251 Fax +886 7 342 2121 email asoschang@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Lin et al Running head recto: COP-NLR predicts survival of NPC patients receiving IMRT DOI: http://dx.doi.org/10.2147/OTT.S137000",Non-OADS,/arxiv_data1/oa_pdf/8b/85/ott-10-2751.PMC5457124.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/85/ott-10-2751.PMC5457124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/85/ott-10-2751.PMC5457124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/91/cia-12-911.PMC5457126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 911–915Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  911CAse serIesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S13536 4 Full-thickness macular hole formation following  anti-VeGF injections for neovascular age-related  macular degeneration stamatina A Kabanarou1 Tina Xirou1 George Mangouritsas1 Christina Garnavou-Xirou2 eirini Boutouri1 Ilias Gkizis1 Irini Chatziralli3 1retina Department, Korgialeneio  Benakeio, Hellenic red Cross  Hospital, Athens, Greece; 2retina  Department, King’s College Hospital,   London, UK; 32nd Department of  Ophthalmology, University of Athens,   Athens, GreecePurpose:  Macular hole (MH) is part of a group of age-related degenerative diseases characterized  by pathology of vitreomacular interface.",Non-OADS,/arxiv_data1/oa_pdf/20/91/cia-12-911.PMC5457126.pdf
"Keywords:  macular hole, age-related macular degeneration, anti-VEGF Introduction Age-related macular degeneration (AMD) is the leading cause of irreversible visual  loss in elderly population in the developed world and its prevalence increases with  age, ranging from 0.2% (for people aged 55–64 years) to 13% (for those older  than 85 years).1–3 Neovascular AMD (nAMD) can lead to visual impairment due  to the development of choroidal neovascularization (CNV), and its prevalence is  estimated to be 0.17%–5.8%.1,3 Vascular endothelial growth factor (VEGF) is the  main angiogenic factor involved in the pathogenesis of nAMD.4 Therefore, over  the last two decades, intravitreal anti-VEGF agents are considered the standard of  care in nAMD, aiming to block CNV activity and consequently prevent vision loss  and improve vision in some cases.5 Specifically, the two FDA-approved anti-VEGF  agents for nAMD are ranibizumab (Lucentis®; Novartis, Basel, Switzerland), a  recombinant antigen-binding fragment that neutralizes all isoforms of VEGF-A,6  and aflibercept (Eylea; Bayer Healthcare, Berlin, Germany), which is a recombinant  fusion protein consisting of human VEGF receptor extracellular domains from  receptors 1 and 2 (VEGFR1 and VEGFR2) fused to the Fc domain of the human  IgG backbone and also binded to all isomers of the VEGF-A family, VEGF-B, and  placental growth factor.7Correspondence: stamatina A Kabanarou retina Department, Korgialeneio  Benakeio Hellenic red Cross Hospital,  1 erithrou stavrou street 115 26,  Athens, Greece Tel +30 21 3206 8251 email stamatina_k@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Case Series Y ear: 2017 Volume: 12 Running head verso: Kabanarou et al Running head recto: Macular hole after anti-VEGF for AMD DOI: http://dx.doi.org/10.2147/CIA.S135364",Non-OADS,/arxiv_data1/oa_pdf/20/91/cia-12-911.PMC5457126.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/20/91/cia-12-911.PMC5457126.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/20/91/cia-12-911.PMC5457126.pdf
"https://doi.org/10.1177/1177625017710009 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Gene Regulation and Systems Biology Volume 11: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177625017710009 Introduction Type 2 diabetes mellitus (T2DM) is a heterogeneous collection  of diseases with the single common characteristic of an impaired response to insulin.",Non-OADS,/arxiv_data1/oa_pdf/67/61/10.1177_1177625017710009.PMC5457139.pdf
The generated data set is in the National Center for Biotechnology Information Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/pro-jects/geo/) database (GSE 13271).,OADS,/arxiv_data1/oa_pdf/67/61/10.1177_1177625017710009.PMC5457139.pdf
"https://doi.org/10.1177/1177390117711938 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Analytical Chemistry Insights Volume 12: 1–6 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177390117711938 Introduction Since the discovery of a blue carbocyanine compound in  1856,1 the cyanine class has been studied extensively for vari- ous applications, such as in vivo imaging,2–6 ex vivo imaging  (pH sensing and DNA stains),7,8 blood spatter analysis,9 and  solar energy conversion.10,11 The interest in the use of these  dyes for the treatment and imaging of cancer and other   diseases has increased in the past few decades.",Non-OADS,/arxiv_data1/oa_pdf/05/83/10.1177_1177390117711938.PMC5457140.pdf
https://doi.org/10.1177/1179546817709787 Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.,Non-OADS,/arxiv_data1/oa_pdf/8e/3e/10.1177_1179546817709787.PMC5457142.pdf
"org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed  as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Cardiology Volume 11: 1–11 © The Author(s) 2017 DOI: 10.1177/1179546817709787 Introduction Aortic diseases, or aortopathies, include thoracic abdominal  aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA).",Non-OADS,/arxiv_data1/oa_pdf/8e/3e/10.1177_1179546817709787.PMC5457142.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700171/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/19/b3/1700171.PMC5457143.pdf
"https://doi.org/10.1177/1178221817711418 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Substance Abuse: Research and Treatment Volume 11: 1–9 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178221817711418 Introduction Cannabis sativa is one of society’s oldest cultivated plants,  with records of its propagation and use dating back thousands of years.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/10.1177_1178221817711418.PMC5457144.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1601217/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/95/51/1601217.PMC5457145.pdf
SUPPLEMETARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700004/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/bb/1700004.PMC5457146.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 353–358Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 353 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S128321 Investigating a self-scoring interview simulation  for learning and assessment in the medical  consultation Catherine Bruen1 Clarence Kreiter2 Vincent Wade3 T eresa Pawlikowska1 1Health Professions Education Centre,   Faculty of Medicine and Health  Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland;  2Department  of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA;  3School of Computer  Science and Statistics, Faculty of Engineering, Mathematics and Science,  Trinity College Dublin, Dublin, IrelandAbstract: Experience with simulated patients supports undergraduate learning of medical  consultation skills.",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
"9 Adaptive simulation is a learning environment that more deeply explores Correspondence: Catherine Bruen Health Professions Education Centre, Faculty of Medicine and Health Sciences, Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin 2, IrelandTel +353 1 402 2572Fax +353 1 402 2470Email catherinebruen@rcsi.ieJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Bruen et alRunning head recto: A self-scoring interview simulationDOI: http://dx.doi.org/10.2147/AMEP .S128321",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
Available from: http://www.etu.ie/.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
Available from: http://www.etu.ie/.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 358 Bruen et al  15.,Non-OADS,/arxiv_data1/oa_pdf/4f/b2/amep-8-353.PMC5457147.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700184/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/af/73/1700184.PMC5457148.pdf
"Center for Disease Control, “National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011 ”(CDC, 2011); https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.",Non-OADS,/arxiv_data1/oa_pdf/af/73/1700184.PMC5457148.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pragmatic and Observational Research 2017:8 91–97Pragmatic and Observational Research Dovepress submit your manuscript | www.dovepress.com Dovepress  91 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/POR.S127974Reduced adherence to antiretroviral therapy is  associated with residual low-level viremia Franco Maggiolo1 Elisa Di Filippo1 Laura Comi1 Annapaola Callegaro2 Giorgio L Colombo3,4 Sergio Di Matteo4 Daniela Valsecchi5 Marco Rizzi1 1USC of Infectious Diseases,  2USC Microbiology and Virology,   3Department of Drug Sciences,   University of Pavia, 4S.A.V.E.",Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
"Achieving and maintaining viral load “undetectability” is the recommended target of cART in Correspondence: Franco Maggiolo USC Malattie Infettive, ASST Papa Giovanni XXIII, Via Oms 1, 24128, Bergamo, ItalyEmail franco31556@hotmail.comJournal name: Pragmatic and Observational Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Maggiolo et alRunning head recto: Association of reduced adherence to ART and residual LL V DOI: http://dx.doi.org/10.2147/POR.S127974",Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
Chair and Coordinator: Churchill D. Available from:  http://www.bhiva.org/documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
"Pragmatic and Observational Research 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Pragmatic and Observational Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pragmatic-and-observational-research-journalPragmatic and Observational Research is an international, peer-reviewed,  open access journal that publishes data from studies designed to reflect more   closely medical interventions in real-world clinical practice compared with   classical randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 97 Association of reduced adherence to ART and residual LLV  33.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/por-8-091.PMC5457149.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 1021–1029Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1021Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13203 0 Efficacy of nepafenac ophthalmic suspension 0.1%  in improving clinical outcomes following cataract  surgery in patients with diabetes: an analysis of  two randomized studies rishi P singh1 giovanni staurenghi2 ayala Pollack3 adeniyi adewale4 Thomas M Walker4 Dana sager4 robert lehmann5 1Cole eye institute, Cleveland  Clinic Foundation, Cleveland, Oh,   Usa; 2Department of Biomedical  and Clinical science luigi sacco,   luigi sacco hospital, University of  Milan, Milan, italy; 3Ophthalmology  Department, Kaplan Medical Center,   rehovot, israel; 4alcon research ltd.,   Fort Worth, TX, 5lehmann eye Center,   nacogdoches, TX, UsaObjective:  To assess the efficacy of nepafenac 0.1% ophthalmic suspension in improving the  clinical outcomes following cataract surgery (CS) in patients with nonproliferative diabetic  retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
"Keywords:  cataract surgery, nonproliferative diabetic retinopathy, nepafenac 0.1%, postopera - tive macular edema, visual outcomes Introduction Postoperative macular edema (ME) following cataract surgery is an important cause  for suboptimal visual outcomes, particularly in high-risk patients such as those with  diabetes.1–8 A retrospective database study of 81,984 consecutive phacoemulsification Correspondence: robert lehmann lehmann eye Center, nacogdoches,  TX 75965, Usa Tel +1 936 569 8278 Fax +1 936 569 0275 email doctorlehmann@me.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Singh et al Running head recto: Nepafenac 0.1% vs vehicle following cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S132030",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/ human/000818/WC500212717.pd f. Accessed October 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
"Available from:  http://www.mdinteractive.com/files/uploaded/file/CMS2016/2016_ PQRS_Measure_191_11_17_2015.pd f. Accessed on May 6,  2016.",OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/7c/opth-11-1021.PMC5457150.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 359–364Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 359 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S135538 An active learning curriculum improves fellows’  knowledge and faculty teaching skills Jennifer A Inra1,2  Stephen Pelletier2  Navin L Kumar1,2 Edward L Barnes3,4  Helen M Shields1,2 1Division of Gastroenterology,   Hepatology and Endoscopy, Brigham  and Women’s Hospital, 2Harvard  Medical School, Boston, MA, USA;   3Division of Gastroenterology and  Hepatology, University of North Carolina, Chapel Hill, NC, USA;   4University of North Carolina School  of Medicine, Chapel Hill, NC, USAObjectives:  Traditional didactic lectures are the mainstay of teaching for graduate medical  education, although this method may not be the most effective way to transmit information.",Non-OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
"We created an active learning curriculum for Correspondence: Jennifer A Inra Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, 75 Francis Street, ASB2, Boston, MA 02115, USATel +1 617 732 6389Fax +1 617 978 0840Email jinra@partners.org Journal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Inra et alRunning head recto: Active learning curriculum for fellowsDOI: http://dx.doi.org/10.2147/AMEP .S135538",Non-OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 364 Inra et al active learning sessions may be a useful tool for other sub- specialty fellowship programs.,Non-OADS,/arxiv_data1/oa_pdf/01/70/amep-8-359.PMC5457152.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1d/87/ndt-13-1419.PMC5457153.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1419–1425Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1419OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13876 2 Development of a Body image concern scale  using both exploratory and confirmatory factor  analyses in chinese university students Wenxin he Qiming Zheng Yutian Ji chanchan shen Qisha Zhu Wei Wang Department of clinical Psychology  and Psychiatry, school of Public  health, Zhejiang University college  of Medicine, hangzhou, People’s  republic of chinaBackground:  The body dysmorphic disorder is prevalent in general population and in  psychiatric, dermatological, and plastic-surgery patients, but there lacks a structure-validated,  comprehensive self-report measure of body image concerns, which is established through both  exploratory and confirmatory factor analyses.",Non-OADS,/arxiv_data1/oa_pdf/1d/87/ndt-13-1419.PMC5457153.pdf
"However, none of these correspondence: Wei Wang Department of clinical Psychology and  Psychiatry, school of Public health,  Zhejiang University college of Medicine,  Yuhangtang road 866, hangzhou, Zhejiang  310058, People’s republic of china Tel +86 571 8820 8188 email drwangwei@zju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: He et al Running head recto: Body image concerns DOI: http://dx.doi.org/10.2147/NDT.S138762",Non-OADS,/arxiv_data1/oa_pdf/1d/87/ndt-13-1419.PMC5457153.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1d/87/ndt-13-1419.PMC5457153.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/87/ndt-13-1419.PMC5457153.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 163–169Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  163 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S117770Evaluation of effectiveness and safety of a herbal  compound in primary insomnia symptoms and  sleep disturbances not related to medical or  psychiatric causes Giancarlo Palmieri1,2  Paola Contaldi1  Giuseppe Fogliame1 1ANARDI Medical  and Scientific  Association, Scafati, Italy; 2Department  of Internal Medicine, Niguarda Cà  Granda Hospital, Milan, ItalyBackground and purpose: Sleep disturbances and related daytime activities impairment are  common diseases nowadays.",Non-OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
"Keywords: insomnia, sleep disturbance, fatigue, tension Introduction Sleep-related disorders are a heterogeneous cluster of disturbances varying from restless  legs syndrome to insomnia, including more than 70 different and specific diagnoses.1 Sleep- related disorders affect from 25% to 33% of people all over the world, this is according Correspondence: Giancarlo Palmieri Department of Internal Medicine, Niguarda Cà Granda Hospital, Piazza Ospedale Maggiore 3 –20162- Milan, ItalyTel +39 02 6444 2247Email giancarlo.palmieri@ospedaleniguarda.it Journal name: Nature and Science of Sleep Article Designation: CLINICAL TRIAL REPORTY ear: 2017V olume: 9Running head verso: Palmieri et alRunning head recto: Herbal compound in primary insomnia symptoms and sleep disturbancesDOI: http://dx.doi.org/10.2147/NSS.S117770",Non-OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
Available from: http://www.nps.org.au/publications/health-professional/nps-news/2010/nps-news-67.,Non-OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/e7/75/nss-9-163.PMC5457154.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/23/77/ijn-12-4019.PMC5457155.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4019–4035International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4019OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13263 9 successful in vivo hyperthermal therapy  toward breast cancer by chinese medicine  shikonin-loaded thermosensitive micelle Y onghua su1,* Nian huang1,* Di chen2,* li Zhang2,* Xia Dong2 Yun sun2 Xiandi Zhu2 Fulei Zhang2 Jie gao2 Ying Wang2 Kexing Fan2 Puichi lo3 Wei li2 changquan ling1 1Department of Integrative Oncology,   changhai hospital of Traditional  chinese Medicine, 2International  Joint cancer Institute, The second  Military Medical University, shanghai,   3Department of Biomedical sciences,   city University of hong Kong,   Kowloon T ong, hong Kong, china *These authors contributed equally  to this workAbstract:  The Chinese traditional medicine Shikonin is an ideal drug due to its multiple targets  to tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/23/77/ijn-12-4019.PMC5457155.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/23/77/ijn-12-4019.PMC5457155.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/77/ijn-12-4019.PMC5457155.pdf
This is an open access article underthe CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
THIS IS AN OPEN ACCESS ARTICLE UNDERTHE CC BY-NC-ND LICENSE ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).ISSN 2452-302X http://dx.doi.org/10.101 6/j.jacbts.2016.08.001,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
Additional information about the programscan be found at: http://www.nhlbi.nih.gov/research/ funding/sbir/about-program.htm#structure .,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
The Small Market Award (http://1.usa.gov/1v0Wxn1 )i sd e s i g n e dt os u p p o r t projects focused on pediatric or rare diseaseindications requiring FDA clearance.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
The Bridge Award ( http://1.usa.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"As a result, the NHLBI participates inthe recently published NIH Commercialization Read-iness Pilot (CRP) (link to solicitation: PAR-16-026 [http://grants.nih.gov/grants/guide/pa- ﬁles/PAR-16- 026.html ]).",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
Future opportu-nities to participate in the I-Corps at NIH program willbe announced on our website ( http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"Popular webinars in the series include HowPharma Evaluates New Treatment Opportunities (http://bit.ly/SBHangout-PharmaEval ), IP for the New Biomedical Innovator ( http://bit.ly/IPbasics ), and Identifying and Connecting With Your Customer.These webinars are archived on the NHLBI YouTube channel ( http://bit.ly/SmallBizHangouts-YouTube ).",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
The NHLBIdeveloped the Pilot Program to Provide RegulatorySupport to SBIR/STTR Awardees Developing MedicalDevices (Diagnostics and Therapeutics) (PPRS) (link to solicitation: PA-16-335 [ http://grants.nih.gov/ grants/guide/pa- ﬁles/PA-16-335.html ]) in collabora- tion with the FDA Center for Devices and RadiologicalHealth to provide early FDA access to awardeesdeveloping and testing technologically innovative orsubstantial risk medical devices.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"For contact infor-mation, see our website ( http://www.nhlbi.nih.gov/ research/funding/sbir/contact-us.htm ).",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"The NHLBI Innovation Conference ( http://bit.ly/ NHLBIshowcase ) is an annual event that brings together small businesses, a n g e li n v e s t o r s ,v e n t u r e capitalists, strategic partners, and business leadersfrom the biotech, pharmaceutical, and medtech in-dustries focused on the NHLBI mission, including cardiovascular indication s. The conference features presentations by top NHLBI-funded small businesseswith innovative and commercially relevant technol-ogies, expert keynotes and panels addressing topicsrelevant to early-stage companies, and opportunitiesfor networking.",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
More information on showcase opportunities and coaching is available on our website ( http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"”For more information on any of the programs mentioned in this article orto discuss a potential application, please visitour website ( http://www.nhlbi.ni h.gov/research/ funding/sbir/ ).",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"Topics of Special Interestcan change at any time, so applicants are encouraged to check the website ( http://www.nhlbi.",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
nih.gov/research/funding/sbir/funding-oppo rtunities/omnibus_grant_solicitation.htm ) frequently for updates and sign up for the listserv ( http://bit.ly/NHLBI-SBIR-Updates )t ob e notiﬁed of new funding opportunities.,Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"Examples of recent cardiovascular topics addressed by NHLBI RFAs and Topics of Special Interest /C15Bioreactors for reparative medicine /C15Biocompatible ﬂuid sealant for paravalvular leaks /C15Smartphone apps to increase accessibility and evaluation of the latest educational materials and trial research on cardiovascular, nutritional, and physical activity information /C15Technology that enables immediate, user-friendly measures of average daily sodium intake /C15New animal models for the study of chronic venous insuf ﬁciency and post-thrombotic syndrome /C15Development of mechanical circulatory suppo rt devices for individuals with congenital heart disease and single ventricle physiology after Fontan surgical palliation /C15Innovative technology and/or service delivery model or design targeted at increasing the adoption, uptake, and sust ainability of evidence-based guideline recommendations /C15New and improved methods to assess, monito r, or predict cardiovascular toxicity of therapeutic agents For links to current funding opportunities covering all aspects of the NHLBI mission, please visit our website ( http://www.nhlbi.nih.gov/research/funding/sbir/funding-opportunities/ ).",Non-OADS,/arxiv_data1/oa_pdf/4c/f6/main.PMC5457156.pdf
"https://doi.org/10.1177/1178221817711415 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Substance Abuse: Research and Treatment Volume 11: 1–10 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178221817711415 Introduction Marijuana use is associated with a number of adverse physical  and behavioral health outcomes, including poorer perfor-mance on neurocognitive tests, lower educational attainment, and risk of marijuana use disorder (ie, abuse or dependence).",Non-OADS,/arxiv_data1/oa_pdf/1f/a4/10.1177_1178221817711415.PMC5457171.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/cia-12-897.PMC5457172.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 897–901Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  897OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13726 4 Association between butyrylcholinesterase  K variant and mild cognitive impairment in the  Thai community-dwelling patients natsalil Pongthanaracht1 somchai Yanarojana1 Darawan Pinthong1 supeenun Unchern1 Amnuay Thithapandha1 Prasert Assantachai2 Porntip supavilai1 1Department of Pharmacology, Faculty  of science, 2Department of Preventive  and social Medicine, Faculty of  Medicine siriraj hospital, Mahidol  University, Bangkok, ThailandObjective:  To study the association of the butyrylcholinesterase K variant (BChE-K) and the  plasma BChE activity with mild cognitive impairment (MCI) in Thai community-dwelling  patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/cia-12-897.PMC5457172.pdf
"Recently, genetic variation  is used as biomarkers for MCI and progression of MCI leading to dementia.8Correspondence: Porntip supavilai Department of Pharmacology, Faculty of  science, Mahidol University, 272 rama 6  road, Bangkok 10400, Thailand Tel/fax +66 2 961 0727 email porntip.sup@mahidol.ac.t h Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Pongthanaracht et al Running head recto: Butyrylcholinesterase K variant and mild cognitive impairment DOI: http://dx.doi.org/10.2147/CIA.S137264",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/cia-12-897.PMC5457172.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/cia-12-897.PMC5457172.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/cf/d3/cia-12-897.PMC5457172.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 379–389International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  379OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJWH.S13087 0 Household food insecurity is associated with  both body mass index and middle upper-arm  circumference of mothers in northwest ethiopia:  a comparative study achenef Motbainor alemayehu Worku abera Kumie school of Public Health, college  of Health sciences, addis ababa  University, addis ababa, ethiopiaBackground:  Food insecurity and associated malnutrition result in serious health problems in  developing countries.",Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
"Keywords:  food insecurity, undernutrition, BMI, MUAC, Ethiopia, food-security, maternal  nutrition Introduction Food insecurity can be defined as a state or condition in which people experience  limited or uncertain physical and economic access to safe, sufficient, and nutritious  food to meet their dietary needs or food preferences for a productive, healthy, and correspondence: achenef Motbainor school of Public Health, college  of Health sciences, addis ababa  University, PO Box 23676,  code 1000, addis ababa, ethiopia Tel +251 91 303 6325 email motbainor2@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Motbainor et al Running head recto: Maternal undernutrition and food insecurity DOI: http://dx.doi.org/10.2147/IJWH.S130870",Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
"Available from: https://www.odi.org/resources/ docs/3964.pd f. Accessed April 18, 2017.",OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
"Available from: http://www.ifpri.org/sites/ default/files/publications/essprn26.pd f. Accessed April 18, 2017.",Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
Available from: http://www.fao.org/3/a-i3862e.,Non-OADS,/arxiv_data1/oa_pdf/6b/f5/ijwh-9-379.PMC5457173.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1289–1295Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1289 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S137795Development and validation of an   Arabic-language headache questionnaire   for population-based surveys Naglaa A El-Sherbiny1 Hatem Samir Shehata2 Hanan Amer2 Alaa Elmazny2 Mohamed Masoud1 Hanan Helmy2 Nevin M Shalaby2 1Faculty of Medicine, Fayoum  University, Faiyum, Egypt; 2Faculty  of Medicine, Cairo University, Cairo,   EgyptBackground: The reported prevalence of headache disorders in Arab regions varies consid- erably between countries.",Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"4,5 Other principal barriers responsible for poor headache care include: the paucity of  large-scale epidemiological studies in Arab countries, limited funding, large and often   Correspondence:  Hatem Samir Shehata Faculty of Medicine, Cairo University,  23 Amin Samy Street, off Kasr Alaini, Cairo 11562 EgyptTel +20 112 444 4179Email samirhatem@hotmail.com Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: El-Sherbiny et alRunning head recto: Validation of Arabic-language headache questionnaireDOI: http://dx.doi.org/10.2147/JPR.S137795",Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"The questions were assessed using the Flesch reading ease score, which identifies the number of words in sentences and the number of syllables in words, and then develops a readability formula (using the follow-ing link): http://www.readabilityformulas.com/freetests/six-readability-formulas.php.",OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
Available from: http://www.sis.gov.eg/newvr/Egypt-inFigures2015/EgyptinFigures/pages/english%20Link.html.,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1295 Validation of Arabic-language headache questionnaire Supplementary material A sample of the Arabic-language headache questionnaire for population-based surveys  in Egypt عينة من استبيان لقياس مدي انتشار الصداع النصفي في جمهورية مصر العربية Interviewer name and signature (to be completed by the interviewer) اسم مقدم االستبيان و االمضاء...................................,Non-OADS,/arxiv_data1/oa_pdf/cc/3a/jpr-10-1289.PMC5457174.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/4e/ijn-12-4059.PMC5457176.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4059–4071International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4059OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12411 9 Vesicular melatonin efficiently downregulates  sodium fluoride-induced rat hepato- and broncho- TNF-α, TGF-β expressions, and associated  oxidative injury: a comparative study of liposomal  and nanoencapsulated forms Suvomoy Sana Swarupa Ghosh Nirmalendu Das Sibani Sarkar Ardhendu Kumar Mandal Drug Development, Diagnostics  and Biotechnology, CSIR-Indian  Institute of Chemical Biology, West  Bengal, IndiaAbstract:  The importance of fluoride as a natural and industrial toxicant is recognized  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/2e/4e/ijn-12-4059.PMC5457176.pdf
"Keywords:  sodium fluoride, reactive oxygen species, inflammatory mediators, oxidative injury,  vesicular melatonin targeting Introduction Fluorine, being the most electronegative element, reacts with other elements to  form ionized fluorides.1 Fluorides are found widely in food of both animal and plant  origin due to their extensive prevalence in air, soil, and water and are an important  environmental pollutant arising from natural and industrial sources.2 Living organ - isms come in contact with fluoride through food, drinking water, fluoride additives,  toothpastes, fluoride gel,3 and inhalation of hydrofluoric gases through smoke, vapors,  dust from burning coal, industrial manufacture of phosphate fertilizers, and volcanoes.4  Fluoride, on entering soft tissues after crossing cell membranes by simple diffusion, Correspondence: Ardhendu Kumar  Mandal CSIR-Indian Institute of Chemical Biology,  4, Raja SC Mullick Road, Jadavpur,  Kolkata 700032, West Bengal, India Tel +91 33 2499 5879 Fax +91 33 2473 5197 email ardhendu_mandal@yahoo.co.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sana et al Running head recto: Vesicular melatonin prevents oxidative injury DOI: http://dx.doi.org/10.2147/IJN.S124119",Non-OADS,/arxiv_data1/oa_pdf/2e/4e/ijn-12-4059.PMC5457176.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/4e/ijn-12-4059.PMC5457176.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/4e/ijn-12-4059.PMC5457176.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/36/ott-10-2739.PMC5457177.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2739–2744OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2739Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13241 0 Overexpression of ecotropic viral integration site-1  is a prognostic factor of lung squamous cell cancer Xueliang Xu1 shengchen liu2 Xia Ji1 1Department of respiratory Medicine,   2Department of emergency, linyi  People’s hospital, linyi, chinaAim:  To explore the expression and clinical significance of ecotropic viral integration site-1  (EVI1) of lung squamous cell cancer (SCC).",Non-OADS,/arxiv_data1/oa_pdf/14/36/ott-10-2739.PMC5457177.pdf
"EVI1 was also demonstrated to regulate lots of cellular processes in tumorigenesis correspondence: Xia Ji Department of respiratory Medicine,  linyi People’s hospital, #27, Jiefangdong  road, linyi, shandong 276003, china Tel +86 139 5391 8392 Fax +86 0539 822 2186 email jixialinyi321@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Xu et al Running head recto: EVI1 as a prognostic marker of SCC DOI: http://dx.doi.org/10.2147/OTT.S132410",Non-OADS,/arxiv_data1/oa_pdf/14/36/ott-10-2739.PMC5457177.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/14/36/ott-10-2739.PMC5457177.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/36/ott-10-2739.PMC5457177.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1565–1577International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1565OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11588 6 In vitro dose comparison of respimat® inhaler  with dry powder inhalers for COPD maintenance  therapy anna-Maria Ciciliani1,2 Peter langguth1 herbert Wachtel2 1Institute of Pharmacy and  Biochemistry, Faculty 09 (Chemistry,   Pharmaceutics and geosciences),   Johannes gutenberg University, Mainz,   2analytical Development Department,   Boehringer Ingelheim Pharma  gmbh & Co. K g, Ingelheim, germanyBackground:  Combining in vitro mouth–throat deposition measurements, cascade impactor  data and computational fluid dynamics (CFD) simulations, four different inhalers were compared  which are indicated for chronic obstructive pulmonary disease (COPD) treatment.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
Jun 2015: A-33:   (http://online.liebertpub.com/doi/pdfplus/10.1089/jamp.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"Available from: http://www.goldcopd.or g. Accessed  December 1, 2005.",OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"Available from: http://www.thepharmaletter.com/article/spiriva- respimat-oked-for-copd-in-europ e. Accessed November 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
Available  from: http://www.gsk.com/en-gb/media/press-releases/2013/relvar- ellipta-receives-european-marketing-authorisation-for-the-treatment- of-asthma-and-copd /.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"Available from:  http://www.drugs.com/newdrugs/fda-approves-anoro-ellipta-chronic- obstructive-pulmonary-3992.htm l. Accessed February 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
Available  from: http://us.gsk.com/en-us/media/press-releases/2014/gsk-receives- approval-for-incruse-ellipta-umeclidinium-in-the-us-for-the-treatment- of-copdandnbsp /.,Non-OADS,/arxiv_data1/oa_pdf/04/6a/copd-12-1565.PMC5457178.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/b5/ndt-13-1427.PMC5457179.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1427–1434Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1427OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13450 3 effects of stimulus parameters on motor seizure  duration in electroconvulsive therapy sung Woo Joo Yeon ho Joo chang Y oon Kim Jung sun lee Department of Psychiatry, University  of Ulsan college of Medicine, asan  Medical center, seoul, KoreaObjective:  This study examined the effect of stimulus parameters on the occurrence of adequate  seizures and reconsidered the factors related to motor seizure duration.",Non-OADS,/arxiv_data1/oa_pdf/d1/b5/ndt-13-1427.PMC5457179.pdf
"In one previous study of  patients with bipolar depression, the response rate was significantly higher in the  ECT group than in the pharmacological treatment group.1 It has been reported that the  combination of ECT with pharmacotherapy was found to be most effective in patients  with schizophrenia who were nonresponsive to prior pharmacotherapy.2 Furthermore,  the indications for ECT have been progressively extended to include post-traumatic  stress disorder, treatment-resistant obsessive compulsive disorder, treatment-resistant  dyskinesia, and treatment-resistant Tourette’s syndrome.3,4 The motor seizure duration has been considered as a standard for determining the  therapeutic adequacy, and a motor seizure lasting 20–25 seconds at minimum has been  typically recommended.5 Stimulus dose, age, sex, treatment number, and psychotropic correspondence: Jung sun lee Department of Psychiatry, University of  Ulsan college of Medicine, asan Medical  center, 88 Olympic-ro 43-gil, songpa-gu,  seoul 05505, Korea Tel +82 2 3010 3422 Fax +82 2 3010 3410 email js_lee@amc.seoul.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Joo et al Running head recto: The effect of stimulus parameters on seizure duration in ECT DOI: http://dx.doi.org/10.2147/NDT.S134503",Non-OADS,/arxiv_data1/oa_pdf/d1/b5/ndt-13-1427.PMC5457179.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d1/b5/ndt-13-1427.PMC5457179.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/b5/ndt-13-1427.PMC5457179.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/af/ijwh-9-373.PMC5457180.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 373–378International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  373RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S13158 5 Hereditary hemorrhagic telangiectasia and  pregnancy: potential adverse events and  pregnancy outcomes Omar Bari1 Philip R Cohen2 1School of Medicine, University of  California San Diego, La Jolla, CA,   USA; 2Department of Dermatology,   University of California San Diego,   La Jolla, CA, USAAbstract:  Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant condition  with a prevalence of ~1 in 5,000 individuals.",Non-OADS,/arxiv_data1/oa_pdf/b0/af/ijwh-9-373.PMC5457180.pdf
"HHT type 1 is due to mutations in the endoglin ( ENG ) gene, while  HHT type 2 is due to mutations in the activin receptor-like kinase-1 ( ALK-1 ) gene.3 Correspondence: Omar Bari School of Medicine, University of  California San Diego, 9500 Gilman Drive,  La Jolla, CA 92093, USA email obari@ucsd.ed u  Philip R Cohen Department of Dermatology, University  of California San Diego, 8899 University  Center Lane, San Diego, CA 92122, USA email mitehead@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Bari and Cohen Running head recto: Hereditary hemorrhagic telangiectasia and pregnancy DOI: http://dx.doi.org/10.2147/IJWH.S131585",Non-OADS,/arxiv_data1/oa_pdf/b0/af/ijwh-9-373.PMC5457180.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/b0/af/ijwh-9-373.PMC5457180.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/af/ijwh-9-373.PMC5457180.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/31/copd-12-1579.PMC5457181.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1579–1587International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1579OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13184 7 Identifying the heterogeneity of COPD by V/P  sPeCT: a new tool for improving the diagnosis  of parenchymal defects and grading the severity  of small airways disease M Bajc1 Y Chen2 J Wang3 XY li4 WM shen4 CZ Wang3 h huang2 a lindqvist5 XY he6 1Department of Clinical science  Physiology and nuclear Medicine,   skåne University hospital, lund,   sweden; 2respiratory Department,   Changzheng hospital, shanghai,   3respiratory Department, Xinqiao  hospital, Chongqing, 4respiratory  Department, huadong hospital,   shanghai, China; 5Department of  Pulmonary Medicine, heart and lung  Center, helsinki University hospital  and helsinki University, helsinki,   Finland; 6suzhou University affiliated  T umor hospital, Wuxi, ChinaIntroduction:  Airway obstruction and possible concomitant pulmonary diseases in COPD  cannot be identified conventionally with any single diagnostic tool.",Non-OADS,/arxiv_data1/oa_pdf/a1/31/copd-12-1579.PMC5457181.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a1/31/copd-12-1579.PMC5457181.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/31/copd-12-1579.PMC5457181.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2017:10 197–204Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  197 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S109648Pharmacogenetics in inflammatory bowel  disease: understanding treatment response and  personalizing therapeutic strategies Jesús K Yamamoto-Furusho  Inflammatory Bowel Disease Clinic,   Department of Gastroenterology,  Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,  Tlalpan, Mexico Abstract: Inflammatory bowel disease (IBD) is a chronic and heterogeneous disorder character - ized by remitting and relapsing periods of activity.",Non-OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
"12Correspondence: Jesús K  Yamamoto-FurushoInflammatory Bowel Disease Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Colonia Sección XVI, Tlalpan, CP 14000, MéxicoTel +52 55 5573 3418Fax +52 55 5655 0942Email kazuofurusho@hotmail.comJournal name: Pharmacogenomics and Personalized Medicine Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Y amamoto-FurushoRunning head recto: Pharmacogenetics in inflammatory bowel diseaseDOI: http://dx.doi.org/10.2147/PGPM.S109648",Non-OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
"Pharmacogenomics and Personalized Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 204 Yamamoto-Furusho 77.,Non-OADS,/arxiv_data1/oa_pdf/9f/e6/pgpm-10-197.PMC5457182.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4007–4018International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4007OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13560 5 electroactive BaTiO3 nanoparticle-functionalized  fibrous scaffolds enhance osteogenic differentiation  of mesenchymal stem cells Yiping Li,1,2 Xiaohan Dai,1  Yunyang Bai,2 Yun Liu,2  Yuehong Wang,1 Ousheng  Liu,1 Fei Yan,1 Zhangui Tang,1  Xuehui Zhang,3–5 Xuliang  Deng2,4,5 1Department of Prosthodontics,   Xiangya Stomatological Hospital &  School of Stomatology, Central South  University, Changsha, 2Department  of Geriatric Dentistry, 3Department  of Dental Materials & Dental Medical  Devices Testing Center, Peking  University School and Hospital of  Stomatology, 4National Engineering  Laboratory for Digital and Material  T echnology of Stomatology, 5Beijing  Laboratory of Biomedical Materials,   Peking University School and Hospital  of Stomatology, Beijing, People’s  Republic of ChinaAbstract:  It has been proven that the surface topographic cues of fiber arrangement can induce  osteogenic differentiation of mesenchymal stem cells.",Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
"Keywords:  topographic substrate, biomimetic electroactivity, ferroelectric ceramic, polarization,  osteogenic responses Introduction Numerous studies have shown that topographic cues of fiber arrangement can regulate  stem cell behaviors such as cell attachment, spreading, growth, and differentiation via  contact guidance.1–4 Randomly oriented fibrous scaffolds could typically encourage  osteogenic differentiation, and aligned fibrous scaffolds could promote myogenic  or neurogenic differentiation in stem cells.5–7 Our previous researches showed that  electrospun poly-( l-lactic acid) (PLLA) fiber orientation played an important role in  regulating osteoblast response and confirmed that bone marrow mesenchymal stem  cells (BM-MSCs) cultured on randomly oriented PLLA nanofibers showed enhanced  osteogenic-specific fate compared with those cultured on aligned nanofibers.8,9 Yin et  al  demonstrated that osteogenesis in vivo was driven by randomly oriented electrospun  PLLA fiber scaffolds.10Correspondence: Zhangui Tang  Xiangya Stomatological Hospital & School  of Stomatology, Central South University,  72 Xiangya Road, Changsha 410078,  People’s Republic of China  Tel +86 731 8480 5480 Fax +86 731 8480 5480 email tangzhanguixiangya@163.co m  Xuehui Zhang Department of Dental Materials &  Dental Medical Devices Testing  Center, Peking University School and  Hospital of Stomatology, Zhongguancun  South Avenue No 22, Beijing 100081,  People’s Republic of China Tel +86 10 8219 5748 Fax +86 10 6216 4691 email zhangxuehui914@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Improved osteogenic differentiation of BM-MSCs by BTO/PLLA fibrous scaffold DOI: http://dx.doi.org/10.2147/IJN.S135605",Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
Available from:   http://spie.org/Publications/Proceedings/Paper/10.1117/12.881858.,Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/d7/ijn-12-4007.PMC5457183.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/13/ijn-12-4037.PMC5457184.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 4037–4057International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4037OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S13298 4 glucose- and temperature-sensitive nanoparticles  for insulin delivery Jun-Zi Wu1 gareth r Williams2 he-Yu li1 Dongxiu Wang3 huanling Wu1 shu-De li4 li-Min Zhu1 1college of chemistry, chemical  engineering and Biotechnology,   Donghua University, shanghai, People’s  republic of china; 2Ucl school of  Pharmacy, University college london,   london, UK; 3central laboratory,   environmental Monitoring center of  Kunming, 4school of Basic Medical  sciences, Kunming Medical University,   Kunming, People’s republic of chinaAbstract:  Glucose- and temperature-sensitive polymers of a phenylboronic acid derivative and  diethylene glycol dimethacrylate (poly(3-acrylamidophenyl boronic acid- b-diethylene glycol  methyl ether methacrylate); p(AAPBA- b-DEGMA)) were prepared by reversible addition– fragmentation chain transfer polymerization.",Non-OADS,/arxiv_data1/oa_pdf/bf/13/ijn-12-4037.PMC5457184.pdf
"1168,  chunrong West road, Yuhua subdistrict,  chenggong New District, Kunming,  650228, People’s republic of china email shudeli006@vip.sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wu et al Running head recto: Glucose- and temperature-sensitive NPs for insulin delivery DOI: http://dx.doi.org/ 10.2147/IJN.S13298 4",Non-OADS,/arxiv_data1/oa_pdf/bf/13/ijn-12-4037.PMC5457184.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bf/13/ijn-12-4037.PMC5457184.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/13/ijn-12-4037.PMC5457184.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
"12–14 Extraoral causes comprise medication use, psychological factors, and  pathologies related to the nose, tonsils, lungs, and stomach.5,6,14–16 Treatment options, Correspondence: Azizah Bin Mubayrik Oral Medicine and Diagnostic Science Department, College of Dentistry, King Saud University, 3680 - King Saud University Unit No 3ar Riyadh 12372 - 7453 Kingdom of Saudi ArabiaEmail aalmobeirik@ksu.edu.saJournal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Bin Mubayrik et alRunning head recto: Self-perception, knowledge, and awareness of halitosisDOI: http://dx.doi.org/10.2147/CCIDE.S129679",Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
Available from: http://www.dentalcare.com/en-US/dental-education/continuing-education/ce130/ce130.aspx.,Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
Available from: http://www.smj.eg.net/journals/pdf/229.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
" Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/66/64/ccide-9-045.PMC5457280.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1279–1287Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1279 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S125264Upregulation of miR-375 level ameliorates  morphine analgesic tolerance in mouse   dorsal root ganglia by inhibiting the  JaK2/sT aT3 pathway haiqin li Rong Tao Jing Wang lingjie Xia Department of clinical Pain, The  People’s hospital of henan Province,   Zhengzhou, People’s Republic of chinaAbstract:  Several lines of evidence indicate that microRNAs (miRNAs) modulate tolerance  to the analgesic effects of morphine via regulation of pain-related genes, making dysregula- tion of miRNA levels a clinical target for controlling opioid tolerance.",Non-OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
"6 Previous studies  have shown downregulation of miRNA (miR-96, miR-182 and miR-183) levels in rat DRG with pain, 7 whereas considerable increases of miR-21 level occur in DRG after correspondence: lingjie Xia Department of clinical Pain, The People’s hospital of henan Province, 7 Weiwu Road, Zhengzhou, 450003, People’s Republic of chinaemail linjie_xia@163.comJournal name: Journal of Pain Research  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Li et alRunning head recto: miR-375 could ameliorate morphine analgesic toleranceDOI: http://dx.doi.org/10.2147/JPR.S125264",Non-OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1287 miR-375 could ameliorate morphine analgesic tolerance References  1.,Non-OADS,/arxiv_data1/oa_pdf/e3/11/jpr-10-1279.PMC5457281.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/75/16/40801_2017_Article_104.PMC5457307.pdf
1)http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/75/16/40801_2017_Article_104.PMC5457307.pdf
"Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma (EMA/HMPC/3968/2008) http://www.ema.europa.eu/docs/en_ GB/document_library/Herbal_-_HMPC_assessment_report/2011/ 05/WC500106358.pdf .",Non-OADS,/arxiv_data1/oa_pdf/75/16/40801_2017_Article_104.PMC5457307.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/16/9f/40801_2017_Article_105.PMC5457308.pdf
2012. https://www.uspharmacist.com/article/drug-induced-skin-disorders .,Non-OADS,/arxiv_data1/oa_pdf/16/9f/40801_2017_Article_105.PMC5457308.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8c/3e/40801_2017_Article_106.PMC5457309.pdf
2017. http://kff.org/other/state-indicator/children-0-18/?currentTimeframe=0 .,Non-OADS,/arxiv_data1/oa_pdf/8c/3e/40801_2017_Article_106.PMC5457309.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d9/fa/40801_2017_Article_107.PMC5457310.pdf
2016. http://www.encepp.eu/standards_and_guidances .,Non-OADS,/arxiv_data1/oa_pdf/d9/fa/40801_2017_Article_107.PMC5457310.pdf
2010. http://www.dva.gov.au/sites/default/ﬁles/ﬁles/publications/datastatistical/treatmentpop/Tpop Dec2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/fa/40801_2017_Article_107.PMC5457310.pdf
"Census of population and hous- ing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2011.2013. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/ 2033.0.55.001Main ?Features12011?OpenDocument .",Non-OADS,/arxiv_data1/oa_pdf/d9/fa/40801_2017_Article_107.PMC5457310.pdf
2013. https://reporting.aihw.gov.au/Reports/ openRVUrl.do?rsRID=SBIP%3A%2F%2FMETASERVER% 2FAIHW%2FReleasedPublic%2FH ospitals%2FRep orts%2FHDU_ Principal ?Diagnosis%2C ?2008-09 ?to?2009-10.srx%28Report% 29.,Non-OADS,/arxiv_data1/oa_pdf/d9/fa/40801_2017_Article_107.PMC5457310.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/eb/57/40801_2017_Article_108.PMC5457311.pdf
http://www.vll.se/ startsida/halsa-och-vard/vara-sjukhus/lycksele-lasarett .,OADS,/arxiv_data1/oa_pdf/eb/57/40801_2017_Article_108.PMC5457311.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e2/d2/40801_2017_Article_109.PMC5457312.pdf
http://dx.doi.org/10.1016/j.bjhh.2016.12.002 Available online  23  January  2017,OADS,/arxiv_data1/oa_pdf/96/02/main.PMC5457456.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/8a/main.PMC5457457.pdf
"Mucositis, nausea and vomiting,  diarrhea,  poor  oral  intake,  mal- absorption  and  prolonged  malnutrition  are  some  of  the complications  often  observed.1–3 http://dx.doi.org/10.1016/j.bjhh.2016.09.016 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/1b/8a/main.PMC5457457.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/8a/main.PMC5457457.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.11.008 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/93/6e/main.PMC5457458.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/6e/main.PMC5457458.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.11.007 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/82/6f/main.PMC5457459.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/6f/main.PMC5457459.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/6f/main.PMC5457459.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs279/en/ [internet;  cited  22.02.16].,OADS,/arxiv_data1/oa_pdf/82/6f/main.PMC5457459.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/b6/main.PMC5457460.pdf
"There  are  no  randomized  trials,  most http://dx.doi.org/10.1016/j.bjhh.2016.09.014 1516-8484/©  2016  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/94/b6/main.PMC5457460.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/b6/main.PMC5457460.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/09/main.PMC5457461.pdf
"http://dx.doi.org/10.1016/j.bjhh.2017.01.003 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/4e/09/main.PMC5457461.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/09/main.PMC5457461.pdf
Available from: http://www.ebi.ac.uk/ipd/hpa/table1.html .,OADS,/arxiv_data1/oa_pdf/4e/09/main.PMC5457461.pdf
Available  from:  http://www.koonec.com/k-blog/ 2010/06/20/hardy-weinberg-equilibrium-calculator/ .,Non-OADS,/arxiv_data1/oa_pdf/4e/09/main.PMC5457461.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/0f/main.PMC5457462.pdf
"http://dx.doi.org/10.1016/j.bjhh.2016.09.017 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/c6/0f/main.PMC5457462.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/0f/main.PMC5457462.pdf
"Additionally,  pairwise  LD  between  SNPs was evaluated using  the  software  HaploView  (version  4.2; http://www.broad.mit.edu/mpg/haploview/ )  and  expressed  as D/primeand  R2.",OADS,/arxiv_data1/oa_pdf/c6/0f/main.PMC5457462.pdf
http://dx.doi.org/10.1016/j.bjhh.2017.02.005,OADS,/arxiv_data1/oa_pdf/d9/78/main.PMC5457464.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/8d/main.PMC5457465.pdf
"http://dx.doi.org/10.1016/j.bjhh.2017.01.005 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/26/8d/main.PMC5457465.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/8d/main.PMC5457465.pdf
"In  adults,  the  disease  has  an  insidious  onset,  with  no DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2017.01.003 .",Non-OADS,/arxiv_data1/oa_pdf/43/c0/main.PMC5457466.pdf
"Hemorrhagic  events  are  highly  heterogeneous  but  patients frequently present  mild  mucocutaneous  bleeding.5,6Major bleeding  risk  is  low  in  pediatric  patients  but  in  adults,  addi- tional modiﬁers  such  as  existing  comorbidities,  age,  activities and  medications  may  affect  the  risk  of  signiﬁcant  bleeding.6 The main goal of ITP  treatment  is  to  raise  the  platelet  count  to control bleeding  symptoms  and  to  prevent  major  hemorrhage as  well  as  to  minimize  treatment  toxicity  and  maximize  qual- ity of  life.6The  treatment  is  rarely  indicated  when  the  platelet count  is  above  20  ×  109/L  in  the  absence  of  other  factors  such as major bleeding.6First  line  therapy  is  generally  based  on the use of  corticosteroids  with  an  initial  response  rate  of approximately  80%  or  intravenous  immunoglobulin  (IgIV  or anti-D in  Rh  positive  patients),  when  a  rapid  increase  in  the platelet  count  is  needed,  with  a  transient  response  in  approx- imately  80%  of  cases.6When  the  patient  fails  to  respond or relapses  after  ﬁrst-line  therapy,  the  second-line  treat- ment used generally consists  of  immunosuppressive  agents, rituximab,  splenectomy  and  more  recently  thrombopoietin receptor  antagonists  (TRA).2,6TRA  (romiplostim,  eltrombopag) are new  agents  that  have  very  high  efﬁcacy  and  few  side  effects but  are  expensive  and  still  need  to  be  evaluated  over  a  longer follow-up.6,7 http://dx.doi.org/10.1016/j.bjhh.2017.02.008 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/43/c0/main.PMC5457466.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/c0/main.PMC5457466.pdf
"http://dx.doi.org/10.1016/j.bjhh.2017.03.003 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/50/1e/main.PMC5457467.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/1e/main.PMC5457467.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/main.PMC5457469.pdf
"E-mail address:  dr.g.lima.oliveira@gmail.com  (G.  Lima-Oliveira).multi-tasking analysis  that  provides  valuable  information  on a  broad  range  of  clinical  conditions  (i.e.,  anemia,  hemostasis, inﬂammation,  malignancies).1The  samples  for  CBC  are  hence routinely requested  in  virtually  all  healthcare  environments, including  emergency  departments,  and  clinical  and  surgical http://dx.doi.org/10.1016/j.bjhh.2017.01.004 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/a9/2e/main.PMC5457469.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/2e/main.PMC5457469.pdf
Available from:  http://www.westgard.com/biodatabase1.htm [cited  04.10.16].,OADS,/arxiv_data1/oa_pdf/a9/2e/main.PMC5457469.pdf
DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2017.02.007 .,OADS,/arxiv_data1/oa_pdf/e8/06/main.PMC5457470.pdf
"Interestingly,  in  recent  years,  telomere  attrition  has  also been described  in  a  number  of  different  conditions,  ranging from  depression  to  poor  immune  function  and  diabetes,  where patients do not have  mutations  in  telomerase  biology  genes.6 Most notably, shorter  leukocyte  telomere  length  (LTL)  has  been directly  associated  with  cardiovascular  disease7and  it  has http://dx.doi.org/10.1016/j.bjhh.2017.03.004 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/main.PMC5457470.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/06/main.PMC5457470.pdf
http://dx.doi.org/10.1016/j.bjhh.2017.01.007 Available online  27  February  2017,OADS,/arxiv_data1/oa_pdf/c1/82/main.PMC5457471.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/9b/main.PMC5457472.pdf
"http://dx.doi.org/10.1016/j.bjhh.2017.02.007 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/58/9b/main.PMC5457472.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/9b/main.PMC5457472.pdf
"After  completing  six  years  of treatment using  imatinib,  our  patient  developed  pancytopenia http://dx.doi.org/10.1016/j.bjhh.2017.02.004 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/ae/a4/main.PMC5457473.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/a4/main.PMC5457473.pdf
"The  study conﬁrmed  a  mean  decrease  in  plasma  volume  of  10.8%  (equiv- alent to  around  500  mL  in  a  70  kg  adult)  after  15  min,  which DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2017.01.004 .",Non-OADS,/arxiv_data1/oa_pdf/24/25/main.PMC5457476.pdf
"In  regard  to  the  magnitude  of these changes  (mean  values),  hemoglobin  varied  from  12.8  g  to 13.5  g/dL,  hematocrit  from  40.6  to  42.6%,  platelet  counts  from 297 to  320  ×  109/L,  and  WBC  counts  from  7.37  to  7.62  ×  109/L.4 In  this  issue  of  the  Brazilian  Journal  of  Hematology  and Hemotherapy,  Lima-Oliveira  et  al.5report  the  ﬁndings  of a study  performed  in  19  healthy  volunteers  that  aimed http://dx.doi.org/10.1016/j.bjhh.2017.03.007 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",OADS,/arxiv_data1/oa_pdf/24/25/main.PMC5457476.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/25/main.PMC5457476.pdf
"Laboratory  tests  showed  anemia  (Hb:  6.7  g/dL;  hema- tocrit: 21%)  and  cholestasis  (total  bilirubin:  16.01  mg/dL; direct bilirubin:  12.11  mg/dL)  with  a  slight  elevation  of  liver http://dx.doi.org/10.1016/j.bjhh.2017.02.006 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/1a/66/main.PMC5457482.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/66/main.PMC5457482.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/03/main.PMC5457483.pdf
"http://dx.doi.org/10.1016/j.bjhh.2017.02.009 1516-8484/©  2017  Associac ¸˜ao  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/1a/03/main.PMC5457483.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/03/main.PMC5457483.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 260–266  K L Gatford et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3 Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0032 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research K L Gatford  et al.,Non-OADS,/arxiv_data1/oa_pdf/81/2a/ec-6-260.PMC5457489.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0077 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 4Endocrine Connections 6:4 E1–2  J Köhrle Igniting stage two in Endocrine Connections Endocrine ConnectionsOpen Access Igniting stage two in Endocrine  Connections Josef Köhrle Institute of Experimental Endocrinology, Charité – Universitätsmedizin Berlin, Berlin, Germany Now in its sixth year, Endocrine Connections  was the  first Open Access journal devoted to hormones.",Non-OADS,/arxiv_data1/oa_pdf/29/2e/ec-6-E1.PMC5457491.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0077 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Editorial J Köhrle Igniting stage two in  Endocrine ConnectionsEndocrine Connections 6:E2 E2–E2 advance this key subject of contemporary endocrinology,  in order to provide expert advice to regulatory authorities  and policy decision makers.",Non-OADS,/arxiv_data1/oa_pdf/29/2e/ec-6-E1.PMC5457491.pdf
"Social media has become an inherent element of  science communication in the 21st century; if you  are eager to instantly follow novel trends, the latest  endocrine information, or contribute to debates on new  work published in Endocrine Connections,  you will find  tweets @EndoConnect and may join this lively endocrine  community together with the European young endocrine  scientists and researchers of EYES ( http://www.ese- hormones.org/youngendo/ ).",Non-OADS,/arxiv_data1/oa_pdf/29/2e/ec-6-E1.PMC5457491.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd6 3Endocrine Connections 6:3 267–277  D Glintborg et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License .DOI: 10.1530/EC-17-0034 http://www.endocrineconnections.org © 2017 The authors Published by Bioscientifica Ltd Research D Glintborg  et al.,Non-OADS,/arxiv_data1/oa_pdf/ed/1c/ec-6-267.PMC5457494.pdf
http://www.jspnm.com/topics/data/ kaiin20150128.pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/51/ancr-17-184.PMC5457813.pdf
http://www.ncpc.org.uk/sites/default/files/ Anita_IHIBreakthroughSerieswhitepaper2003.pdf .,Non-OADS,/arxiv_data1/oa_pdf/33/51/ancr-17-184.PMC5457813.pdf
"Copenhagen, Denmark: WHO Regional Office for Europe; 2009. http://www.euro.who.int/document/ E92645.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.health.ny.gov/environmental/indoors/air/mold/task_force/docs/final_toxic_mold_task_force_report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
"West’s Encyclopedia of American Law, edition 2. http://legal-dictionary.thefreedictionary.com/Building+Codes .",Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
International Codes—adoption by state.http://www.iccsafe.org/wp-content/uploads/stateadoptions.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.iccsafe.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.mainelegislature.org/legis/bills/bills_122nd/ chappdfs/RESOLVE174.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.maine.gov/dep/ waste/publications/legislativereports/documents/finalmoldreport.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
"New York City, Local Law 13 of 2014. http://www1.nyc.gov/assets/ buildings/local_laws/ll13of2014.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://urbangreencouncil.org/sites/default/files/ greencodestaskforce_fullreport.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.landlord.com/state-habitability-statutes-by-state.htm .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.nchh.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
https://leginfo.legislature.ca.gov/faces/billNavClient.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.rampasthma.org/wp-content/uploads/2015/04/SB-655- Mitchell-Sponsor-Fact-Sheet-15-05-27.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
"Washington, DC: Environ- mental Law Institute; 2016. https://www.eli.org/sites/default/files/ docs/2016_mold_database.pdf .",Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.acac.org/forms/ otherpdfs/alanhmold.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
https://www.cdph.ca.gov/programs/ IAQ/Documents/statement_on_building_dampness_mold_and%20health2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.cdph.ca.gov/programs/ IAQ/Documents/DMH-Stmt_201602_ENG.pdf .,OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
Final report for Act 341 of 2011. http://plantboard.arkansas.gov/PlantIndustry/ Documents/Mold%20Advosiry%20Board%20Final%20Report.pdf.,OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.portal.state.pa.us/portal/server.pt/community/asthma/14228/pennsylvania_mold_manag ement_task_force_report/557608.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.nchh.org/ Portals/0/Contents/FloodCleanupGuide_screen_.pdf .,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
https://www.epa.gov/sites/production/ files/2014-08/documents/moldremediation.pdf .,OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
https://www.epa.gov/sites/production/files/2016-02/documents/esh_multifamily_building_upgrades_508c_02_09_2016.pdf .,OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
http://www.enterprisecommunity.com/servlet/servlet.,Non-OADS,/arxiv_data1/oa_pdf/48/d1/jpump-23-388.PMC5457817.pdf
"We evaluated the scale for the kappa coefficients using the free statistical software “R.”We categorized interobserver agreement as follows, (<0.20, poor; 0.21 –0.40, fair; 0.41 –0.60, moderate; 0.61–0.80, substantial; and 0.81 –1.00, near-perfect) (R package version 2.6.1; The; http://www.r-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/d3/43/rct-41-382.PMC5457822.pdf
Sensitivity of our results to this  second assumption was assessed in eAppendix E (http://links.lww.com/EDE/B186).,OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"In eAppendix E (http://links.lww.com/EDE/B186), we tested the sensitivity of our results to alterna-tive average durations in the susceptible class.",OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Estimating the Effective Reproduction Number  of Rotavirus The effective reproduction number, Rt(), measures the  number of secondary cases infected per primary case at time  t and can be calculated as21 RtIugu t Iu agaut a()() () (), =() − −=∞ =∞∑ ∑/circumflexnosp /circumflexnosp 0 where Iu/circumflexnosp() is the rotavirus infection incidence at time u  and gu() is the probability density of the generation interval  distribution at time u, which we calculated in eAppendix B  (http://links.lww.com/EDE/B186).",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"The mean of the generation  interval was 2.1 days (SD = 0.9), which agrees with the esti- mated rotavirus incubation period of 2 days.1 In eAppendix E  (http://links.lww.com/EDE/B186), we tested the sensitivity of  our results to a longer generation interval.",OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"22,23 (Reasoning and details are avail- able in eAppendix B; http://links.lww.com/EDE/B186.)",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Because the original reported rotavirus incidence data were aggregated by week, our analy- ses relied on weekly data (eFigure 15; http://links.lww.com/EDE/B186).",OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Preliminary Analyses: Simulation Study Using simulations, we assessed the effect of correct- ing for residual serial correlation (described in eAppendix A; http://links.lww.com/EDE/B186).",OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
Further details are provided in eAppendix B (http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
25–29  Example code is provided in eAppendix C (http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
Optimal model  fit was obtained when a delay of up to 2 weeks for temperature  and when a delay of up to 3 weeks for the log proportion of  susceptible individuals were included in the model (eFigure  16; http://links.lww.com/EDE/B186).,Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
We observed that weeks with higher propor - tions of susceptible individuals were associated with a higher effective reproduction number (eFigure 16a; http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"In eAppendix D (http://links.lww.com/EDE/B186), we compare results of multivariate models  with different numbers of delayed terms.",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Additional results of our final  model, including the estimated coefficients, are available in eAppendix D (http://links.lww.com/EDE/B186).",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Sensitivity Analyses Sensitivity analyses showed, first, that there were only  minor changes in the results when the average duration in the  susceptible class was varied from 9 months to 3, 15, and 30  months (eFigures 22–26; http://links.lww.com/EDE/B186).",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Second, stronger associations for one or both factors were  observed when the serial interval was delayed or lengthened  (eFigures 27–29; http://links.lww.com/EDE/B186).",OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Third,  results were sensitive to the assumption of complete immu-nity, with the effect of the proportion of susceptible individuals  becoming insignificant when 15% of the infected individuals  are assumed to re-enter the susceptible class 6 months after infection (eFigures 30–31; http://links.lww.com/EDE/B186).",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
The results of sensitivity analyses are presented and further discussed in eAppendix E (http://links.lww.com/EDE/B186).,OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
"Removing seasonal and serial correlation reduces the possibility of arriving at spu-rious associations between two variables 13 and may thereby  result in a loss of significance of originally identified, logically attractive variables.12 As we showed in our simulation analy- ses (eAppendix A; http://links.lww.com/EDE/B186), ordinary regression analysis detects spurious associations in serially correlated data, and serial correlation correction using autore-gressive moving average error terms does not hinder the abil-ity to detect an association.",Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
Available at:  https://www.soa.org/research-reports/2013/research-2013-arima-arimax-ben-appl-rates/.,OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/89/c6/ede-28-503.PMC5457827.pdf
Available at: http://archives.drugabuse.gov/pdf/monographs/04.pdf.,OADS,/arxiv_data1/oa_pdf/4e/ea/adm-11-224.PMC5457834.pdf
Available at: https://www.drugabuse.gov/related-topics/trends-stat- istics/overdose-death-rates.,Non-OADS,/arxiv_data1/oa_pdf/d9/60/adm-11-217.PMC5457835.pdf
"(SAMHSA’s detailed RAM process and results are described in the report entitled Advancing the Care of Preg- nant and Parenting Women With Opioid Use Disorder and Their Infants: A Foundation for Clinical Guidance , available at https://www.regulations.gov/document?D=SAMHSA- 2016-0002-0001) The Guide , which is intended for healthcare providers, will be published by SAMHSA after a period of public review and comment.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"Consist- ent with the WHO method, the librarian searched PubMed, PsycInfo, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Embase, and CENTRAL (Cochrane Center Register of Controlled Trials) databases using the listed search terms (see Appendix A, http://links.lww.com/ JAM/A53).",OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"Forty- two articles were dropped, leaving a final list of 75 articles (see Appendix B, http://links.lww.com/JAM/A54) selected to identify relevant evidence regarding treatment of pregnant and parenting women with OUD and their infants and children.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"They abstracted relevant information from the eligible articles to generate a summary table presenting the key details of the study design and major findings (see Supplemental Material, http://links.lww.com/JAM/A51).",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
Available at: https://www.acog.org/-/media/Committee- Opinions/Committee-on-Health-Care-for-Underserved-Women/co524.pdf?dmc=1&ts=20160302T1440499290 American Society of Addiction Medicine.,Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"Available at: http://www.asam.org/quality-practice/guidelines-and-consensus-documents/npg Hudak ML, Tan RC; Committee On Drugs, Committee On Fetus And Newborn, American Academy of Pediatrics.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"Available at: http://pediatrics.aappublications.org/content/129/2/e540 Reece-Stremtan S, Marinelli KA; The Academy of Breastfeeding Medicine.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
Available at: http://www.bfmed.org/Media/Files/Protocols/ Guidelines%20for%20Breastfeeding%20and%20Substance%20Use%20or%20Use%20Disorder.pdf World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
"Available at: http://www.who.int/substance_abuse/publications/pregnancy_guidelines/en/J Addict Med /C15Volume 11, Number 3, May/June 2017 Treating Pregnant Women With Opioid Use Disorder /C2232017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
Available at: http://www.samhsa.gov/ data/sites/default/files/NSDUH-FRR1- 2014/NSDUH-FRR1-2014.pdf.,OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
Available at: http://www.bfmed.org/Resources/Protocols.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b3/11/adm-11-178.PMC5457836.pdf
Medicine (2017) 96:21(e6359)Received: 25 May 2016 / Received in ﬁnal form: 18 February 2017 / Accepted: 20 February 2017 http://dx.doi.org/10.1097/MD.0000000000006359Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/71/09/medi-96-e6359.PMC5457840.pdf
Medicine (2017) 96:21(e6447)Received: 8 May 2016 / Received in ﬁnal form: 23 February 2017 / Accepted: 2 March 2017 http://dx.doi.org/10.1097/MD.0000000000006447Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a5/46/medi-96-e6447.PMC5457842.pdf
Medicine (2017) 96:21(e6531)Received: 19 November 2016 / Received in ﬁnal form: 6 March 2017 / Accepted: 13 March 2017 http://dx.doi.org/10.1097/MD.0000000000006531Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7d/e3/medi-96-e6531.PMC5457843.pdf
"1, http://links.lww.com/MD/B651 which illustrates the risk ofbias across the included studies), a moderate number of trials had unclear risk of selection bias: 50% (4 trials)[22,25,26,29]had an unclear risk of bias for random sequence generation, and 62.5%(5 trials) [22,24,25,27,29]had an unclear risk of bias for allocation concealment.",Non-OADS,/arxiv_data1/oa_pdf/7d/e3/medi-96-e6531.PMC5457843.pdf
"The results indicate that the treatment effect in HbA1c ( P<.02) and FBG ( P<.01) was inversely related to ALA dose (see Supplementary Table 2, http://links.lww.com/MD/B651).Subgroup analysis of characteristics treated as categorical predictors (see Supplementary Figures 2 –4, http://links.lww.com/ MD/B651) revealed no signi ﬁcantin ﬂuences bydose orother traits: method of intake, endpoint baseline value, duration, ALA source, study design, and MQS, as indicated by P-value.",OADS,/arxiv_data1/oa_pdf/7d/e3/medi-96-e6531.PMC5457843.pdf
Available at: http://www.heart.org/HEARTORG/HealthyLiving/HealthyEating/Nutrition/Polyunsaturated-Fats_UCM_301461_Article.jsp#.WCTR7dQrLcs.,Non-OADS,/arxiv_data1/oa_pdf/7d/e3/medi-96-e6531.PMC5457843.pdf
Medicine (2017) 96:21(e6632)Received: 24 October 2016 / Received in ﬁnal form: 12 March 2017 / Accepted: 26 March 2017 http://dx.doi.org/10.1097/MD.0000000000006632Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/83/medi-96-e6632.PMC5457845.pdf
Medicine (2017) 96:21(e6652)Received: 13 November 2016 / Received in ﬁnal form: 27 March 2017 / Accepted: 29 March 2017 http://dx.doi.org/10.1097/MD.0000000000006652Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/03/80/medi-96-e6652.PMC5457846.pdf
"S1, http://links.lww.com/MD/B693).",Non-OADS,/arxiv_data1/oa_pdf/03/80/medi-96-e6652.PMC5457846.pdf
Medicine (2017) 96:21(e6668)Received: 29 June 2016 / Received in ﬁnal form: 25 March 2017 / Accepted: 28 March 2017 http://dx.doi.org/10.1097/MD.0000000000006668Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"MiRNA and mRNA expression pro ﬁles of CP The expression pro ﬁle of CP was downloaded from Gene Expression Atlas (http://www.ebi.ac.uk/gxa)[12]at European Bioinformatics Institute of the European Molecular Biology Laboratory (EMBL-EBI, http://www.ebi.ac.uk/).",OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"[20] Using gene set enrichment analysis (GSEA) software, the enriched KEGG pathways (http://www.genome.jp/kegg/) were identi ﬁed based on the mRNA expression pro ﬁle of CP.",OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"Besides, we conducted the functional enrichment analysis for the targets ofDEmiRs using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) tool (http://david.abcc.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"Function analysis of genes and miRNAs in CP patients After the GSEA analysis, a total of 73 downregulated pathways and 84 upregulated pathways were identi ﬁed (Supplementary Table 1, http://links.lww.com/MD/B706) and 40 sig-pathways were acquired (Supplementary Fig.",OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"2A, http://links.lww.com/ MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"2C, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"2D, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"In the 166 DEmiR-DEG pairs, 76 pairs downregulated and 90 pairs upregulated the target genes(Supplementary Table 2, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"3, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"4, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"6A, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
"6B, http://links.lww.com/MD/B706).",Non-OADS,/arxiv_data1/oa_pdf/1d/da/medi-96-e6668.PMC5457847.pdf
Medicine (2017) 96:21(e6682)Received: 19 October 2016 / Received in ﬁnal form: 21 March 2017 / Accepted: 22 March 2017 http://dx.doi.org/10.1097/MD.0000000000006682Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/f0/medi-96-e6682.PMC5457848.pdf
Medicine (2017) 96:21(e6684)Received: 29 October 2016 / Received in ﬁnal form: 15 March 2017 / Accepted: 19 March 2017 http://dx.doi.org/10.1097/MD.0000000000006684Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b2/ec/medi-96-e6684.PMC5457849.pdf
Medicine (2017) 96:21(e6753)Received: 13 January 2017 / Received in ﬁnal form: 30 March 2017 / Accepted: 3 April 2017 http://dx.doi.org/10.1097/MD.0000000000006753Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/54/24/medi-96-e6753.PMC5457851.pdf
Medicine (2017) 96:21(e6839)Received: 30 January 2017 / Received in ﬁnal form: 8 April 2017 / Accepted: 13 April 2017 http://dx.doi.org/10.1097/MD.0000000000006839Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/10/5a/medi-96-e6839.PMC5457853.pdf
Medicine (2017) 96:21(e6843)Received: 24 January 2017 / Received in ﬁnal form: 11 April 2017 / Accepted: 12 April 2017 http://dx.doi.org/10.1097/MD.0000000000006843Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6e/fc/medi-96-e6843.PMC5457855.pdf
Medicine (2017) 96:21(e6862)Received: 8 October 2016 / Received in ﬁnal form: 4 April 2017 / Accepted: 9 April 2017 http://dx.doi.org/10.1097/MD.0000000000006862Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/42/1a/medi-96-e6862.PMC5457856.pdf
Medicine (2017) 96:21(e6871)Received: 16 January 2017 / Received in ﬁnal form: 16 April 2017 / Accepted: 19 April 2017 http://dx.doi.org/10.1097/MD.0000000000006871Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/57/e6/medi-96-e6871.PMC5457857.pdf
Medicine (2017) 96:21(e6876)Received: 18 December 2016 / Received in ﬁnal form: 2 April 2017 / Accepted: 16 April 2017 http://dx.doi.org/10.1097/MD.0000000000006876Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3d/88/medi-96-e6876.PMC5457858.pdf
Medicine (2017) 96:21(e6882)Received: 25 January 2017 / Received in ﬁnal form: 7 April 2017 / Accepted: 16 April 2017 http://dx.doi.org/10.1097/MD.0000000000006882Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/ba/medi-96-e6882.PMC5457859.pdf
Medicine (2017) 96:21(e6912)Received: 12 September 2016 / Received in ﬁnal form: 30 March 2017 / Accepted: 23 April 2017 http://dx.doi.org/10.1097/MD.0000000000006912Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/be/medi-96-e6912.PMC5457860.pdf
The dataset that was used for the analysis is available at https://doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/72/be/medi-96-e6912.PMC5457860.pdf
Medicine (2017) 96:21(e6916)Received: 30 December 2016 / Received in ﬁnal form: 20 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000006916Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/45/b3/medi-96-e6916.PMC5457861.pdf
Available at: [http://handbook.cochrane.org/].,OADS,/arxiv_data1/oa_pdf/45/b3/medi-96-e6916.PMC5457861.pdf
Medicine (2017) 96:21(e6918)Received: 18 February 2017 / Received in ﬁnal form: 20 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000006918Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/8d/medi-96-e6918.PMC5457862.pdf
"2015;The World Health Organization, Retrieved from http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.",Non-OADS,/arxiv_data1/oa_pdf/98/8d/medi-96-e6918.PMC5457862.pdf
Medicine (2017) 96:21(e6920)Received: 12 October 2016 / Received in ﬁnal form: 17 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000006920Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/39/f7/medi-96-e6920.PMC5457863.pdf
"1, http://links.lww.com/MD/ B702).",Non-OADS,/arxiv_data1/oa_pdf/39/f7/medi-96-e6920.PMC5457863.pdf
Medicine (2017) 96:21(e6942)Received: 15 February 2017 / Received in ﬁnal form: 23 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000006942Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0f/ee/medi-96-e6942.PMC5457865.pdf
Medicine (2017) 96:21(e6952)Received: 13 December 2016 / Received in ﬁnal form: 31 March 2017 / Accepted: 24 April 2017 http://dx.doi.org/10.1097/MD.0000000000006952Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/d0/medi-96-e6952.PMC5457868.pdf
Medicine (2017) 96:21(e6959)Received: 31 May 2016 / Received in ﬁnal form: 4 April 2017 / Accepted: 29 April 2017 http://dx.doi.org/10.1097/MD.0000000000006959Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c8/42/medi-96-e6959.PMC5457869.pdf
Medicine (2017) 96:21(e6962)Received: 3 December 2016 / Received in ﬁnal form: 16 April 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000006962Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a8/9a/medi-96-e6962.PMC5457870.pdf
Medicine (2017) 96:21(e6963)Received: 29 December 2016 / Received in ﬁnal form: 23 April 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000006963Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/07/34/medi-96-e6963.PMC5457871.pdf
Medicine (2017) 96:21(e6965)Received: 30 December 2016 / Received in ﬁnal form: 3 April 2017 / Accepted: 1 May 2017 http://dx.doi.org/10.1097/MD.0000000000006965Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a3/04/medi-96-e6965.PMC5457872.pdf
This study was registered at http://www.clinicaltrials.gov (identi ﬁer: NCT02816918).,Non-OADS,/arxiv_data1/oa_pdf/4a/7e/medi-96-e6966.PMC5457873.pdf
Medicine (2017) 96:21(e6966)Received: 26 December 2016 / Received in ﬁnal form: 27 April 2017 / Accepted: 30 April 2017 http://dx.doi.org/10.1097/MD.0000000000006966Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4a/7e/medi-96-e6966.PMC5457873.pdf
Medicine (2017) 96:21(e6968)Received: 30 June 2016 / Received in ﬁnal form: 25 April 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000006968Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/82/1d/medi-96-e6968.PMC5457875.pdf
Medicine (2017) 96:21(e6970)Received: 20 October 2016 / Received in ﬁnal form: 28 April 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000006970Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3c/b4/medi-96-e6970.PMC5457876.pdf
"Supplemental digital content: All collected data and obtained scores are available upon request, http://links.lww.com/MD/B707 The authors have no funding and con ﬂicts of interest to disclose.",Non-OADS,/arxiv_data1/oa_pdf/87/7d/medi-96-e6972.PMC5457877.pdf
Medicine (2017) 96:21(e6972)Received: 15 November 2016 / Received in ﬁnal form: 27 April 2017 / Accepted: 27 April 2017 http://dx.doi.org/10.1097/MD.0000000000006972Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/7d/medi-96-e6972.PMC5457877.pdf
Medicine (2017) 96:21(e6976)Received: 24 October 2016 / Received in ﬁnal form: 9 March 2017 / Accepted: 28 April 2017 http://dx.doi.org/10.1097/MD.0000000000006976Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d0/6a/medi-96-e6976.PMC5457879.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/d0/6a/medi-96-e6976.PMC5457879.pdf
Medicine (2017) 96:21(e6978)Received: 18 October 2016 / Received in ﬁnal form: 14 April 2017 / Accepted: 1 May 2017 http://dx.doi.org/10.1097/MD.0000000000006978Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7a/6a/medi-96-e6978.PMC5457880.pdf
Medicine (2017) 96:21(e6979)Received: 3 November 2016 / Received in ﬁnal form: 7 March 2017 / Accepted: 30 April 2017 http://dx.doi.org/10.1097/MD.0000000000006979Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/40/6a/medi-96-e6979.PMC5457881.pdf
Medicine (2017) 96:21(e6981)Received: 7 November 2016 / Received in ﬁnal form: 28 April 2017 / Accepted: 28 April 2017 http://dx.doi.org/10.1097/MD.0000000000006981Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cc/0f/medi-96-e6981.PMC5457883.pdf
Medicine (2017) 96:21(e6982)Received: 23 March 2017 / Received in ﬁnal form: 25 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000006982Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5f/64/medi-96-e6982.PMC5457884.pdf
Available at: [http://handbook.cochrane.org/].,OADS,/arxiv_data1/oa_pdf/5f/64/medi-96-e6982.PMC5457884.pdf
Medicine (2017) 96:21(e6985)Received: 22 January 2017 / Received in ﬁnal form: 21 April 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000006985Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/4c/medi-96-e6985.PMC5457885.pdf
Medicine (2017) 96:21(e6986)Received: 27 January 2017 / Received in ﬁnal form: 25 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000006986Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/11/medi-96-e6986.PMC5457886.pdf
Medicine (2017) 96:21(e6987)Received: 27 January 2017 / Received in ﬁnal form: 28 April 2017 / Accepted: 28 April 2017 http://dx.doi.org/10.1097/MD.0000000000006987Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/50/e6/medi-96-e6987.PMC5457887.pdf
Medicine (2017) 96:21(e6993)Received: 6 January 2017 / Received in ﬁnal form: 9 April 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000006993Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0c/49/medi-96-e6993.PMC5457888.pdf
"1, http://links.lww.com/MD/ B708 which shows the positioning process of the phantom in CTscan) representing wide range of textures found in human tissues.It was created for the purpose of image texture analysis and was used in a previous study.",Non-OADS,/arxiv_data1/oa_pdf/0c/49/medi-96-e6993.PMC5457888.pdf
"2, http://links.lww.com/ MD/B708 which shows the images of cartridges of the phantom).A 3D printer (MakerBot Replicator 2 3D; MakerBot Industries LLC, Brooklyn, NY) (for cartridges A –D), a proprietary bonding agent (Ecoborder, Tampa, FL) (for cartridge F), and Colorbond(3D Systems, Inc., Rock Hill, SC) (for cartridge J) were used to create some of these cartridges.",Non-OADS,/arxiv_data1/oa_pdf/0c/49/medi-96-e6993.PMC5457888.pdf
"1, http://links.lww.com/MD/B708 which shows the positioning process of the phantomin CT scan).",Non-OADS,/arxiv_data1/oa_pdf/0c/49/medi-96-e6993.PMC5457888.pdf
Available at: http://pareonline.net/getvn.asp?v=15&n=2.,Non-OADS,/arxiv_data1/oa_pdf/0c/49/medi-96-e6993.PMC5457888.pdf
Medicine (2017) 96:21(e6994)Received: 24 January 2017 / Received in ﬁnal form: 18 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000006994Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/08/a8/medi-96-e6994.PMC5457889.pdf
Medicine (2017) 96:21(e6995)Received: 30 January 2017 / Received in ﬁnal form: 13 April 2017 / Accepted: 18 April 2017 http://dx.doi.org/10.1097/MD.0000000000006995 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/58/medi-96-e6995.PMC5457890.pdf
Medicine (2017) 96:21(e6998)Received: 13 February 2017 / Received in ﬁnal form: 21 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000006998Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3d/aa/medi-96-e6998.PMC5457892.pdf
Medicine (2017) 96:21(e7004)Received: 20 March 2017 / Received in ﬁnal form: 23 April 2017 / Accepted: 26 April 2017 http://dx.doi.org/10.1097/MD.0000000000007004Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/27/b3/medi-96-e7004.PMC5457894.pdf
Medicine (2017) 96:21(e7006)Received: 16 March 2017 / Received in ﬁnal form: 17 April 2017 / Accepted: 21 April 2017 http://dx.doi.org/10.1097/MD.0000000000007006Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/20/40/medi-96-e7006.PMC5457896.pdf
Medicine (2017) 96:21(e7007)Received: 12 March 2017 / Received in ﬁnal form: 16 April 2017 / Accepted: 23 April 2017 http://dx.doi.org/10.1097/MD.0000000000007007Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ee/e2/medi-96-e7007.PMC5457897.pdf
Medicine (2017) 96:21(e7013)Received: 17 February 2017 / Received in ﬁnal form: 19 April 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000007013Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bd/65/medi-96-e7013.PMC5457899.pdf
Medicine (2017) 96:21(e7014)Received: 4 December 2016 / Received in ﬁnal form: 27 April 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000007014Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/12/60/medi-96-e7014.PMC5457900.pdf
Medicine (2017) 96:21(e7019)Received: 6 March 2017 / Received in ﬁnal form: 2 May 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000007019Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/medi-96-e7019.PMC5457901.pdf
Available at: http://data.unicef.org/hiv-aids/global-trends.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/medi-96-e7019.PMC5457901.pdf
Available at: http://data.unicef.org/nutrition/malnutrition.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/medi-96-e7019.PMC5457901.pdf
Available at: http://www.unaids.org/en/regionscountries/countries/burkinafaso.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/medi-96-e7019.PMC5457901.pdf
Available at: http://softadvice.informer.com/ext/www.who.int/childgrowth%2Fsoftware%2Fen.,Non-OADS,/arxiv_data1/oa_pdf/ed/b0/medi-96-e7019.PMC5457901.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d1/ca/1349-7235-56-0749.PMC5457916.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d1/ca/1349-7235-56-0749.PMC5457916.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0b/aa/1349-7235-56-0755.PMC5457917.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/0b/aa/1349-7235-56-0755.PMC5457917.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6b/d4/1349-7235-56-0763.PMC5457918.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6b/d4/1349-7235-56-0763.PMC5457918.pdf
[cited 2016 July 8] Avaiable from: http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou03/14.html (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/76/c9/1349-7235-56-0773.PMC5457919.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/76/c9/1349-7235-56-0773.PMC5457919.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/76/c9/1349-7235-56-0773.PMC5457919.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d3/e2/1349-7235-56-0781.PMC5457920.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d3/e2/1349-7235-56-0781.PMC5457920.pdf
[cited 2017 Feb 3] Available from: https://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/harvoni/harvoni_pi.pdf The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.,Non-OADS,/arxiv_data1/oa_pdf/76/62/1349-7235-56-0787.PMC5457921.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/76/62/1349-7235-56-0787.PMC5457921.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/76/62/1349-7235-56-0787.PMC5457921.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/0c/03/1349-7235-56-0791.PMC5457922.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/0c/03/1349-7235-56-0791.PMC5457922.pdf
Available from: http://rhhd.info/pdf/001008.pdf (in Japa-,Non-OADS,/arxiv_data1/oa_pdf/a4/4c/1349-7235-56-0797.PMC5457923.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a4/4c/1349-7235-56-0797.PMC5457923.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a4/4c/1349-7235-56-0797.PMC5457923.pdf
"Available from: http://www.ncbi.nlm.nih.gov/books/NBK1493/.14.Bologa RM, Levine DM, Parker TS, et al.",Non-OADS,/arxiv_data1/oa_pdf/c6/ae/1349-7235-56-0805.PMC5457924.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c6/ae/1349-7235-56-0805.PMC5457924.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c6/ae/1349-7235-56-0805.PMC5457924.pdf
"This mutation is a very rare variant(rs55931547) with the allele frequency being 0.00003307 inExAC (http://exac.broadinstitute.org/), and no publishedfunctional data are available given the novel variant in rela-tion to the disease.",Non-OADS,/arxiv_data1/oa_pdf/39/0f/1349-7235-56-0811.PMC5457925.pdf
"However, according to the CADD data-base (http://cadd.gs.washington.edu/), which is the in silico protein function prediction program, the score is 12.4 (>10),suggesting that this variant may cause the dysfunction ofCFH.",Non-OADS,/arxiv_data1/oa_pdf/39/0f/1349-7235-56-0811.PMC5457925.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/39/0f/1349-7235-56-0811.PMC5457925.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/39/0f/1349-7235-56-0811.PMC5457925.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ee/85/1349-7235-56-0819.PMC5457926.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ee/85/1349-7235-56-0819.PMC5457926.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/54/a6/1349-7235-56-0823.PMC5457927.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/54/a6/1349-7235-56-0823.PMC5457927.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f5/92/1349-7235-56-0827.PMC5457928.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f5/92/1349-7235-56-0827.PMC5457928.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f4/be/1349-7235-56-0835.PMC5457929.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/f4/be/1349-7235-56-0835.PMC5457929.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/e1/0e/1349-7235-56-0841.PMC5457930.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/e1/0e/1349-7235-56-0841.PMC5457930.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/61/93/1349-7235-56-0847.PMC5457931.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/61/93/1349-7235-56-0847.PMC5457931.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/6b/10/1349-7235-56-0853.PMC5457932.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/6b/10/1349-7235-56-0853.PMC5457932.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5a/64/1349-7235-56-0861.PMC5457933.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/5a/64/1349-7235-56-0861.PMC5457933.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/00/e9/1349-7235-56-0865.PMC5457934.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/00/e9/1349-7235-56-0865.PMC5457934.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/04/81/1349-7235-56-0873.PMC5457935.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/04/81/1349-7235-56-0873.PMC5457935.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5d/40/1349-7235-56-0875.PMC5457936.pdf
"Department of Nephrology, Faculty of Medicine, Saitama Medical University, Japan Received for publication June 22, 2016; Accepted for publication July 24, 2016Correspondence to Dr. Hirokazu Okada, hirookda@saitama-med.ac.jp⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/5d/40/1349-7235-56-0875.PMC5457936.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/54/69/1349-7235-56-0877.PMC5457937.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/54/69/1349-7235-56-0877.PMC5457937.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/81/ba/1349-7235-56-0879.PMC5457938.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/81/ba/1349-7235-56-0879.PMC5457938.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/75/b9/1349-7235-56-0881.PMC5457939.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/75/b9/1349-7235-56-0881.PMC5457939.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/f4/27/1349-7235-56-0883.PMC5457940.pdf
"Department of Neurology, Tenri Hospital, Japan Received for publication July 15, 2016; Accepted for publication July 26, 2016Correspondence to Dr. Kazuto Tsukita, kazusan@kuhp.kyoto-u.ac.jp⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/f4/27/1349-7235-56-0883.PMC5457940.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ac/c0/1349-7235-56-0885.PMC5457941.pdf
"̍JSDF Central Hospital, In ternal Medicine, Japan and̎Genki-kai Yokohama Hospital, Japan Received for publication April 27, 2016; Accepted for publication June 5, 2016Correspondence to Dr. Takao Kubota, t ecmgt-c-hosp@inet.gsdf.mod.go.jp ⡥2017 The Japanese Society of Internal Medicine Journal W ebsite: http://www.naika.or.jp/imonline/index.html",Non-OADS,/arxiv_data1/oa_pdf/ac/c0/1349-7235-56-0885.PMC5457941.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/45/e7/1349-7235-56-0887.PMC5457942.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/45/e7/1349-7235-56-0887.PMC5457942.pdf
"5      http://www.jgenomics.com  58  JJoouurrnnaall  ooff  GGeennoommiiccss   2017; 5: 58-63. doi: 10.7150/ jgen.20358  Research Paper   CNV Analysis of Host Responses to Porcine  Reproductive and Respiratory Syndrome Virus Infection   El Hamidi A. Hay1*, Igseo Choi2*, Lingyang Xu1, 3, Yang Zhou1, 4, Robert R. R. Rowland5, Joan K. Lunney2,  and George E. Liu1  1.",Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
This is an open acc ess article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
"5    http://www.jgenomics.com  59  structural nature of the virus and its high mutation  rate [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
"5    http://www.jgenomics.com  60  deviation (STD) of log R ratio, 0.075 for the waviness   factor, 0.01 for BAF drift and a threshold of 100 low  quality CNVs to eliminate samples (-qclrrsd 0.35  -qcwf 0.075 - qcbafdrift 0.01 -qcnumcnv 100  –qcpassout).",Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
"Summary of CNV regions of extreme groups   Sample  Trait  Counta Gainb Lossc Total length   All samples  VL,WG42  271 319 6778  186,923,627   VLL  VL low  159 55 911 76,462,440   VLH  VL high  163 32 969 84,558,089   WG42L  WG42 low  156 64 1025  79,628,510   WG42H  WG42 high  126 41 1000  68,708,828   a Number of non -redundant CNV regions in a specific sample group  b Number of gain events in the identified CNV regions   c Number of loss events in the identified CNV regions      CNV gene annotation  and network  identification   After the identification of CNV regions for each  group, we performed gene annotation using either  Ensembl genes (http://www.ensembl.org/) or  RefSeq genes.",Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
5    http://www.jgenomics.com  61    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
5    http://www.jgenomics.com  62  production leads to a weak innate immune response  and a slow IFN - γ response [29].,Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
All the data is available  through the database at http://www.animalgenome.,OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
5    http://www.jgenomics.com  63  10.,Non-OADS,/arxiv_data1/oa_pdf/80/f4/jgenv05p0058.PMC5457943.pdf
"103Review Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.103 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:103-109Clinical Implications of New Drugs and Regimens for the Treatment  of Drug-resistant Tuberculosis Yong-Soo Kwon* Department of Internal Medicine, Chonnam Na tional University Hospital, Gwangju, Korea The emergence of drug-resistant tuberculosi s (TB) is a growing problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/cmj-53-103.PMC5457944.pdf
"Key Words:   Tuberculosis;  Tubercu losis, Multidrug- Resistant; Antitu bercular Agents;  Bedaquiline; OPC-67683 This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 20, 2017 Accepted April 4, 2017 Corresponding Author: Yong-Soo Kwon Department of Internal Medicine,  Chonnam National University Hospital,  42 Jebong-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-62-220-6575 Fax: +82-62-225-8578 E-mail: yskwon@jnu.ac.kr INTRODUCTION Tuberculosis (TB) is a chronic infectious disease that has  been in existence for several m illennia.",Non-OADS,/arxiv_data1/oa_pdf/0c/7e/cmj-53-103.PMC5457944.pdf
"110Review Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.110 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:110-117Anticoagulation Therapy during Extracorporeal Membrane  Oxygenator Support in Pediatric Patients Hwa Jin Cho1,3, Do Wan Kim2, Gwan Sic Kim2, and In Seok Jeong2,* Departments of 1Pediatrics, 2Thoracic and Cardiovascular Surgery, Chonnam National  University Hospital, Chonnam National University  Medical School, Gwangju, Korea, 3Extracorporeal Life Support Organizati on, Asia-Pacific Chapter, Ann Arbor, MI Extracorporeal membrane oxygenation (ECMO) is a salvage therapy for critically ill  patients.",Non-OADS,/arxiv_data1/oa_pdf/40/83/cmj-53-110.PMC5457945.pdf
"Key Words: Extracorporeal Membrane Oxygenation; Extracorporeal Life Support;  Anticoagulation; Pediatrics  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 14, 2017 Revised April 22, 2017 Accepted April 28, 2017 Corresponding Author: In Seok Jeong Department of Thoracic and  Cardiovascular Surgery, Chonnam  National University Medical School,  160 Baekseo-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-62-220-6546 Fax: +82-62-227-1636 E-mail: isjeong1201@gmail.com INTRODUCTION Extracorporeal membrane oxygenation (ECMO) is a  life-saving salvage therapy for critically ill patients.",Non-OADS,/arxiv_data1/oa_pdf/40/83/cmj-53-110.PMC5457945.pdf
"118Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.118 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:118-126Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via  Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat Vahid Khanjarsim1, Jamshid Karimi1,*, Iraj Khodadadi1, Adel Mohammadalipour1,  Mohammad Taghi Goodarzi1, Ghasem Solgi2, and Mohammad Hashemnia3 Departments of 1Biochemistry, 2Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan,  3Department of Pathobiology, Veterinary Medicin e Faculty, Razi University, Kermanshah, Iran Nilotinib as a tyrosine kinase  inhibitor has been recently used to improve the liver fib- rosis process, but the exact mechanisms still re quire further clarification.",Non-OADS,/arxiv_data1/oa_pdf/ed/12/cmj-53-118.PMC5457946.pdf
"Key Words:  HMGB1 Protein; Liver Cirrhosis; Nitric Oxide; Rats This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 12, 2017 Revised April 2, 2017 Accepted April 10, 2017 Corresponding Author: Jamshid Karimi Department of Biochemistry, School of  Medicine, Hamadan University of  Medical Sciences, Hamadan, Iran Tel: +98 8138276293, +98 9183132457 Fax: +98 8138380208 E-mail: jamshidkarimi2013@gmail.com INTRODUCTION Liver fibrosis represents one of  the greatest global health  problems, with a worldwide mort ality inferable to cirrhosis  and primary liver cancer of around 1.5 million deaths per  year.1 Fibrosis of the liver is a superfluous accumulation  of scar tissue that results fr om proceeding inflammation  and death of liver cells that oc cur in most types of liver dis- eases with several types of etiologies such as immunological responses, metabolic disorders, infection and toxins.",Non-OADS,/arxiv_data1/oa_pdf/ed/12/cmj-53-118.PMC5457946.pdf
"127Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.127 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:127-132The Effect of Perineural Administration of Dexmedetomidine on  Narcotic Consumption and Pain Intensity in Patients Undergoing Femoral Shaft Fracture Surgery; A Randomized Single-Blind Clinical Trial Elham Memary1, Alireza Mirkheshti1, Ali Dabbagh2, Mehrdad Taheri1, Aida Khadempour1, and  Sadegh Shirian3,4* 1Department of Anesthesiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, 2Department of Anesthesiology,  Modaress Hospital, Shahid Beheshti University of Medical Sciences, Tehran, 3Department of Pathology, School of Veterinary Medicine,  Shahrekord University, Shahrekord, 4Shiraz Molecular Pathology Research Center, Dr Daneshbod Lab, Shiraz, Iran Dexmedetomidine is a selective -2 adrenoceptor agonist with anxiolytic, sedative, and  analgesic properties that prolongs analgesi a and decreases opioid-related side effects  when used in neuraxial and perineural area s as a local anesthetics adjuvant.",Non-OADS,/arxiv_data1/oa_pdf/9e/ef/cmj-53-127.PMC5457947.pdf
"Key Words:  Dexmedetomidine; Nerve block; Pr opofol; Narcotics; Pain management This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received January 11, 2017 Revised January 25, 2017 Accepted January 26, 2017 Corresponding Author: Sadegh Shirian Department of Pathology, School of  Veterinary Medicine, Shahrekord  University, Rahbar Street  88186-34141.",Non-OADS,/arxiv_data1/oa_pdf/9e/ef/cmj-53-127.PMC5457947.pdf
"133Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.133 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:133-139Correlation of Prognostic Factors of Invasive Lobular Carcinoma  with ADC Value of DWI and SUVMax of FDG-PET Bo Bae Choi1, Sung Hun Kim2,*, Chang Suk Park3, and Na Young Jung4 Department of Radiology, 1Chungnam University Hospital, Daejeon, 2Seoul St. Mary’ Hospital, College of Medicine, The Catholic University  of Korea, Seoul, 3Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, 4Bucheon St. Mary’s Hospital,  College of Medicine, The Catholic University of Korea, Bucheon, Korea Invasive lobular carcinoma (ILC) is the seco nd most common kind of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2e/ce/cmj-53-133.PMC5457948.pdf
"Key Words:  Invasive Lobular Carcinoma; Breast; Magnetic Resonance Imaging;  Diffusion Magnetic Resonance Imag ing; Positron-Emission Tomography This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 14, 2017 Revised April 6, 2017 Accepted April 13, 2017 Corresponding Author: Sung Hun Kim Department of Radiology, Seoul St.  Mary ’ Hospital, College of Medicine,  The Catholic University of Korea,  222 Banpo-daero, Seocho-gu,  Seoul 06591, Korea Tel: +82-2-2258-6250 Fax: +82-2-2258-1457 E-mail: rad-ksh@catholic.ac.kr INTRODUCTION Breast cancer tumors are very heterogeneous, and show  variable behavior, progression, and response to therapy.",Non-OADS,/arxiv_data1/oa_pdf/2e/ce/cmj-53-133.PMC5457948.pdf
"140Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.140 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:140-146Clinical Significance of p53 Protein Expression, Beta-catenin  Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer Dong Won Baek1, Byung Woog Kang1,*, Soyoon Hwang1, Jong Gwang Kim1,*, An Na Seo2,  Han Ik Bae2, Oh Kyoung Kwon3, Seung Soo Lee3, Ho Young Chung3, and Wansik Yu3 1Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University Cancer Research  Institute, Kyungpook National Universit y School of Medicine, Departments of 2Pathology, 3Surgery, Kyungpook National University  Hospital, Kyungpook National University School of Medicine, Daegu, Korea This study assessed the expression of the p53 protein, beta-catenin, and HER2 and their  prognostic implications in patients with  EBV-associated gastric cancer (EBVaGC).",OADS,/arxiv_data1/oa_pdf/37/87/cmj-53-140.PMC5457949.pdf
"Key Words:  Epstein-Barr Virus Infections; Stomach Neoplasms;  Tumor  Suppressor  Protein p53; Beta Catenin; Human epidermal growth factor receptor-2  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received January 25, 2017 Revised March 10, 2017 Accepted March 16, 2017 Corresponding Author: Jong Gwang Kim Department of Oncology/Hematology,  Kyungpook National University  Medical Center, Kyungpook National  University School of Medicine,  Kyungpook National University  Cancer Research Institute, 807  Hoguk-ro, Buk-gu, Daegu 41404,  Korea Tel: +82-53-200-2623 Fax: +82-53-200-3399 E-mail: jkk21c@knu.ac.kr Byung Woog Kang Department of Oncology/Hematology,  Kyungpook National University  Medical Center, Kyungpook National  University School of Medicine, 807  Hoguk-ro, Buk-gu, Daegu 41404,  Korea Tel: +82-53-200-2622Fax: +82-53-200-3399E-mail: bwkang@knu.ac.kr INTRODUCTION Recent data from the The Cancer Genome Atlas (TCGA)  data revealed that Epstein-Barr virus (EBV)-associated tumors showed a PIK3CA mutation, PD-L1/2  over- expression, EBV-CIMP, CDKN2A  silencing, and immune  cell signaling.",Non-OADS,/arxiv_data1/oa_pdf/37/87/cmj-53-140.PMC5457949.pdf
"147Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.147 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:147-152Correlations between High Platelet Reactivity, Extent of Coronary  Artery Disease, and Periprocedural Myonecrosis in Patients with Acute Coronary Syndrome Kyeong Ho Yun1, Jum Suk Ko1,*, Jeong Mi Lee2, and Sang Jae Rhee1 1Department of Cardiovascular Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, 2Department of public  health, Wonkwang University School of Medicine, Iksan, Korea The purpose of the present study was to evaluate the correlations between high platelet  reactivity (HPR) and the extent of corona ry atherosclerosis and periprocedural my- onecrosis in patients with acute corona ry syndrome (ACS) who underwent percuta- neous coronary intervention (PCI).",OADS,/arxiv_data1/oa_pdf/10/09/cmj-53-147.PMC5457950.pdf
"Key Words: Blood Platelets; Atherosclero sis; Percutaneous Coronary  Intervention;  Myocardial Infarction This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 1, 2017 Revised March 18, 2017 Accepted March 22, 2017 Corresponding Author: Jum Suk Ko Department of Cardiovascular  Medicine, Regional  Cardiocerebrovascular Center,  Wonkwang University Hospital, 895  Muwang-ro, Iksan 54538, Korea Tel: +82-63-859-2526 Fax: +82-63-852-8480 E-mail: nemor@daum.net INTRODUCTION Platelet P2Y12 receptor inhibitor non-responsiveness,  characterized as high on-tre atment platelet reactivity  (HPR), has been shown to be correlated with adverse car-diovascular events after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/10/09/cmj-53-147.PMC5457950.pdf
"153Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.153 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:153-160Carotid Atherosclerosis and Electrocardiographic Left Ventricular  Hypertrophy in the General Population: The Namwon Study Nam-Ho Kim1,2, Min-Ho Shin3, Sun-Seog Kweon3,4, Jum Suk Ko1,2, and Young-Hoon Lee2,5,* 1Division of Cardiology, Department of Internal Medic ine, Wonkwang University School of Medicine, Iksan, 2Regional  Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, 3Department of Preventive Medicine, Chonnam National University  Medical School, Gwangju, 4Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Hwasun, 5Department  of Preventive Medicine & Institute of Wonkwang Medical Scie nce, Wonkwang University School of Medicine, Iksan, Korea This study aimed to investig ate the relationship between carotid atherosclerosis and  left ventricular hypertrophy on electrocar diogram (ECG-LVH) on adults living in the  community.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/cmj-53-153.PMC5457951.pdf
"Key Words: Hypertrophy, Left Ventricular; Carotid Intima-Media Thickness; Plaque,  Atherosclerotic; Adult This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received April 11, 2017 Revised May 9, 2017 Accepted May 10, 2017 Corresponding Author: Young-Hoon Lee Department of Preventive Medicine,  Wonkwang University School of  Medicine, 460 Iksandae-ro, Iksan  54538, Korea Tel: +82-63-850-6971Fax: +82-63-859-1995E-mail: lyh8275@hanmail.net INTRODUCTION Cardiovascular disease (CVD) accounts for nearly  one-third of all deaths worldwide, and coronary artery dis-ease (CAD) is the main contributor to CVD.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/cmj-53-153.PMC5457951.pdf
"161Original Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.161 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:161-167MicroRNA-29 Family Suppresses the Invasion of HT1080 Human  Fibrosarcoma Cells by Regulating Matrix Metalloproteinase 2 Expression  Jin Hee Kim1, Songhee Jeon2, and Boo Ahn Shin1,* Departments of 1Microbiology and Immunology, 2Biomedical Sciences, Center for Creative Biomedical Scientists, Chonnam National  University Medical School, Gwangju, Korea Matrix metalloproteinase 2 (MMP2) is a po tent protumorigenic, proangiogenic, and  prometastatic enzyme that is overexpressed in metastatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/48/66/cmj-53-161.PMC5457952.pdf
"Key Words: Fibrosarcoma; Matrix Metallopro teinase 2; MicroRNAs; Neoplasm  Invasiveness   This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received April 29, 2017 Revised May 12, 2017 Accepted May 15, 2017 Corresponding Author: Boo Ahn Shin Department of Microbiology and  Immunology, Chonnam National  University Medical School, 42  Jaebong-ro, Dong-gu, Gwangju  61469, Korea Tel: +82-61-379-2743Fax: +82-61-379-2753E-mail: bashin@jnu.ac.kr INTRODUCTION Tumor metastasis is the last stage of tumorigenesis in  which malignant cancer cells me tastasize to organs distant  from the primary tumor.1 During tumor development, tu- mor cells are released from the primary tumor, enter the surrounding tissues, migrate to distant organs through the circulation system, distribute to the organs via vascular outflow, and form new tumors through cell proliferation in secondary organs.",Non-OADS,/arxiv_data1/oa_pdf/48/66/cmj-53-161.PMC5457952.pdf
"168Letters to the Editor www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.168 ⒸChonnam Medical Journal, 2017 Chonnam Med J 2017;53:168-169Corresponding Author: Eun Hui Bae Department of Internal Medicine, Chonnam National University Me dical School, 42 Jebong-ro, Dong-gu, Gwangju 61469,  Korea  Tel: +82-62-220-6503, Fax: +82-62-225-8578, E-mail: baedak@hanm ail.netArticle History: Received February 9, 2017 Revised March 5, 2017 Accepted March 7, 2017 FIG.",Non-OADS,/arxiv_data1/oa_pdf/f8/44/cmj-53-168.PMC5457953.pdf
"170Images in Clinical Medicine www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.170 ⒸChonnam Medical Journal, 2017 Chonnam Med J 2017;53:170Corresponding Author: Jong Hwan Jung  Division of Nephrology, Department of Internal Medicine, Wonkwa ng University School of Medicine, 895 Muwang-ro, Iksan  54538, Korea Tel: +82-63-859-1667, Fax: +82-63-855-2025, E-mail: chjh0502@gm ail.com  Article History: Received March 14, 2017 Revised March 28, 2017 Accepted March 30, 2017 FIG.",Non-OADS,/arxiv_data1/oa_pdf/85/29/cmj-53-170.PMC5457954.pdf
"171Images in Clinical Medicine www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.171 ⒸChonnam Medical Journal, 2017 Chonnam Med J 2017;53:171-172Corresponding Author: Yun Ju Lim Division of Pediatric Cardiology, Department of Pediatrics, Jej u National University School of Medicine, 15 Aran 13 gil, Jeju  23241, Korea  Tel: +82-64-717-1800, Fax: +82-64-717-1656, E-mail: limyunju@ya hoo.comArticle History: Received March 17, 2017 Revised April 3, 2017 Accepted April 11, 2017 FIG.",Non-OADS,/arxiv_data1/oa_pdf/cc/34/cmj-53-171.PMC5457955.pdf
"83Review Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.83 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:83-94FIG.",Non-OADS,/arxiv_data1/oa_pdf/46/15/cmj-53-83.PMC5457956.pdf
"Key Words:  Neoplasms; Fluorescent Dyes; Drug De livery Systems; Nanotechnology This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received March 21, 2017 Revised April 2, 2017 Accepted April 3, 2017 Corresponding Author: Yong Yeon Jeong Department of Radiology, Chonnam  National University Medical School,  Hwasun Hospital, Molecular  Theranostics Laboratory, 322  Seoyang-ro, Hwasun 58128, Korea Tel: +82-61-379-7102 Fax: +82-61-379-7133 E-mail: yjeong@jnu.ac.kr INTRODUCTION Near-infrared fluorescence (NIRF) imaging is an ap- pealing method for cancer diagnosis at the early stage ow-ing to its multi-detection capabi lities and high sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/46/15/cmj-53-83.PMC5457956.pdf
"95Review Article www.cmj.ac.k r https://doi.org/10.4068/cmj.2017.53.2.95 ⒸChonnam Medical Journal, 2017  Chonnam Med J 2017;53:95-102Structure-Inherent Targeting of Near-Infrared Fluorophores for  Image-Guided Surgery Danbi Jo and Hoon Hyun * Department of Biomedical Sciences, Chonnam Nati onal University Medical School, Gwangju, Korea Although various clinical imaging modalities have been developed to visualize internal  body structures and detect abnormal tissues prior to surgical procedures, most medical  imaging modalities do not provide disease-spec ific images in real-time.",Non-OADS,/arxiv_data1/oa_pdf/20/6f/cmj-53-95.PMC5457957.pdf
"Key Words:  Fluorescent Dyes; Fluorescence; Optical Imaging; Surgery This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/4.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: Received December 9, 2016 Revised January 6, 2017 Accepted January 10, 2017 Corresponding Author: Hoon Hyun Department of Biomedical Sciences, Chonnam National University Medical  School, 160 Baekseo-ro, Gwangju  61469, Korea Tel: +82-61-379-2652 Fax: +82-61-379-8455 E-mail: hhyun@jnu.ac.kr INTRODUCTION The primary and most successf ul approach for the treat- ment of cancer is still surgery, even though radiotherapy and chemotherapy techniques are widely used.",Non-OADS,/arxiv_data1/oa_pdf/20/6f/cmj-53-95.PMC5457957.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1016/s0091- 6749(98)70125-3.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1016/s0091-6749 (98)70126-5.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1016/s0091-6749 (00)90198-2.,OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1097/ 00006454-200005000-00034.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1017/s0022215108003459.8.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1001/ archopht.122.9.1390.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1067/mhn.,Non-OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/e5/rjx099.PMC5457963.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/e3/rjx104.PMC5457964.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/a2/rjx102.PMC5457965.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/e1/bmjqir.u220636.w7996.PMC5457966.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/bmjqir.u218901.w5195.PMC5457967.pdf
http://www.niagarahealth.on.ca/ (accessed 1 March 2015).7.,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/bmjqir.u218901.w5195.PMC5457967.pdf
http://www.who.int/patientsafety/ implementation/checklists/trauma/en/ (accessed 1 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/bmjqir.u218901.w5195.PMC5457967.pdf
https://med.uth.edu/chqs/ surveys/safety-attitudes-and-safety-climate-questionnaire/ (accessed1 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/3c/bmjqir.u218901.w5195.PMC5457967.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/bc/bmjqir.u216281.w6691.PMC5457968.pdf
US Code of Federal Regulations- State Operations Manual Appendix A. CMS; 2013[cited 2014 11/21]; §482.52 (c) (5) A-0952: Available from: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/ downloads/som107ap_a_hospitals.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/bc/bmjqir.u216281.w6691.PMC5457968.pdf
"Philadelphia, PA: The ABIM Foundation;2016 [cited 2016 5/21/16]; Available from: http://www.choosingwisely.org/clinician-lists/#keyword=preoperative.",Non-OADS,/arxiv_data1/oa_pdf/b6/bc/bmjqir.u216281.w6691.PMC5457968.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCE 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/dc/bmjqir.u217231.w6746.PMC5457969.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/78/8b/bmjqir.u212185.w4870.PMC5457970.pdf
Available: http://systems.hscic.gov.uk/eps/dispensing.,Non-OADS,/arxiv_data1/oa_pdf/78/8b/bmjqir.u212185.w4870.PMC5457970.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/4d/bmjqir.u211657.w6106.PMC5457971.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/21/1b/bmjqir.u212202.w4875.PMC5457972.pdf
February 2013. http://www.institute.nhs.uk/commissioning/pct_portal/cquin.html 3.,Non-OADS,/arxiv_data1/oa_pdf/21/1b/bmjqir.u212202.w4875.PMC5457972.pdf
08 December 2008. http://webarchive.nationalarchives.gov.uk/20121102152529/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_091435.pdf 4.,OADS,/arxiv_data1/oa_pdf/21/1b/bmjqir.u212202.w4875.PMC5457972.pdf
2016. http://www.royalsurrey.nhs.uk/about/ 5.,Non-OADS,/arxiv_data1/oa_pdf/21/1b/bmjqir.u212202.w4875.PMC5457972.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/42/bmjqir.u204560.w5376.PMC5457973.pdf
6. https://www.gov.uk/government/publications/bowel-cancer-screening- colonoscopy-quality-assurance.,Non-OADS,/arxiv_data1/oa_pdf/d3/42/bmjqir.u204560.w5376.PMC5457973.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/bmjqir.u219176.w7476.PMC5457974.pdf
"Primer sets were designed using the web-based tool Primer3 (http://bioinfo.ut.ee/primer3/) to amplify two exons containedwithin the deletion in the genes ( NPTN , exon 4, 426 bp andSEMA7A , exon 9, 388 bp) and two intronic regions peripheral to the deletion (chr15q:72.96 Mbp, 509 bp;75.48 Mbp, 417 bp) (Table S1).",OADS,/arxiv_data1/oa_pdf/84/85/CCR3-5-1013.PMC5457985.pdf
The identiﬁed CNVs were systematically compared to CNVs present in the Database of Genomic Variants (DGV)(http://dgv.tcag.ca/dgv/app/home) to assess its frequency in control populations.,OADS,/arxiv_data1/oa_pdf/84/85/CCR3-5-1013.PMC5457985.pdf
"Furthermore, the identiﬁed CNV was compared to CNVs reported to cause known chromosomal imbalancesyndromes that are documented in DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources) GRCh37 (https://decipher.sanger.ac.uk/index).",OADS,/arxiv_data1/oa_pdf/84/85/CCR3-5-1013.PMC5457985.pdf
"HHT1 is caused by mutations in ENG (OMIM 131195 [Online Mendelian Inheritance in Man, http://www.omim.org/entry/131195?",Non-OADS,/arxiv_data1/oa_pdf/92/06/CCR3-5-805.PMC5457996.pdf
"search=eng&highlight=eng]) and HHT2 by mutations in ACVRL1 (OMIM 601284 [Online Mendelian Inheritance in Man, http://www.omim.org/entry/601284?search=acvr l1&highlight=acvrl1]).",Non-OADS,/arxiv_data1/oa_pdf/92/06/CCR3-5-805.PMC5457996.pdf
"A phenotype consisting of HHT and juvenile polyposis syndrome is caused by mutations in the SMAD4 gene (OMIM 600993 [Online Mendelian Inheritance in Man, http://www.omim.org/entry/600993?",Non-OADS,/arxiv_data1/oa_pdf/92/06/CCR3-5-805.PMC5457996.pdf
A hair analysis was performed by Doctor’s Data Labora- tories (http://www.chelationmedicalcenter.com/doctors_data.html).,OADS,/arxiv_data1/oa_pdf/dc/06/CCR3-5-795.PMC5458000.pdf
Available athttp://academic.reed.edu/economics/parker/f11/354/pat/o- ring.pdf (accessed 06 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/dc/06/CCR3-5-795.PMC5458000.pdf
Available at http://bdort.org/ (accessed 12 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/dc/06/CCR3-5-795.PMC5458000.pdf
Available at https://athenaallergy.com/pages/nickel-allergy- and-musical-instruments (accessed 06 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/dc/06/CCR3-5-795.PMC5458000.pdf
Available at http://www.greenfacts.org/en/arsenic/l-2/arse nic-3.htm (accessed 06 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/dc/06/CCR3-5-795.PMC5458000.pdf
More than 5000 variants in the BRCA1 gene have been identiﬁed (BRCA Exchange and ClinVar databases: http:// brcaexchange.org/; https://www.ncbi.nlm.nih.gov/clinvar/?,Non-OADS,/arxiv_data1/oa_pdf/a7/7d/CCR3-5-876.PMC5458035.pdf
"Available at https://www.onkoped ia-guidelines.info/en/onkopedia/guidelines/aplastic-anemia- diagnostics-and-therapy-of-acquired-aplastic-anemia/@@vie w/html/index.html (accessed October 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/e5/5c/CCR3-5-919.PMC5458044.pdf
URL: http://www.eurorad.org/case.,Non-OADS,/arxiv_data1/oa_pdf/14/5f/CCR3-5-863.PMC5458045.pdf
php?id=7733; https://doi.org/DOI: 10.1594/EURORAD/ CASE.7733 10.,Non-OADS,/arxiv_data1/oa_pdf/14/5f/CCR3-5-863.PMC5458045.pdf
"Mutations are distributed throughout the entire coding region and include all different types: missense and nonsense mutations (53%), splice-site muta- tions (20%), deletions (20%), and insertions (7%) [HGMD http://www.hgmd.cf.ac.uk/ac/all.php].",Non-OADS,/arxiv_data1/oa_pdf/49/75/CCR3-5-961.PMC5458048.pdf
The physical examination data at his ten-month fol-low-up showed a large head circumference of 57 cm(45.4 /C61.3 cm is the normal range of the WTO head circumference by age in boys) (http://www.who.int/ childgrowth/standards/en/).,Non-OADS,/arxiv_data1/oa_pdf/49/75/CCR3-5-961.PMC5458048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/b4/main.PMC5458053.pdf
http://dx.doi.org/10.1016/j.eucr.2017.05.005Urology Case Reports 14 (2017) 1 e2,Non-OADS,/arxiv_data1/oa_pdf/f0/b4/main.PMC5458053.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/6c/main.PMC5458054.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.006 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/11/6c/main.PMC5458054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 167 e170,Non-OADS,/arxiv_data1/oa_pdf/11/6c/main.PMC5458054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/72/main.PMC5458055.pdf
http://dx.doi.org/10.1016/j.eucr.2016.12.008Urology Case Reports 13 (2017) 162 e164,Non-OADS,/arxiv_data1/oa_pdf/c9/72/main.PMC5458055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/0c/main.PMC5458056.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.001 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/0c/main.PMC5458056.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 164 e166,Non-OADS,/arxiv_data1/oa_pdf/cb/0c/main.PMC5458056.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.05.007 2049-0801/Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 19 (2017) 29 e32,Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
"Marino, G. Puppini, P. Bartolozzi, Lumbar artery injury following posterior spinal instrumentation for scoliosis, Orthopedics 34 (4) (2011 Apr 11), http://dx.doi.org/10.3928/01477447-20110228-24 .",Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
"62 (11) (2014 Nov) 696 e699, http://dx.doi.org/10.1007/s11748-013-0269-6 .",Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
"(2005) 820 e822, http://dx.doi.org/10.1093/ndt/gfh685 .",Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
"48 (1) (2014) 107e110, http://dx.doi.org/10.4103/0019-5413.125534 .",Non-OADS,/arxiv_data1/oa_pdf/24/49/main.PMC5458057.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cardiorespiratory ﬁtness Metabolic syndromeMeasurementValidation 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/08/main.PMC5458058.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.05.001 2211-3355/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c5/08/main.PMC5458058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/08/main.PMC5458058.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/c5/08/main.PMC5458058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/cd/main.PMC5458059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/cd/main.PMC5458059.pdf
http://dx.doi.org/10.1016/j.eucr.2017.05.002Urology Case Reports 14 (2017) 3 e4,Non-OADS,/arxiv_data1/oa_pdf/b9/cd/main.PMC5458059.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Mi crobiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.04.002,Non-OADS,/arxiv_data1/oa_pdf/ee/83/main.PMC5458062.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Mi crobiology and Infectious Diseases, NMNI ,18,4 7 –49 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ee/83/main.PMC5458062.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Mi crobiology and Infectious Diseases, NMNI ,18,4 7 –49 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ee/83/main.PMC5458062.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Physiologic health risk parameters College studentsHealth behaviorsChronic diseaseHealth promotion 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.05.006 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
http://www.acha-ncha.org/pubs_rpts.html .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
Available at: https://www.cdc.gov/physicalactivity/basics/adults/ .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
https://nces.ed.gov/programs/digest/d13/tables/dt13_302.,OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
http://nces.ed.gov/programs/coe/indicator_cha.asp .,OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
https://www.cdc.gov/nchs/nhanes/ .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
"http://support.sas.com/software/93/ (Accessed July 19, 2016).",OADS,/arxiv_data1/oa_pdf/cf/48/main.PMC5458063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.04.004,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.2967/jnumed.114.143842 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Biother Radiopharm 29,1 2 –17.http://dx.doi.org/10.1089/ cbr.2013.1531 .",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Semin Oncol 27,5 3 –63 [http://www.ncbi.nlm.nih.gov/entrez/query.",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1371/journal.pone.0049829 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Int J Cancer 45,4 5 7 –461 [ http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1968437 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Invest 19,5 5 4 –568 [ http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids= 11458821].",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Res 43, 728 –735 [ http://www.ncbi.nlm.nih.go v/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=6848188 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Res 43, 660–668 [ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=6336658].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/ 10.1089/108497804323071904 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1089/cbr.2008.0493 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.2967/ jnumed.109.071290 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1016/j.radonc.2013.12.001 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1021/mp4005047 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/1078- 0432.CCR-08-0256 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1371/journal.pone.0018198 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/ 10.1158/1078-0432.CCR-09-2495 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"(89)Zr as a PET surrogate radioisotope forscouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.J Nucl Med 46, 1898 –1906 [ http://www.ncbi.nlm.nih.gov/pubmed/16269605 ].",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/ 1535-7163.MCT-13-0108 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/ 10.1634/theoncologist.2008-0012 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1111/ j.1476-5381.2009.00327.x.,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.2967/jnumed.111.094169 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.4161/mabs.2.5.13054 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Synthesis, characterization, and evaluation of a novel bifunctionalchelating agent for the lead isotopes 203Pb and212Pb.Nucl Med Biol 27,9 3–100 [http://www.ncbi.nlm.nih.gov/pubmed/10755652 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1089/ cbr.2005.20.557 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Nucl Med Biol 26, 977 –982 [ http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1089/cbr.2012.1423 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1002/cncr.24793 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-06-2300 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.Biochem Biophys Res Commun 80,8 4 9 –857 [ http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=637870 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Nucl Med Biol 29, 599 –606 [ http://www.ncbi.nlm.nih.gov/pubmed/12088731 ].",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/ 1078-0432.CCR-04-1226 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
Am J Clin Oncol .http://dx.doi.org/10.1097/ COC.0000000000000353 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.3390/ph8030416 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1016/ j.nucmedbio.2016.04.001 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"J Nucl Med 42, 1538 –1544 [http://www.ncbi.nlm.nih.gov/entre z/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=11585870].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodi es and antibody fragments in vivo .Cancer Res 55, 5714s –5720s [ http://www.ncbi.nlm.nih.gov/entrez/query.",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Health Phys 85,3 1–35 [https://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1038/ sj.onc.1206900 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Res 63, 324–328 [ https://www.ncbi.nlm.nih.gov/pubmed/12543783 ].",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/ 1078-0432.CCR-07-0065 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1200/JCO.2007.11.7812 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/1535-7163.MCT-10-0444 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Nat Biotechnol 25, 1134 –1143 [ http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Clin Cancer Res 6, 3327 –3333 [ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=10955820 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Clin Cancer Res 7, 3222 –3228 [ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=11595718 ].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1158/1535-7163.MCT-11-0671 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1038/bjc.2013.189 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Int J Radiat Oncol Biol Phys 85, 1119– 1126. http://dx.doi.org/10.1016/j.ijrobp.2012.09.015 .",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1371/journal.pone.0108511 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1371/journal.pone.0159904 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
Int J Mol Sci 17.http://dx.doi.org/10.3390/ijms17050736 .,OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
http://dx.doi.org/10.1002/cam4.132 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Cancer Res 45, 833– 840 [http://www.ncbi.nlm.nih.gov/entre z/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids=3881173].",OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
EJNMMI Res 1.http://dx.doi.org/10.1186/2191-219X-1-1 .,Non-OADS,/arxiv_data1/oa_pdf/e0/3e/main.PMC5458064.pdf
"Recently, proof-of-concept studies reported thefeasibility of exon skipping, trans -splicing, RNAi, or gene replacement Received 22 November 2016; accepted 11 May 2017; http://dx.doi.org/10.1016/j.omtn.2017.05.008 .",OADS,/arxiv_data1/oa_pdf/44/f8/main.PMC5458066.pdf
475 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/f8/main.PMC5458066.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.omtn.,OADS,/arxiv_data1/oa_pdf/44/f8/main.PMC5458066.pdf
"We also want to thankOliver Keminer for his help and technical assistance with the OperaHigh-Content Screening System and the Columbus Image Data Man-agement and Analysis System (Fraunhofer IME Screening-Port).Finally, we would like to thank Suellen Lopes Oliveira for graphicdesign ( http://www.suelopes.com ) and visualization.",Non-OADS,/arxiv_data1/oa_pdf/44/f8/main.PMC5458066.pdf
"Univerisdad Autonoma de Madrid, Spain bBellvitge Biomedical Research Institute (IDIBELL) and University of Barcelona (UB), L ’Hospitalet, Barcelona, Spain http://dx.doi.org/10.1016/j.redox.2017.05.007 Received 5 May 2017; Accepted 8 May 2017⁎Corresponding author at: Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kardiologie/Kardiologie 1, Langenbeckstr.",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
In order to disseminate the collected knowledge to a broader audience of non-expert scientists and the public we also opened a EU-ROS YouTube channel ( https://www.youtube.,Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
Cluster analysis was performed using Genesis software ( https://genome.tugraz.at/genesisclient/genesisclient_description.shtml ) as described in Mengozzi et al.,OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"A di ﬀerent SODm, Mangafodipir, was studied as a protector against oxaliplatin neurotoxicity and FOLFOX6 side e ﬀects, while its analog calmangafodipir is being studied in combination with FOLFOX6 in advanced metastatic colorectal cancer [ http://clinicaltrials.gov ,a so f 22nd June 2016].",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
〈https://www.journals.elsevier.com/redox-biology/virtual-collections/ emerging-conceptsin-redox-biology-and-oxidative-stress-virt 〉.,Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
〈http://online.liebertpub.com/toc/ars/23/14 〉.,Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"(2016), http://dx.doi.org/10.1111/bph.13517 .",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"(2016), http://dx.doi.org/10.1111/bph.13428 .",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"(2015), http://dx.doi.org/10.1111/bph.13403 .",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"(2016),http://dx.doi.org/10.1111/bph.13544 .",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
〈http://www.bbc.,Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"(2016), http://dx.doi.org/10.1111/bph.",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"Redox Signal., 2016. http://dx.doi.org/10.1089/ars.",OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"Pharmacol., 2016. http://dx.doi.org/10.1111/ bph.13426 .",Non-OADS,/arxiv_data1/oa_pdf/2c/9e/main.PMC5458069.pdf
"National programs based on cytology testing have yielded > 80% drop in http://dx.doi.org/10.1016/j.gore.2017.05.005 Received 10 March 2017; Received in revised form 10 May 2017; Accepted 19 May 2017⁎Corresponding author at: University of Minnesota, Department of Obstetrics, Gynecology and Women's Health, 420 Delaware St SE, MMC 395, Minneapolis, MN 55455, United States.",Non-OADS,/arxiv_data1/oa_pdf/20/3c/main.PMC5458073.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/3c/main.PMC5458073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.011 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
"20 (1) (2007) 115 e132, http://dx.doi.org/10.1128/cmr.00027-06 .",Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
"12 (5) (2016 Nov) 3256 e3260, http://dx.doi.org/10.3892/ etm.2016.3774 .",Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
"45 (7) (2007) 807 e825, http://dx.doi.org/10.1086/521259 .",Non-OADS,/arxiv_data1/oa_pdf/de/b0/main.PMC5458075.pdf
"The goal of this study is to evaluate whether including an assessment of grammar comprehension and production in clinical language functional magnetic resonance imaging (fMRI) can provide us with additional areas of activation in the language network and to compare these results with a http://dx.doi.org/10.1016/j.nicl.2017.05.021 Received 8 October 2016; Received in revised form 3 May 2017; Accepted 25 May 2017⁎Corresponding author at: Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, 760 Westwood Plaza, Ste B8-169, CA 90095, USA.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.07.018 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"01, 23 –36.http://dx.doi.org/10.4236/jbbs.2011.12005 .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/S0093-934X (02)00553-9 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.0618-13.2013 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1136/jnnp-2013-305659 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"Neurosurgery 60, 67 –82.http://dx.doi.org/10.1227/01.NEU.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"J. Neurolinguistics 28, 63 –80.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1093/cercor/bhp055 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1007/ s11065-007-9026-x .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1111/cogs.12445 .M.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2012.12.037 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"140, 35 –48.http://dx.doi.org/10.1016/j.bandl.",OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.3171/ 2014.12.JNS14629 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.cognition.2003.11.002 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/B978-012692535-7/50095-1 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.jneuroling.2007.03.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.3171/2013.6.JNS122470 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1152/physrev.00006.2011 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1007/s00426- 011-0357-0 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"30, 71 –90.http://dx.doi.org/10.1023/A:1005256224207 .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"J. Neurolinguistics 23, 44 –65.http://dx.doi.org/10.1016/j.jneuroling.2009.",OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1212/01.WNL.0000141852.65175.A7 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/0028- 3932(71)90022-4 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1227/01.NEU.0000360392.15450.C9 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1093/cercor/bhr386 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.conb.2006.03.007 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.tics.2005.07.004 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2010.06.032 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1162/jocn_a_00044 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.cortex.2016.04.019 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"1146, 2 –22.http://dx.doi.org/10.1016/j.brainres.2006.08.111 .",OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1111/epi.12068 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"The role of Broca's area in regular past-tense morphology: an event-related potential study.Neuropsychologia 49, 1 –18.http://dx.doi.org/10.1016/j.neuropsychologia.2010.10.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1002/hbm.22189 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"Neurology 36,505–510 (http://www.ncbi.nlm.nih.gov/pubmed/3960324) .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1002/hbm.22096 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.cortex.2011.09.009 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1126/science.472757 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1002/ hbm.20287 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.07.057 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.01.005 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.06.036 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.acra.2011.12.017 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"120, 83 –95.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2014.09.014 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3446-14.2015 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1007/s11065-014- 9258-5 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.09.035 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"Neurolinguistics 27, 1 –17.http://dx.doi.org/10.1016/j.jneuroling.2013.06.003 .",OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/S0304-3940(03)00561-5 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"98, 57 –65.http://dx.doi.org/10.1016/j.bandl.2006.",OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1162/jocn_a_00118 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/S0911-6044(01)00039-2 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"5, 1 –20.http://dx.doi.org/10.3389/fnsys.2011.00001 .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"4, 1 –19.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1038/ 35094573 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"2012, 1 –8.http://dx.doi.org/10.1155/2012/198183 .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1111/j.1528-1167.2009.02192.x .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/ j.neuron.2011.09.014 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1016/j.bandl.2012.04.005 .,OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.3171/2015.4.JNS141962 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
"4, 181. http://dx.doi.org/10.3389/fpsyg.2013.00181 .",Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0485-12.2012 .,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/main.PMC5458087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/2d/main.PMC5458091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/2d/main.PMC5458091.pdf
http://dx.doi.org/10.1016/j.eucr.2017.05.001Urology Case Reports 14 (2017) 5 e7,Non-OADS,/arxiv_data1/oa_pdf/ad/2d/main.PMC5458091.pdf
"Mitochondria are good candidates for playing a key role in this process (reviewed in [3–5]), because they are essential components of almost all eukaryotic cells, controlling several important cellularfunctions, such as adenosine triphosphate (ATP) synthesis [6], regula- tion of Ca ++homeostasis (reviewed in [7,8] ), generation of reactive oxygen species (ROS) (reviewed in [9–14]), activation of apoptosis http://dx.doi.org/10.1016/j.redox.2017.05.017 Received 5 April 2017; Received in revised form 24 May 2017; Accepted 24 May 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Intensive Care 1 (2011) 41, http://dx.doi.org/10.1186/2110-5820- 1-41.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Schumacker, H. Gomez, et al., Mitochondrial function in sepsis, Shock 45 (2016) 271 –281, http://dx.doi.org/10.1097/SHK.0000000000000463 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Nicholls, Mitochondria and calcium signaling, Cell Calcium 38 (2005) 311 –317, http://dx.doi.org/10.1016/j.ceca.2005.06.011 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"13 (2012) 566 –578, http://dx.doi.org/10.1038/nrm3412 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"292 (2007) H2023 –H2031, http://dx.doi.org/10.1152/ajpheart.01283.2006 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"51 (2011) 1289 –1301, http://dx.doi.org/10.1016/j.freeradbiomed.",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"287 (2012) 4434 –4440, http://dx.doi.org/10.1074/jbc.R111.271999 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"48 (2012) 158 –167, http://dx.doi.org/10.1016/j.molcel.2012.",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Siegel, Mitochondrial ROS ﬁre up T cell activation, Immunity 38 (2013) 201 –202, http://dx.doi.org/10.1016/j.immuni.2013.02.005 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Kozlov, Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction, Biomolecules 5 (2015)472 –484, http://dx.doi.org/10.3390/biom5020472 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"11 (2010) 621 –632, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care 16 (2012) 235, http://dx.doi.org/10.1186/ cc11381 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"279 (2004) 36803 –36808, http://dx.doi.org/10.1074/jbc.M405297200 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Schwabe, Hepatic in ﬂammation and ﬁbrosis: functional links and key pathways, Hepatology 61 (2015) 1066 –1079, http://dx.doi.org/10.1002/hep.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Welling, Myeloid cells in hepatocellular carcinoma, Hepatology 62 (2015) 1304 –1312, http://dx.doi.org/10.1002/hep.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Moschen, G. Szabo, Interleukin-1 and in ﬂammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis, Hepatology 00 (2016) 1 –39,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"182 (2010) 745 –751, http://dx.doi.org/10.1164/rccm.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"185 (2012) 851 –861, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[25] M. Singer, The role of mitochondrial dysfunction in sepsis-induced multi-organ failure, Virulence 5 (2013) 1 –7,http://dx.doi.org/10.4161/viru.26907 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care Med.41 (2013) 182 –194, http://dx.doi.org/10.1097/CCM.0b013e3182676657 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Ding, W. Gao, Autophagy in the liver, Hepatology 47 (2008) 1773 –1785, http://dx.doi.org/10.1002/hep.22146 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"89 (2009) 549 –561, http://dx.doi.org/ 10.1038/labinvest.2009.8 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"81 (2007) 1 –5,http://dx.doi.org/10.1189/jlb.0306164 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"85 (2007) 435 –445, http://dx.doi.org/10.1038/sj.icb.7100100 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"22 (2009) 240 –273, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Shock 26 (2006) 438 –449, http://dx.doi.org/10.1097/01.shk.0000228172.32587.7a .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"1(2000) 207 –215, http://dx.doi.org/10.1089/109629600750018132 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"35 (2007) 2408 –2416, http://dx.doi.org/10.1097/01.CCM.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"69 (2009) 479 –491, http://dx.doi.org/10.1111/j.1365- 3083.2009.02255.x .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"10 (2009) 369 –377, http://dx.doi.org/10.1089/sur.2009.9935 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"2 (2010) 422 –430, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"93 (2013) 1247 –1288, http://dx.doi.org/ 10.1152/physrev.00037.2012 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"216 (1992) 117 –134, http://dx.doi.org/10.1097/00000658- 199208000-00002 .A.V.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care 10 (2006) R154, http://dx.doi.org/10.1186/cc5086 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"39 (2011)1050 –1055, http://dx.doi.org/10.1097/CCM.0b013e31820eda29 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[49] E. Hao, F. Lang, Y. Chen, H. Zhang, X. Cong, X. Shen, et al., Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor, PLoS One8 (2013), http://dx.doi.org/10.1371/journal.pone.0069452 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"32 (2004) 478 –488, http://dx.doi.org/10.1097/01.CCM.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care 17 (2013) P1,http://dx.doi.org/10.1186/cc11939 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"303 (2012) G1373 –G1383, http://dx.doi.org/10.1152/ajpgi.00056.2012 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"290 (2006)G543 –G549, http://dx.doi.org/10.1152/ajpgi.00331.2005 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"352 (2007) 91 –96,http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Kozlov, M. van Griensven, S. Haindl, I. Kehrer, J.C. Duvigneau, R.T. Hartl, et al., Peritoneal in ﬂammation in pigs is associated with early mitochondrial dysfunction in liver and kidney, In ﬂammation 33 (2010) 295 –305, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"43 (2013) 532 –542, http://dx.doi.org/10.1111/eci.12069 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"166 (2002) 98 –104, http://dx.doi.org/10.1164/rccm.200109-016OC .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[64] D. De Backer, D. Orbegozo Cortes, K. Donadello, J.-L. Vincent, Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock, Virulence 5 (2014) 73 –79,http://dx.doi.org/10.4161/viru.26482 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"32 (2004) 1825 –1831, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Pept.131 (2005) 89 –96,http://dx.doi.org/10.1016/j.regpep.2005.07.001 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Rautou, D.C. Valla, The signi ﬁcance of nonobstructive sinusoidal dilatation of the liver: impaired portal perfusion orinﬂammatory reaction syndrome, Hepatology 62 (2015) 956 –963, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"291 (2008) 714 –720, http://dx.doi.org/10.1002/ar.20646 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"22 (2015) 572 –586, http://dx.doi.org/10.1089/ars.2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"47 (2006) 167 –177, http://dx.doi.org/10.1111/j.1574- 695X.2006.00072.x .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care 19 (2013) 123 –127, http://dx.doi.org/10.1097/ MCC.0b013e32835eba6d .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"4 (2013) 138, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"417 (2009) 183 –193, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"285 (2010) 19699 –19704, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"466 (2000) 130 –134, http://dx.doi.org/10.1016/S0014-5793(99)01773-1 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"234 –235 (2002) 63 –70,http://dx.doi.org/10.1023/A:1015921513720 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Care 14 (2010) R110, http://dx.doi.org/10.1186/cc9059 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"393 (2012) 1485 –1512, http://dx.doi.org/10.1515/hsz- 2012-0198 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"12 (2016)287 –294, http://dx.doi.org/10.2147/TCRM.S97989 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[84] E. Hatano, A. Tanaka, S. Iwata, S. Satoh, T. Kitai, S. Tsunekawa, et al., Induction ofendotoxin tolerance in transgenic mouse liver expressing creatine kinase, Hepatology 24 (1996) 663 –669, http://dx.doi.org/10.1053/jhep.1996.v24.",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Wanders, et al., Hydrogen sul ﬁde donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energeticstatus, PLoS One 8 (2013), http://dx.doi.org/10.1371/journal.pone.0063497 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Zuckerbraun, Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death andhepatic injury from infection/sepsis in mice, Hepatology 53 (2011) 2053– 2062, http://dx.doi.org/10.1002/hep.24324 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"40 (2012) 2841 –2849, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"88 (2008) 70 –77,http://dx.doi.org/10.1038/labinvest.3700691 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[92] S. Crumm, M. Cofan, E. Juskeviciute, J.B. Hoek, Adenine nucleotide changes in the remnant liver: an early signal fro regeneration after partial hepatectomy, Hepatology 48 (2008) 898 –908, http://dx.doi.org/10.1002/hep.22421.ADENINE .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"191 (2000) 1975 –1985, http://dx.doi.org/10.1084/jem.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"1833 (2013) 3448 –3459, http://dx.doi.org/10.1016/j.bbamcr.2013.06.001 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"185 (1997) 1481 –1486, http://dx.doi.org/10.1016/S0378-4274(98)A.V.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"19 (2013) 992 –995, http://dx.doi.org/10.1007/s10156-012-0528-y .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"193 (2015) 795 –801, http://dx.doi.org/10.1016/j.devcel.2010.12.007.Peroxiredoxin .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"121 (2011) 1986 –1999, http://dx.doi.org/10.1172/JCI43839 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Robin, F. Bonnet, B. Fromenty, Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease, Hepatology 58 (2013) 1497 –1507, http://dx.doi.org/10.1002/hep.26226 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"20 (2014) 308 –324, http://dx.doi.org/ 10.1089/ars.2012.4609 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Terracciano, et al., Growth-hormone-induced signal transducer and activatorof transcription 5 signaling causes gigantism, in ﬂammation, and premature death but protects mice from aggressive liver cancer, Hepatology 55 (2012) 941 –952, http://dx.doi.org/10.1002/hep.24765 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Kornfeld, K. Friedbichler, L. Blaas, G. Egger, H. Esterbauer, et al., Impairment of hepatic growth hormone and glucocorticoid receptorsignaling causes steatosis and hepatocellular carcinoma in mice, Hepatology 54 (2011) 1398 –1409, http://dx.doi.org/10.1002/hep.24509 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"302 (2012) R1134 –R1142, http://dx.doi.org/10.1152/ajpregu.00842.2010 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"107 (2010) 106 –116, http://dx.doi.org/10.1161/CIRCRESAHA.109.214601 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"20 (2014) 247 –266, http://dx.doi.org/10.1089/ars.2012.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Woo, H. Erdjument-Bromage, P. Tempst, et al., TLR signalling augments macrophage bactericidal activity through mito- chondrial ROS, Nature 472 (2011) 476 –480, http://dx.doi.org/10.1038/ nature09973 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"208 (2011) 519 –533, http://dx.doi.org/10.1084/jem.20102049 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Hildeman, et al., Mitochondria are required for antigen-speci ﬁc T cell activation through reactive oxygen species signaling, Immunity 38 (2013) 225 –236, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Sauer, M. Kaminski, S. Opp, T. Ruppert, P. Grigaravicius, et al., T cell activation is driven by an ADP-Dependent glucokinase linkingenhanced glycolysis with mitochondrial reactive oxygen species generation, Cell Rep. 2 (2012) 1300 –1315, http://dx.doi.org/10.1016/j.celrep.2012.10.009 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"83 (2005) 336 –343, http://dx.doi.org/10.1111/j.1440-1711.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"40 (2006) 369 –378, http://dx.doi.org/10.1080/ 10715760500539139 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Min, M. Aghajan, N. Kaplowitz, JNK mediates mouse liver injury through a novel Sab (SH3BP5) dependent pathway leading to inactivation of intramitochondrial Src, Hepatology (2016), http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Cai, Z. Jiang, H. Wang, Q. Li, et al., Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression inhuman obstructive cholestasis is mediated through tumor necrosis factor alpha and C-Jun NH2-terminal kinase/stress-activated protein kinase-signali, Hepatology 55 (2012) 1485 –1494, http://dx.doi.org/10.1002/hep.24801 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Fu, et al., Defects, mitochondrial dysfunction, ROS overproduction, and a rapid mousehematopoietic cell –targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging –like phenotype, Blood 120 (2012) 2589 –2599, http://dx.doi.org/10.1182/blood- 2012-01-404004 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"105 (2010) 771 –785, http://dx.doi.org/ 10.1007/s00395-010-0124-1 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Acta 2008 (1782) 280 –285, http://dx.doi.org/ 10.1016/j.bbadis.2008.01.007 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[128] T. Decker, P. Kovarik, Serine phosphorylation of STATs, Oncogene 19 (2000) 2628 –2637, http://dx.doi.org/10.1038/sj.onc.1203481 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Sepuri, Q. Zhang, T. Koeck, et al., Function of mitochondrial Stat3 in cellular respiration, Science 323 (2009)793 –798, http://dx.doi.org/10.1126/science.1164551 (80-).",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Brenner, M. Karin, A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches, Gastroenterology 143 (2012) 307 –320, http://dx.doi.org/10.1053/j.gastro.2012.06.004.A .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"(2004), http://dx.doi.org/10.1096/ fj.03-0771fje .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"192 (2000) 1001 –1014, http://dx.doi.org/10.1084/jem.192.7.1001 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Tereshkova, P.M. Chumakov, Prooxidant properties of p66shc are mediated by mitochondria in human cells,PLoS One 9 (2014) e86521, http://dx.doi.org/10.1371/journal.pone.0086521 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"356 (1994) 295 –298, http://dx.doi.org/10.1016/0014- 5793(94)01290-3 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"1807 (2011) 491 –502, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"108 (2011) 1017 –1036, http://dx.doi.org/10.1161/ CIRCRESAHA.110.225730 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"[141] P. Bernardi, V. Giorgio, EBEC 2012 –an energetic time in Freiburg, EMBO Rep. 14 (2013) 7 –9,http://dx.doi.org/10.1038/embor.2012.200 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"Jones, et al., The ADP/ATP translocator is not essential for the mitochondrial permeability transi-tion pore, Nature 427 (2004) 461 –465, http://dx.doi.org/10.1038/ nature02318.1 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"1365 (1998) 385 –392, http://dx.doi.org/10.1016/S0005-2728(98)00090-5 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"95 (2015) 1111 –1155, http://dx.doi.org/10.1152/physrev.00001.2015 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"595 (2016) 68 –71,http://dx.doi.org/10.1016/j.abb.2015.11.028 .",OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"285 (2010) 3806 –3814, http://dx.doi.org/ 10.1074/jbc.M109.059782 .",Non-OADS,/arxiv_data1/oa_pdf/6d/eb/main.PMC5458092.pdf
"http://dx.doi.org/10.1016/j.ejro.2017.05.003 Received 28 March 2017; Received in revised form 22 May 2017; Accepted 22 May 2017⁎Corresponding author at: Department of Radiology, Level 1, Lambeth Wing, St Thomas ’Hospital, Westminster Bridge Road, London, SE1 7EH, United Kingdom.European Journal of Radiology Open 4 (2017) 69– 74 Available online 01 June 2017 2352-0477/ © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6f/81/main.PMC5458094.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/81/main.PMC5458094.pdf
Gaseous HCl was gener- ated by dropping 100 mL of sulfuric acid (12 N) over slurry of sodium http://dx.doi.org/10.1016/j.redox.2017.05.014 Received 24 March 2017; Received in revised form 15 May 2017; Accepted 23 May 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/1d/00/main.PMC5458096.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/00/main.PMC5458096.pdf
September 2015. http://apps.who.int/iris/ bitstream/10665/186275/1/9789241509565_   eng.pdf (accessed 08 March 2016).,OADS,/arxiv_data1/oa_pdf/be/2f/CD003650.PMC5458097.pdf
"Number 6, September 2006. https://www.unicef.org/ publications/files/Progress_   for_   Children_   No._  5_  -_  English.pdf (accessed 11 September 2010).",Non-OADS,/arxiv_data1/oa_pdf/fa/fe/CD008892.PMC5458098.pdf
2003. http://apps.who.int/iris/ bitstream/10665/68122/1/WHO_   V-B_  03.07_   eng.pdf (accessed 11 September 2010).,OADS,/arxiv_data1/oa_pdf/fa/fe/CD008892.PMC5458098.pdf
3. http://www.who.int/tdr/publications/ documents/diagnostics-evaluation-3.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/fa/fe/CD008892.PMC5458098.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/9e/ITX-9-39.PMC5458104.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/e9/ITX-9-55.PMC5458105.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ITX-9-66.PMC5458106.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/a3/ITX-9-78.PMC5458107.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu - tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,  distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/0f/ITX-9-1.PMC5458108.pdf
Available at http://www.vsep.com/company/articles/2.html .,Non-OADS,/arxiv_data1/oa_pdf/6d/0f/ITX-9-1.PMC5458108.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu - tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,  distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/0f/ITX-9-12.PMC5458109.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/97/ITX-9-17.PMC5458110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/45/ITX-9-25.PMC5458111.pdf
Available at: http://ntp.niehs.nih.gov/iccvam/docs/acu-tetox_docs/BRD_TMER/BRDvol1_Nov2006.pdf Accessed on 16 April 2014.,Non-OADS,/arxiv_data1/oa_pdf/13/45/ITX-9-25.PMC5458111.pdf
Available at: http://www.epa.gov/hpv/pubs/general/nih2001a.pdf Accessed on 16 April 2014.,OADS,/arxiv_data1/oa_pdf/13/45/ITX-9-25.PMC5458111.pdf
Available at: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-33062010000200023.,Non-OADS,/arxiv_data1/oa_pdf/13/45/ITX-9-25.PMC5458111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribu- tion License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/ec/ITX-9-30.PMC5458112.pdf
"http://www.merckmanuals.com Bull LB, Culvenor CC, Dick AJ.",Non-OADS,/arxiv_data1/oa_pdf/c0/ec/ITX-9-30.PMC5458112.pdf
"26 Based on the ability of CSWKYWFGEC to undergo ASC internaliza-tion, 26by analogy with our previous studies,27we designed a bimodal peptide D-WAT composed of CSWKYWFGEC and of the Received 27 January 2017; accepted 10 May 2017; http://dx.doi.org/10.1016/j.omto.2017.05.003 .",OADS,/arxiv_data1/oa_pdf/5d/8f/main.PMC5458115.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/8f/main.PMC5458115.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁveﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.omto.2017.05.003 .,Non-OADS,/arxiv_data1/oa_pdf/5d/8f/main.PMC5458115.pdf
Published by Elsevier Ireland Ltd. Th is is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Rheumatic heart diseaseSequelae Complications 1.,Non-OADS,/arxiv_data1/oa_pdf/07/f3/main.PMC5458122.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.007 2352-9067/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/07/f3/main.PMC5458122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/f3/main.PMC5458122.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/07/f3/main.PMC5458122.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.006 2352-9067/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/6e/main.PMC5458123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/6e/main.PMC5458123.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/b4/6e/main.PMC5458123.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.005 2352-9067/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.co m/ijc-heart-and-vasculature,Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"Young 26 (02) (2015) 230 –236, http://dx.doi.org/10.1017/s1047951115001626 .",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"Sadiq, Myocardial infarction with normal coronaries: an unexpected ﬁnding in a 13-year-old girl with systemic lupus erythematosus, Lupus 22 (14) (2013) 1518 –1522, http://dx.doi.org/10.1177/ 0961203313503913 .",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"Colvin, N. Brooks, Myocardial infarction with normal coronary arter- ies and factor XII de ﬁciency, Heart 53 (2) (1985) 230 –234, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"28 (3) (2016) 180 –184, http://dx.doi.org/10.1016/j.jsha.2015.11.",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"169 (1) (2009) 27 –29,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"24 (2) (2003) 216 –229, http://dx.doi.org/10.1161/01.atv.",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
"[9] Z. Ye, E.H. Liu, J.P. Higgins, et al., Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls, Lancet 367 (9511) (2006) 651 –658, http://dx.doi.org/10.1016/s0140-6736(06)68263-9 .",Non-OADS,/arxiv_data1/oa_pdf/68/29/main.PMC5458124.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: LactateNo-re ﬂow phenomenon Postconditioning Reperfusion arrhythmiaST-segment elevation myocardial infarctionStunning 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/d0/main.PMC5458128.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.002 2352-9067/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/0d/d0/main.PMC5458128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/d0/main.PMC5458128.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/0d/d0/main.PMC5458128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: FibrinolyticPercutaneous coronary interventionST-segment elevation myocardial infarctionNon PCI-capable settings Coronary artery disease 1.,Non-OADS,/arxiv_data1/oa_pdf/90/34/main.PMC5458129.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.003 2352-9067/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/90/34/main.PMC5458129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/34/main.PMC5458129.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/90/34/main.PMC5458129.pdf
"2014 September 2014. https://sites.google.com/site/riskofbiastool/ , 2014 (accessed 16.07.31 ).",Non-OADS,/arxiv_data1/oa_pdf/90/34/main.PMC5458129.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: CYP2C19Genetic polymorphism Microvascular angina Epoxyeicosatrienoic acidChronic in ﬂammation 1.,Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
http://dx.doi.org/10.1016/j.ijcha.2017.03.001 2352-9067/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.,Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
"(2013) eht513, http://dx.doi.org/10.1093/eurheartj/eht513 .",Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
"( 2 0 1 6 ) , http://dx.doi.org/10.1152/ajpheart.00473.",Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
http://dx.doi.org/10.1161/ JAHA.115.002387 .,Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
"5( 7 )( 2 0 0 9 )7 5 7 –771, http://dx.doi.org/10.1517/17425250902932923 .",Non-OADS,/arxiv_data1/oa_pdf/01/74/main.PMC5458130.pdf
This is an open a ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Smoking cessation Homeless person Vulnerable populationWeight gain 1.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.05.012 2211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1136/ bmj.e4439 .,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1016/S0306-4603(98)00014-8 .,OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1016/j.addbeh.2013.11.017 .,OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.1016/j.addbeh.2004.02.034 .,OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.2307/2136404 .,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.5993/AJHB.33.6.7 .,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
http://dx.doi.org/10.5993/AJHB.37.6.2 .,Non-OADS,/arxiv_data1/oa_pdf/55/6b/main.PMC5458131.pdf
